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Footnote: To prevent the stories from being traceable to existing people, the narratives 
presented in the chapters of this dissertation are fictitious but based on all the experi-
ences patients, their families and friends, and professionals have shared with me, within 
and outside my consulting room.
It’s warm here, inside; no wonder, with me wearing a cardigan and jeans, but I just can’t bear to see the scars on my arms and legs. So much shame, for what I’m doing to myself to just not feel the other pain. Right, focus on the manuscript, these wonderful children’s 
stories about a world so indescribably bigger than mine. My crayon 
practically does the sketching for me, bringing the words to life, an-
other world. Being an illustrator keeps me going in this world, no, my 
dreamt-up world, but anyway, it’s something at least. The other world, 
the ‘real’ world, no longer exists for me. Too fearful to be a part of it, 
too scared that everything will happen all over again. The sexual abuse, 
the physical abuse. The memories keep forcing themselves into my 
mind, keep playing like a film clip in repeat mode. Without me being 
able to find the stop button. Quietly playing in my room, seeing my 
uncle coming closer… No, stop, keep focusing on the illustration. It’s 
almost as if the images keep getting worse, keep taking up more and 
more space in my head, my life. While I’m taking up less and less room 
in the outside world. How I would love to go out again, though. When 
was the last parent-teacher meeting I attended? Have tried treat-
ment, have tried to create more room in my head, to learn to manage 
my memories of the abuse. But why do they keep telling me that my 
thoughts of killing myself and my self-harming behaviour need to be 
tackled first. How?! Have given it a try, twice, treatment, having insist-
ed on it myself, but terminating twice as well, on the therapist’s advice, 
because I hadn’t stopped cutting myself in-between sessions. The fear 
of treatment is becoming just as insurmountable as my memories. It’s 
too dangerous. Better to stay inside. And draw. Illustrating these sto-
ries that I so love to read to my three little darlings, giving them little 
illicit sneak previews. The only times I feel truly connected. And all 
these pages filling up with my pictures… With hardly anyone knowing 
about the void, this non-world this successful illustrator is living in.
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Chapter 1
General 
introduction
This chapter is partly based on: Hendriks, L., de Kleine, R. A., Hendriks, G. J., & van 
Minnen, A. (2016). Intensive cognitive-behavioral treatment of PTSD: An over-
view of massed outpatient treatment programs. In C. R. Martin, V. R. Preedy and 
V. B. Patel (Eds.), Comprehensive guide to post-traumatic stress disorder (pp. 
1-16). Cham, Switzerland: Springer International.
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Posttraumatic stress disorder (PTSD)
After experiencing or witnessing a life-threatening event such as actual or 
threatened death, serious injury, or sexual violence, it is normal for people to 
have upsetting memories, feel tense, or have trouble falling asleep. Most will 
start to feel better after some weeks. However, in some, event-related symptoms 
persist longer and some will go on to develop a posttraumatic stress disorder 
(PTSD). The lifetime prevalence of PTSD is estimated at 7-10%  
(de Vries & Olff, 2009; Kessler, Petukhova, Sampson, Zaslavsky, & Wittchen, 
2012; Kilpatrick et al., 2013). Individuals suffering from PTSD will have  
recurrent, involuntary, and intrusive recollections of the traumatic event, avoid 
situations that may remind them of the traumatic event(s), while they will 
develop and maintain more negative beliefs and feelings than healthy peers and 
experience hyperarousal symptoms (DSM-5 classification, APA, 2013), which, 
together, makes PTSD a severe disorder. Besides these debilitating symptoms, 
PTSD is associated with an increased risk of other psychological disorders,  
a higher risk of (attempted) suicide compared to people without PTSD, raised 
societal costs, and an elevated risk of adverse life-course consequences such as 
failure at school, marital instability, and unemployment (Kessler, 2000). The 
high prevalence in combination with the high burden to both the individual and 
society, stress the importance of effective treatment. This dissertation focuses 
on ways to improve the delivery of existing PTSD treatment programmes, test-
ing and evaluating the outcomes of a massed format.
Current trauma-focused treatment (TFT) programmes
Trauma-focused treatments (TFTs) for PTSD comprise individually deliv-
ered psychotherapeutic interventions that utilise trauma-focused cognitive 
and/or behavioural techniques or eye movement desensitisation and repro-
cessing (EMDR; Watts et al., 2013). The empirical support for the effective-
ness of TFT programmes in ameliorating PTSD and related psychopathology 
is strong (Cusack et al., 2016) and they have been shown to be more effec-
tive than nontrauma-focused psychotherapies and psychotropic medication 
(Lee et al., 2016). As a result, TFT is recommended worldwide in the official 
PTSD treatment guidelines (see e.g. International Society for Traumatic Stress 
Studies, ISTSS, Foa, Keane, Friedman, & Cohen, 2009; National Institute for 
Health and Care Excellence Guidelines on PTSD, NICE, 2018; van Balkom et 
al., 2013). TFT programmes typically last several months with sessions mostly 
being scheduled weekly.
Why do we need intensive TFT?
Notwithstanding their status as first-line treatments for PTSD and their proven 
effectiveness, not all PTSD patients respond (sufficiently) to the existing TFT 
programmes. Furthermore, current approaches leave room for improvement 
with respect to dropout and accessibility. There is some evidence to suggest 
that more condensed programmes in which the treatment sessions are deliv-
ered within the space of a few weeks are effective as well, rendering them good 
candidates for a next-step solution for those PTSD patients not responding 
to present formats. Additionally, due to their relative briefness these massed 
protocols may reduce dropout and make effective treatment more accessible to 
more patients.
Response
Approximately 40% of PTSD patients do not respond (Loerinc et al., 2015) 
to weekly dosed approaches. To explain this, we need to pinpoint indicators 
of remission, such as trauma characteristics, comorbidity, and demograph-
ics, but, thus far, few stable person-specific predictors of treatment outcome 
have been identified (see e.g. Ehlers et al., 2013; Ehring et al., 2014; Powers, 
Halpern, Ferenschak, Gillihan, & Foa, 2010; van Minnen, Arntz, & Keijsers, 
2002; van Minnen, Harned, Zoellner, & Mills, 2012). However, we do 
know from some studies that particular treatment-delivery factors influence 
outcome. For instance, treatment outcome was found to be negatively affected 
by irregular session attendance, which suggests that these patients received too 
low a dose of the treatment for it to take (optimal) effect (Tarrier, Sommerfield, 
Pilgrim, Faragher, 2000). And although in their meta-analysis Powers and 
colleagues (2010) found the number of sessions in general not to be related to 
treatment outcome, they did observe that the addition of a number of sessions 
indeed enhanced outcome in those patients that were not remitted after the 
standard dose of treatment (Foa et al., 2005). Thus, while pre-treatment 
patient characteristics may not consistently predict TFT outcome, an increased 
treatment dosage may potentially improve outcome. This comports well with 
findings of dose-response relationships of treatments for anxiety disorders as 
well as PTSD showing that higher treatment doses predicted more symptom 
reduction and improved functioning even after symptom severity and patient 
characteristics had been taken into account (Glenn et al., 2013; Olatunji et al., 
2014). A recent study evaluating cognitive processing therapy and prolonged 
exposure showed that higher session frequencies were associated with signifi-
cantly greater PTSD symptom decrease, even when controlling for the amount 
of sessions (Gutner, Suvak, Sloan, & Resick, 2016). Equally, a meta-analy-
sis examining the effects of psychotherapy for depression in relation to the 
number of treatment sessions showed a strong association between therapy 
intensity (more sessions per week) and better treatment gains (Cuijpers, Huib-
ers, Ebert, Koole, & Andersson, 2013). Findings of animal studies about fear 
extinction learning (i.e. the development of new associations with the stimu-
lus that inhibits the manifestation of the original fear memory - the proposed 
working mechanism of exposure-based TFT programmes) also support 
the relevance of intensive treatment schedules. In reviewing animal studies, 
Fitzgerald, Seemann, and Maren (2014) suggested that massed fear extinction 
training might enhance outcome but that several other factors are relevant too, 
such as the optimal number and spacing of sessions. Although general find-
ings of experimental animal fear extinction research are mixed, some studies 
indeed show that massed training results in better outcomes (e.g. Cain, Blouin, 
General introductionChapter 1
1716
& Barad, 2003), suggesting that condensed TFT formats may provide oppor-
tunities for patients not or only partially responding to regular-dosed TFT 
as the briefer, intensive formats permit higher dosing of exposure techniques 
aimed at extinction learning.
Dropout
Another issue concerning weekly based TFT is that large groups of patients 
drop out of treatment prematurely. A meta-analysis of PTSD treatments, 
including TFT as well as supportive counselling, found that, on average, 18% 
of patients drops out (Imel, Laska, Jakupcak, & Simpson, 2013). With drop-
out rates running up to 52%, the percentage varied significantly across studies 
and even though some clinicians propose that especially TFTs cause drop-
out because of the strong emotions they evoke, the meta-analysis found no 
evidence that this particular approach predicts increased dropout. On the 
contrary, the observed variability in dropout was driven by methodological 
differences among studies, one of which was the number of sessions delivered: 
the extended treatments that provided more (weekly) sessions were more likely 
to have higher numbers of patients discontinuing the programme prematurely. 
This suggests that dropout may be prevented by a more compact treatment 
delivery. Similar to previous studies on treatment outcome, the studies on drop-
out show that it is not just the number of sessions but the session frequency that 
can be linked to (more) positive treatment effects.
Accessibility
Besides remission and dropout rates warranting optimisation, many PTSD 
patients do not even receive TFT to begin with (Cahill, Foa, Hembree, 
Marshall, & Nacash, 2006; Ehlers, Gene-Cos, & Perrin, 2009), with eligi-
ble patients missing out due to the fact that clinicians tend not to consider 
TFT programmes for them (Becker, Zayfert, & Anderson, 2004). When asked 
about this underuse, clinicians most frequently report a fear that comorbid 
conditions might interfere with this type of treatment or that PTSD-related or 
comorbid symptoms may worsen as a result of the emotions trauma-focused 
interventions may evoke (Becker et al., 2004). This is unfortunate given that 
several studies investigating predictors of PTSD treatment outcome showed 
that comorbid disorders (Ehlers et al., 2013; Olatunji, Cisler, & Tolin, 2010; 
Powers et al., 2010; van Minnen et al., 2002, 2012) and trauma type (Ehlers et 
al., 2013; Powers et al., 2010; van Minnen et al., 2002) do not predict poorer 
outcomes. Instead, intensive TFT programmes that offer massed sessions in an 
adequate dose will make effective treatment more accessible to patients with 
certain comorbid conditions considering that, due to their shorter duration, 
any comorbidity is likely to interfere less with the treatment, preventing poor 
adherence, irregular attendance, and dropout. Together with the ease of deliv-
ery, these factors may then raise the status and foster dissemination of effective 
PTSD treatment.
Speed of symptom reduction and practical issues
Besides potentially improving the response in patients who fail to respond to 
regular TFT, reducing dropout rates, and increasing the accessibility of guide-
lined treatment, intensive TFT may also positively affect the speed of PTSD 
symptom reduction as well as that of associated symptoms and problems, such 
as depression, anxiety, and disability in work, social, and family life. Moreover, 
intensive TFT may allow for a more rapid recovery from the negative trau-
ma-related effects that are mediated by core PTSD symptoms as well as other 
problems typically resulting from PTSD (Mueser, Rosenberg, Goodman, & 
Trumbetta, 2002; van Minnen, Zoellner, Harned, & Mills, 2015).
Intensive TFT may offer additional advantages in terms of enhanced avail-
ability and more concurrence with the preferences of PTSD sufferers. Those 
living in remote areas would be well served with massed sessions (Gantt & 
Tinnin, 2007) as it reduces travelling time and interference with occupational 
and social commitments, both crucial factors given our time-limited lifestyle 
(Kehle-Forbes, Polusny, Erbes, & Gerould, 2014). Rapid progress would also 
benefit specific patient populations. In military service members intensive TFT 
would, for instance, facilitate a quick return to their duty stations (Blount, 
Cigrang, Foa, Ford, & Peterson, 2014), while, to circumvent the stigma asso-
ciated with mental healthcare often prevalent in for example the military or 
police organizations, the treatment might be conceptualized as a short, supple-
mentary training course.
Possible risks and disadvantages
Notwithstanding the likely benefits, with its quick succession of trauma-fo-
cused interventions delivered within a short time span, intensive TFT may 
worsen symptoms or cause adverse events in that it may exacerbate depressive 
symptoms, elicit suicidal or self-injuring behaviour, substance abuse, or neces-
sitate acute hospitalisations. Some clinicians are, moreover, concerned that 
the short treatment duration may interfere with building a sound therapeutic 
relationship given that previous studies have shown that in PTSD therapeu-
tic alliance is associated with both adherence and completion of psychological 
treatments (Keller, Zoellner, & Feeny, 2010). Lastly, it is questioned whether 
the effects of intensive TFT are maintained in the long term and whether they 
can be generalised to other contexts such as the home environment.
Intensive TFT for PTSD: Empirical findings so far
With empirical work on the effectiveness of conventional PTSD treatments 
suggesting that optimising the dose of trauma-focused sessions might enhance 
treatment outcome, various research groups have explored the efficacy of 
massed TFT where sessions are delivered within a shorter time frame1. 
1 Literature published before the start of our studies is included; for a review of the latest  
research, we refer to the general discussion in Chapter 6.
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Single trauma
Ehlers and colleagues (2010) conducted a non-controlled study to establish the 
feasibility and acceptability of an 18-h cognitive treatment (CT) programme 
delivered in 5–7 workdays, followed by three optional monthly booster 
sessions. PTSD patients (N = 14) reported intrusive memories that were linked 
to one or two discrete traumatic events in adulthood. Effect sizes (pre-post 
Cohen’s d = 1.72) disclosed a very large improvement of PTSD symptoms, with 
85.7% of the patients no longer meeting the diagnostic criteria for PTSD after 
treatment (as measured with the CAPS, the Clinician-Administered PTSD Scale; 
Blake et al., 1995). Self-reported depressive and anxiety symptoms had like-
wise reduced significantly, as well as PTSD-associated impairments in work, 
social, and family functioning. There were no dropouts and none of the patients 
showed symptom exacerbation on any measure, while treatment effects were 
maintained at nine months. Although this was not a controlled study, the 
obtained outcomes were comparable with a traditional weekly based cognitive 
treatment programme evaluated earlier by the same research group (Ehlers, 
Clark, Hackmann, McManus, & Fennell, 2005) in a comparable PTSD sample.
The research group also compared the effectiveness of their intensive CT 
programme to a 3-month CT with weekly based sessions in a randomised 
controlled study (Ehlers et al., 2014) in which 121 patients who had all devel-
oped PTSD after a single traumatic event in adulthood were randomly allo-
cated to intensive CT, weekly based CT, emotion-focused supportive treatment 
(EFST), or a waiting-list (WL) condition. Results showed the intensive CT to be 
as effective as the weekly based CT, with both treatments being more effective 
than EFST and WL. Again, effect sizes were indicative of a very large ameliora-
tion of PTSD symptoms for both CT programmes. Of the 30 participants in the 
intensive CT group, 73.3% no longer met the PTSD criteria (CAPS) after treat-
ment (pre-post Cohen’s d = 1.95), with improvements in PTSD and depressive 
symptoms occurring faster: controlling for baseline severity, after three weeks 
of treatment self-reported PTSD and depressive symptoms were significantly 
lower in the intensive CT group than they were in the group receiving weekly 
CT. What is more, the effects of the intensive CT had remained at the 40-week 
follow-up, indicating that even though they were obtained in a short period, 
the treatment results were maintained over time. Dropout rates were negligible 
(one patient in each CT group), while the two CT programmes were safe since 
no adverse events were reported for any of the conditions.
It needs to be noted that the Ehlers studies exclusively included patients 
who had suffered a single or two discrete adulthood traumas, while the major-
ity did not present with any comorbid disorders, leaving it unclear whether the 
reported results would extend to other PTSD populations, for instance patients 
reporting multiple trauma in childhood or severe comorbidity (Cloitre, 2014).
Multiple traumas
In a non-controlled study, Gantt and Tinnin (2007) evaluated the effects of an 
intensive TFT programme of 35–70 h delivered within one or two weeks that 
included exposure techniques in 72 patients suffering from trauma-related disor-
ders (PTSD and/or dissociative disorders) after multiple traumas. The authors 
obtained very large effect sizes for the patients diagnosed with PTSD (N = 22; 
pre-post Cohen’s d = 1.97) in terms of self-reported PTSD symptom improve-
ment. Diagnostic recovery rates were not provided but at treatment comple-
tion 77% of the PTSD patients reported an Impact of Events Scale score (IES; 
Horowitz, Wilner, & Alvarez, 1979) below the clinical cut-off point of 25 (post-
treatment scores were the last-returned scores of each patient, i.e. at 1 week, 3 
months, or 6 months). Also, self-reported comorbid mental-health problems, 
including depressive and anxiety symptoms, had diminished significantly. Of 
the total sample (including patients with dissociative disorder instead of PTSD), 
two patients dropped out but the authors omitted to specify from which group. 
Finally, none of the PTSD patients showed symptom exacerbation on the IES.
Using an open design, Lande, Banks Williams, Francis, Gragnani, and 
Morin (2011) tested an intensive TFT programme in 39 military service 
members suffering from PTSD, most of whom had experienced multiple trau-
mas during their military careers. The programme comprised three weeks of 
structured, day-long treatment including cognitive-behavioural techniques 
delivered in both individual and group sessions. No diagnostic recovery rates 
are given but baseline-to-posttreatment reductions in self-reported PTSD and 
depressive symptoms were significant, where the pre-post effect size (Cohen’s 
d = 0.56) showed medium improvement in PTSD symptoms, with none of the 
participants dropping out. Regrettably, the authors did not report on any safety 
issues, while the longer-term stability of the results also is unknown since no 
follow-up was performed.
In line with the Lande and colleagues (2011) study, Blount and colleagues 
(2014) investigated an intensive treatment in a single patient with repeated 
combat-related PTSD. In their case study they describe a 70-h prolonged expo-
sure treatment that they delivered in two weeks, with the patient no longer 
meeting PTSD criteria after treatment as measured by the PSS-I (PTSD Symp-
tom Scale-Interview; Foa, Riggs, Dancu, & Rothbaum, 1993; Foa & Tolin 
2000). Self-reported depressive and anxiety symptoms had also decreased 
significantly, while improvements were maintained at the 6-months follow-up. 
Also these authors did not provide any safety indices.
Overall results of intensive TFT
Thus, although various intensive TFTs for adults with PTSD have been devel-
oped, research into their effectiveness and safety is still exploratory. The 
number of studies is small and the review above shows that their designs had 
several methodological shortcomings. Only one described a controlled trial, 
while some studies solely used self-reported outcome measures and most evalu-
ated small samples. This precludes any firm conclusions from being drawn. 
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Nevertheless, the presented findings are consistent: massed TFT is found 
to be feasible and effective in patients having suffered distinct traumas  
during adulthood (Ehlers et al., 2010, 2014), and there are indications that 
the format is also feasible in adults affected by multiple childhood trau-
mas (Gant & Tinnin, 2007) and in military service members having suffered 
repeated combat-related trauma (Blount et al., 2014; Lande et al., 2011). 
Although tentatively, the medium to large effect sizes suggest that inten-
sive TFT substantially reduces PTSD symptoms within one to three weeks. 
Furthermore and interestingly, in the studies reviewed very few or no 
patients left the programme prematurely, which suggests that the condensed 
protocol helps prevent patients from dropping out. Although patient samples 
were small and results exploratory, compared to the average dropout rates 
reported for conventional PTSD treatments (18%; with figures as high as 
52%; Imel et al., 2013), massed programmes then appear to prevent drop-
out, making it plausible that more patients can be reached and successfully 
treated with intensive, adequately dosed trauma-focused therapy. Contrary 
to the general concerns that TFT may exacerbate symptoms and provoke 
adverse events in PTSD patients, which risks are assumed to be even higher 
during and after intensive treatments (Tarrier et al., 1999), with symp-
toms not worsening and no adverse events occurring, the studies discussed 
showed intensive TFT to be feasible and safe. Furthermore, the patient 
ratings of therapeutic alliance were high and not different from ratings for 
weekly based TFT, although this was investigated in one controlled study 
only (Ehlers et al., 2014). While not improving treatment gains as such, the 
combination of a fast response, low dropout, and the absence of decom-
pensation and adverse events suggests that intensifying TFT programmes 
increases their accessibility and acceptability.
Generalisation to the home environment
Although the available studies on intensive TFT showed that the improvements 
obtained were maintained in the longer term, the concern remains whether 
these treatment effects can be generalised to the home environment. Due to the 
intensity of the programmes, some patients might find the transition from the 
therapy setting to their home, social, or work situation difficult. This might 
particularly be the case for patients showing extreme (generalised) avoidance 
behaviour in a wide range of situations, some (or most) of which may not have 
been addressed during therapy (Ehlers et al., 2010). Here, longer protocols with 
weekly sessions and regular homework assignments might facilitate the tran-
sition process. Also, in some PTSD patients, particularly those that suffered 
multiple traumas in their childhood, the ordeals may have become a more or 
less integral part of their identity (Berntsen, Willert, & Rubin, 2003) at the 
expense of (all) other aspects of their identity (e.g. being a friend, a parent, an 
employee). A less intensive treatment spanning several months will potentially 
enable these patients to focus on other facets of their lives, helping them to 
develop a more balanced identity.
Given the context dependence of extinction learning, which is likely to play 
a role in exposure-based TFT (Craske, Treanor, Conway, Zbozinek, & Vervliet, 
2014; Vervliet, Craske, & Hermans, 2013), and, keeping the above general-
isation issues in mind, exposure to trauma-related situations in daily life (i.e. 
outside the therapy room) is seen as a key feature of successful intensive TFT 
and the maintenance of treatment outcomes. This notion is partly based on 
experimental research in animals that shows that, although intensive train-
ing results in quicker learning, more widely spread trials allow for additional 
extinction learning (Cain et al., 2003). The context-dependency of extinction 
learning has been linked to the high relapse in anxiety disorders (Vervliet et al., 
2013), prompting the postulation that intensive TFT should not be delivered 
within one context (i.e. an inpatient format). Although their contributions to 
the treatment outcome have not been evaluated, some intensive TFT proto-
cols already allow for booster sessions (Ehlers et al., 2010, 2014). Arguably, to 
secure both a fast response and a sound translation to other contexts, intensive 
TFT might then be started off with intensive, massed sessions followed by more 
widely spaced follow-up or booster sessions to promote generalisation of the 
treatment effects (Lang & Craske, 2000).
Gaps in research
Although few in number, the preliminary results to date suggest that offering 
prolonged trauma-focused sessions within one to three weeks is feasible and 
effective in adult individuals coping with PTSD. Although treatment response 
seems not superior to that recorded for conventional weekly based TFT, massed 
programmes do speed up the reduction of PTSD (and comorbid) symptoms, 
substantially lower dropout, and improve accessibility while disproving clinical 
concerns as there are no indications of symptoms worsening or adverse events. 
Nevertheless, besides more controlled and larger-scale clinical trials of these 
intensive approaches, it also remains to be established whether massed treat-
ment affords generalisation of the outcomes. Possibly, following up massed 
TFT by a series of more widely spaced (booster) sessions may foster their main-
tenance and translation to everyday life.
Intensive TFT for complex PTSD
Despite the promising initial results, given that clinicians tend to rule some 
(types of) patients out for TFT because they perceive barriers in terms of serious 
adverse events and symptom exacerbation (Becker et al., 2004), research should 
also test intensive TFT in specific, more complex PTSD populations for whom 
little or no evidence is available. For instance patients with a history of multi-
ple childhood trauma, patients suffering from high levels of comorbid disor-
ders, or patients meeting the symptoms of complex PTSD should be included 
in research. Recently, the World Health Organization (WHO, 2018) diagnostic 
system, the International Classification of Diseases and Related Health Prob-
lems (ICD), formally introduced a distinction between PTSD and complex 
PTSD within the spectrum of stress and trauma disorders (Brewin et al., 2017). 
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Patients meeting the symptoms of the ICD-11 definition of complex PTSD 
not only suffer from re-experiencing, avoidance and hyperarousal symptoms 
but also from disturbances in affect dysregulation, negative self-concept, and 
interpersonal problems (Ford, 2015; Maercker et al., 2013). There is a heated 
debate about the most suitable treatment of these more complex patients, 
with some clinicians and researchers highlighting the importance of tailoring 
treatments to this population by providing sequenced or integrated treatments 
directly addressing symptoms uniquely associated with complex PTSD instead 
of stand-alone TFT (Cloitre, 2015). This would imply treatments being length-
ened rather than shortened whereas especially these complex populations might 
benefit most from a shorter, intensive TFT as this approach is expected to mini-
mise (the feared) interference of their comorbidity, and PTSD and comorbid 
symptom exacerbation between sessions.
Intensive TFT for adolescents
In addition to the studies exploring new approaches to the treatment of PTSD 
in adult populations, recent years have seen substantial progress in the research 
of programmes for children and adolescents. Several controlled studies support 
the effectiveness of psychological treatment in these young patients living with 
PTSD, with TFT showing the best evidence (Gillies, Taylor, Gray, O’Brien, 
& D’Abrew, 2013) including the trauma-focused cognitive behavioural ther-
apy (TF-CBT) as developed by Cohen, Mannarino, and Deblinger (2006) and 
the prolonged exposure protocol by Foa, McLean, Capaldi, and Rosenfield 
(2013). But again, most of these studies investigated TFT effectiveness in young 
patients having experienced single trauma, with limited research having been 
conducted in children and adolescents showing symptoms op complex PTSD or 
other comorbid complaints (Smith et al., 2013). Comparable to most adult TFT 
programmes, the majority of the existing youth protocols offer weekly sessions 
over the course of several months (and sometimes several years) and, similar 
to youth outpatient mental-health care in general where dropout ranges from 
28% up to 75% (de Haan, Boon, de Jong, Hoeve, & Vermeiren, 2013), with 
rates running up to 33% (Cohen, Mannarino, & Iyengar, 2011), dropout is still 
relatively high here as well. Notwithstanding the proven effectiveness of TFT in 
adolescents, yet again clinicians hesitate to use the trauma-focused components 
of the current programmes and prefer components such as relaxation skills and 
psychoeducation (Allen & Johnson, 2011). 
To tackle the problems with treatment dosage in the (more) extended 
schemes causing irregular attendance and dropout, and to encourage clini-
cians to do apply the evidence-based trauma-focused techniques rather than the 
nontrauma-focused methods of multi-component treatments like TF-CBT in 
this young population as well, one of the important next-generation approaches 
to be tested might then be intensive TFT. Another crucial complication of 
spread-out treatment programmes is that because of persistent PTSD-associated 
avoidance behaviour children and adolescents may not be able to attend school 
regularly or have frequent contact with peers, imposing serious restrictions on 
their daily functioning and compromising their general development. In these 
cases intensive TFT would not only benefit the dosage of the trauma-focused 
interventions but also ameliorate avoidance behaviour in as short a period as 
possible, minimising the adverse effects on the cognitive and socioemotional 
development of the young patients. 
Aim and outline of the dissertation
Taking everything into account, PTSD is a prevalent and severely impairing 
mental-health problem and the high impact on the individual as well as on soci-
ety as a whole makes it even more striking that TFT is not being implemented 
more widely. Indubitably, existing TFT programmes warrant improvement 
given that not all PTSD patients profit from the treatment and dropout levels 
tend to be high. Furthermore, it seems important to identify those patients for 
whom the existing trauma-focused programmes are not accessible because 
clinicians perceive barriers in prescribing TFT. We need to look critically at the 
delivery format and try to find approaches that will benefit more, and more 
complex patient groups. In this dissertation, possibilities to improve current 
TFT programmes targeting patients with PTSD are explored, one of which, in 
view of the promising first results with massed TFTs, is an intensive prolonged 
exposure (iPE) programme. The treatment preserves the effective components 
of prolonged exposure therapy (Foa, Hembree, & Rothbaum, 2007), one of 
the guideline-recommended first-line TFTs (see e.g. ISTSS, Foa et al., 2009; 
NICE, 2018; van Balkom et al., 2013) but sessions are delivered within a 
much shorter timeframe. The effects on response and dropout are empirically 
tested, with special attention being paid to the safety of the format especially in 
more complex adult patients who are generally not considered for prolonged 
exposure. The potential of the iPE protocol is also tested in adolescent PTSD 
patients to see whether intervening at an early stage of PTSD might help 
ameliorate the disturbing consequences of this potentially persistent, crippling 
disorder. 
When and why do therapists opt for or rule out TFT for PTSD? 
As a first aim, this dissertation investigates when therapists elect to choose TFT 
as a treatment for patients with PTSD and when not. For this, we conducted an 
exploratory survey to see whether trauma professionals applied TFT in their 
practice, whether they were trained in the approach and regarded it as credible, 
and if and why they perceived barriers in offering TFT (Chapter 2; van Minnen, 
Hendriks, & Olff, 2010). In the second experimental part of this study, the 
trauma therapists are randomised to two conditions and asked, after watch-
ing various videotapes of PTSD patients in which type of trauma, comorbidity, 
and the patients’ treatment preferences varied, which treatment they deem best 
suited for each particular patient. Besides the therapist factors we derived from 
the survey, patient factors that might explain the underutilisation of TFT are 
described. 
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Is a highly intensive prolonged exposure programme feasible, effective and 
safe for adult patients with complex PTSD?
The first results of massed TFT programmes are promising, suggesting they are 
a feasible and effective approach to the treatment of PTSD. However, although 
again there are tentative but favourable results, it remains to be established 
whether the intensive delivery format is less appropriate for patients with 
complex PTSD, as is the common belief among referring and trauma profes-
sionals. The second aim of this dissertation therefore was to investigate the 
feasibility, effectiveness, and safety of a highly intensive prolonged exposure 
(iPE) programme for those more complex adult PTSD patients who are gener-
ally ruled out for or not responding to conventional (weekly based) TFT, 
whereby it is explored whether our intensive protocol helps promote treat-
ment availability and improves results in terms of dropout, as is suggested by 
the available studies on massed TFT. Our iPE programme is introduced and 
its feasibility explored in four cases of adults who developed PTSD and high 
levels of comorbidity after multiple interpersonal trauma and failed to improve 
during regular weekly based TFT (Chapter 3; Hendriks, de Kleine, van Rees, 
Bult, & van Minnen, 2010). The programme, which was delivered within the 
space of one week, consisted of daily sessions of prolonged imaginal exposure, 
exposure by drawing where the participant is instructed to draw the scene(s) 
of the hotspots of the traumatic memory, and exposure in vivo to trauma-re-
lated situations and materials. The participants were treated by a team of 
therapists, with therapists rotating during the treatment, each therapist provid-
ing several sessions per participant. The effectiveness and safety of the iPE is 
further explored in an open clinical trial in a larger cohort of adult patients 
with (complex) PTSD after multiple interpersonal trauma, high levels of comor-
bidity, and a history of multiple treatment attempts (Chapter 4; Hendriks, de 
Kleine, Broekman, Hendriks, & van Minnen, 2018). The main purpose of 
this trial was to examine whether the iPE programme would ameliorate PTSD 
symptoms and moderate dropout rates as hypothesised, while, in view of the 
widespread clinician-perceived barriers to (intensive) TFT, safety was moni-
tored throughout the treatment. Finally, distinct treatment response trajectories 
were identified and possible predictors of these trajectories explored, aimed at 
examining which patients might benefit (most) from iPE.
Is a highly intensive prolonged exposure programme feasible, effective and 
safe in adolescent patients with complex PTSD and comorbid disorders 
following multiple interpersonal trauma?
A large proportion of patients who suffered multiple interpersonal traumas 
were exposed to their traumatic experiences, and as a result developed PTSD 
symptoms, during their childhood. Given the severe long-term consequences 
associated with untreated PTSD (Kessler, 2000), TFT, and more specifically iPE, 
needs to be implemented as soon after the onset of PTSD symptoms as possi-
ble. The third aim of this dissertation therefore was to investigate the feasibility, 
effectiveness, and safety of iPE in adolescent patients with complex PTSD and 
comorbid disorders following multiple interpersonal trauma. In addition, the 
results are presented of a time-series design in which participants are randomly 
allocated to one of five baseline lengths before starting the iPE (Chapter 5; 
Hendriks, de Kleine, Heyvaert, Becker, Hendriks, & van Minnen, 2017). 
Finally, the results of all studies are reviewed and discussed in the light of previ-
ous research (Chapter 6), concluding with practical implications for clinical 
PTSD practice, with special attention being paid to therapist rotation, poten-
tially a key factor for successful implementation of TFT and iPE in those PTSD 
patients for whom therapists tend not to consider evidence-based PTSD treat-
ments.
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He looks up to John no end. All those years of experience work-ing as a clinical psychologist! His role model. He’s running his hand along the top of his desk, his own desk! Having spent three months wandering around the trauma department like  
a nomad, pushing his books and records around in his little filing cabi-
net, he’s now sitting in his own consulting room in the outpatient wing. 
Not bad for someone who’s just completed his Master’s. Soon he’ll 
be delivering his first unsupervised exposure intervention. He’s going 
to do this, he knows he can! Right? He’s watched John do it so often. 
Doing such a great job! Although… he has seen him deviate from the 
protocol, the prescribed technique, when things were getting really 
hard, when John saw patients getting truly anxious and fearful, losing 
their grip on reality. He’s seen him stop and discuss with them how to 
calm themselves down, during and outside sessions. Often not even 
returning to the exposure part in the subsequent sessions. Even though 
during training you’re told that those are the times that you need to 
press on, get back to the exposure exercise as quickly as possible. 
Never stop! Of course, he’s going to handle things differently. Bring it 
on, let’s see this first patient. After ten minutes, eyes closed, his patient 
will be reliving the hardest moments of his trauma, the most gruelling 
details. Just hope things’ll turn out right, run smoothly, for what will the 
team think, going about things so expeditiously, and then messing up?
What a whippersnapper, that Vince, the new boy. After three months 
looking in telling me that he will never discontinue exposure, not even 
when the patient sitting across from him is scared out of her wits 
thinking the perpetrator is walking around in the room. Easy for him, no 
responsibilities, just being a psychology graduate. But what if things do 
go wrong? I can already envisage the headlines: Woman (34) dies after 
running into road in confused state after seeing trauma therapist. Okay, 
stop blowing things out of proportion. Actually, I do get energised by 
the boy’s bravado. And, granted again, there’s truth in what Vince’s say-
ing: it is paramount to stick with it when things get really rough during 
exposure, no matter what, because the problems the patient has to deal 
with day in, day out are far more severe and debilitating. Still, in daily 
practice things are not always so clear-cut. The handbooks don’t tell 
you how to manage your own fears as a therapist, how to cope with the 
media and critical colleagues cracking down on you, how to deal with 
the huge responsibility, not to mention the ever-increasing caseload. 
You’re mostly left to your own devices, alone, behind the closed door 
of your office, really.
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Chapter 2
When do trauma 
experts choose 
exposure therapy for 
PTSD patients?  
A controlled study  
of therapist and  
patient factors
This chapter is based on: Van Minnen, A., Hendriks, L., & Olff, M. (2010).  
When do trauma professionals choose exposure therapy for PTSD patients?  
A controlled study of therapist and patient factors. Behaviour Research and 
Therapy, 48, 312-320.
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ABSTRACT
To investigate when and why therapists opt for or rule out imaginal expo-
sure (IE) for patients with posttraumatic stress disorder (PTSD), 255 trauma 
experts were randomised to two conditions in which they were presented with 
four cases in which the patients’ comorbidity and treatment preferences were 
manipulated. The results confirmed IE to be an underutilized approach, with 
the majority of professionals being undertrained in the technique. As predicted, 
the patient factors influenced the expert’s choice of therapy: In case of a comor-
bid depression, IE was significantly less preferred than medication. Also, IE was 
significantly more likely to be offered when patients expressed a preference for 
trauma-focused treatment. The therapist factors were also found to be impor-
tantly related to treatment preferences, with high credibility in the technique 
being positively related to the therapists’ preference for IE. Perceived barriers to 
IE, such as a fear of symptom exacerbation and dropout, were negatively related 
to the perceived suitability of the treatment when patients had suffered multiple 
traumas in childhood. The results are discussed in the light of clinical implica-
tions and the need of exposure training for trauma professionals.
INTRODUCTION
Despite the strong evidence for the efficacy of exposure techniques in the 
treatment of posttraumatic stress disorder (PTSD; Cahill, Rothbaum, Resick, 
& Folette, 2009), the approach is underutilized in clinical practice (Becker, 
Zayfert, & Anderson, 2004; Rosen et al., 2005). In their survey, Becker and 
colleagues (2004) showed that a large majority (83%) of the 207 licensed 
doctoral-level psychologists questioned never opted for exposure therapy to 
treat their PTSD patients. But what are the reasons for this underutilization? 
Why do therapists fail to exploit exposure-based treatments for this population 
in spite of their proven effectiveness? Which therapist-related and patient-re-
lated factors are implicated here and how do they interact (Becker, Darius, & 
Schaumberg, 2007)? Although mostly explorative in nature, some studies have 
begun to delineate predictive factors of clinicians’ treatment preferences. To 
add to the existing knowledge, apart from a comprehensive therapist survey, 
we conducted a controlled study among experts working in this trauma field 
in which we evaluated the effects of several therapist and patient factors on the 
preference for one of four recommended and widely used treatments for PTSD.
Therapist factors
Training in and experience with exposure for PTSD are likely to influence the 
decision to use the approach. When Becker and colleagues (2004) asked the 
practising psychologists in their survey to rate these two factors, they found 
that only 31% had had formal training in the use of imaginal exposure (IE) 
and that this group was more likely to report current use of the technique 
than the untrained respondents. When asked to list the factors that prevented 
them from using IE, the respondents indicated limited training (60%) as the 
most important factor. Sprang, Craig, and Clark (2008) found that specialized 
trauma training resulted in a more frequent use of trauma-specific treatment 
approaches (among which exposure) as opposed to no preference for a treat-
ment approach.
Another factor likely to influence the decision to use exposure is its 
perceived credibility, i.e. the way the therapist’ interprets the rationale and 
effects of the technique and his or her personal stance towards it. Although 
some studies showed that the patient’s confidence in and preference for the 
treatment was related to the therapist’s choice for prolonged exposure therapy 
(see e.g. Zoellner, Feeny, Cochran, & Pruitt, 2003), few studies have directly 
addressed associations between the therapist’s views of and his/her use of the 
approach. Frueh, Cusack, Grubaugh, Sauvageot, and Wells (2006) did study 
clinicians’ perspectives on cognitive behavioural therapy (CBT) for PTSD and 
found that many of the respondents reported a fear of addressing the trauma 
directly (also see Waller, 2009) and that they had little faith in their ability to 
help PTSD patients effectively using exposure techniques. Devilly and Huther 
(2007), moreover, observed that especially inexperienced therapists found 
exposure therapy less credible than cognitive therapy, decreasing the likelihood 
that they would choose a trauma-focused approach like exposure.
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In addition to low treatment credibility, the barriers therapists perceive to 
exposure might also inhibit their use of the technique. These include the often-
noted perception that exposure techniques are more distressing than other 
interventions (Devilly & Huther, 2007), that they may exacerbate symptoms 
(Frueh et al., 2006) especially in patients with comorbid disorders (Becker et 
al., 2004), or that exposing patients to their traumas will lead to treatment 
dropout and revictimization (Cahill, Foa, Hembree, Marshall, & Nacash, 
2006; Cook, Schnurr, & Foa, 2004; Ruscio & Holohan, 2006). There are also 
practitioners who believe that exposure techniques are only suitable for survi-
vors of discrete or single-incident traumas and that these survivors must be 
relatively stable and healthy (Cook et al., 2004; Ruscio & Holohan, 2006). 
In Becker and colleagues’ (2004) survey, clinicians reported fewer barriers to 
exposure when they were more experienced in treating PTSD patients.
Finally, Sprang and colleagues (2008) found the therapist’s sex to be a deter-
minant in treatment preference: compared to their male counterparts, female 
therapists were less likely to avail themselves of CBT including exposure, while 
Devilly and Huther (2007) observed that the female respondents estimated the 
distress caused by exposure as more severe than the male respondents.
Patient factors
Patient variables, such as comorbidity and treatment preference may also be of 
importance in the therapists’ choice of treatment. Becker and colleagues (2004) 
reported that a large number of clinicians (37%) saw any comorbid diagnosis 
as a likely contraindication for exposure (IE) for PTSD. Exploring patient pref-
erences for exposure versus medication, Zoellner, Feeny, and Bittinger (2009) 
reported a similar trend: fewer therapists opted for exposure when PTSD 
patients had a concurrent depression. Najavits (2006) observed that clinicians 
rated present-focused treatment (e.g. supportive counselling) more positively 
than past-focused treatment (e.g. exposure therapy) for PTSD patients with 
comorbid substance abuse.
The patient’s preference for a particular treatment may also be important 
in determining the clinician’s choice of treatment, with several studies suggest-
ing that PTSD patients may be more receptive to exposure than is indicated 
by current clinical practice utilization rates. In two studies, women with and 
without PTSD preferred prolonged exposure to medication (sertraline; Angelo, 
Miller, Zoellner, & Feeny, 2008; Cochran, Pruitt, Fukuda, Zoellner, & Feeny, 
2008), which is in line with findings that trauma victims in general seem to 
prefer a psychological treatment (counselling) to medication (Roy-Byrne, 
Berliner, Russo, Zatzick, & Pitman, 2003). Also when other alternative 
(psychological) treatment options were offered, respondents in an analogue 
study showed a strong preference for CBT-based treatments, including expo-
sure, despite the high levels of discomfort anticipated with exposure (Tarrier, 
Liversidge, & Gregg, 2006). These results were replicated in the analogue 
study by Becker and colleagues (2007), in which the respondents predomi-
nantly indicated exposure or another CBT variant as the therapy of choice over 
other treatments including supportive therapy, eye movement reprocessing 
and desensitization (EMDR) and medication. It must be noted, however, that 
these ‘patient preference’ studies not always concerned actual PTSD patients; 
some included participants who had been traumatized but did not develop 
PTSD, or respondents who were presented with ‘what if’ cases. This may have 
important implications for the reported treatment preference outcomes and 
thus complicates the interpretation of the results. For instance, in the Becker 
and colleagues (2007) study, the patients’ preference for exposure therapy was 
less pronounced when the data of the PTSD patients were analysed separately. 
Possibly, avoidance symptoms typical of this population negatively affected the 
patients’ willingness to undergo exposure treatment. Finally, the credibility of 
a treatment (Becker et al., 2007; Zoellner et al., 2003), personal positive reac-
tions to a treatment (Becker et al., 2007), the assumed underlying mechanisms 
of a treatment (e.g. ‘‘I have to talk about it’’; Angelo et al., 2008), and treatment 
effectiveness (Cochran et al., 2008) were all found to be related to the patients’ 
preference for exposure-based therapies.
In view of the notion that, despite its proven effectiveness, exposure ther-
apy is underutilized in the treatment of PTSD, the aim of the present study 
was to examine which therapist and patient factors foster or inhibit the choice 
for exposure therapy in trauma professionals working in this field. To this end 
we first explored whether the participating therapists (1) used exposure ther-
apy in their practice, (2) were trained in the treatment approach, (3) regarded 
the therapy as credible, (4) perceived barriers preventing them from offering 
the therapy in their practice, and finally (5) whether these variables differed 
between male and female therapists. We subsequently examined if and how 
the use of and training in exposure techniques were related to treatment 
credibility and perceived barriers. To determine whether these relationships 
were specific to exposure therapies, we included three other guideline-recom-
mended or well-known PTSD treatments in our survey: EMDR, another trau-
ma-focused treatment internationally recommended for PTSD (Foa, Keane, 
Friedman, & Cohen, 2009), and two nontrauma-focused treatments: phar-
macotherapy, which is also mentioned in PTSD treatment guidelines, and 
present-centred supportive counselling, a widely used treatment approach not 
specifically included in official PTSD treatment guidelines but yielding posi-
tive effects (see Mc Donagh-Coyle et al., 2005; Schnurr et al., 2007). Because 
it is underutilized in PTSD, we expected the participating therapists to use 
exposure therapy less often relative to the other treatment options and to be 
less (well) trained in the approach, and that they would consider exposure 
therapy less suitable (reflecting low treatment credibility) for and see more 
barriers to its use in this population. We also hypothesized that the therapists 
that were (better) trained in the technique and more experienced in its use in 
PTSD patients would find the approach more suitable (reflecting high treat-
ment credibility) and mention fewer or less prohibitive factors.
In the second, experimental part of our study we presented 255 trauma 
experts with four videotapes each showing a PTSD patient. Having viewed a 
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tape, the therapists were asked to indicate on a list specifying the four treat-
ment options to what extent they thought the treatment would be suited for 
this particular patient. In addition, we manipulated the choice of treatment by 
randomizing the respondents to two conditions in which the patient varia-
bles ‘comorbid depression’ and ‘patient preference’ were introduced. Because 
trauma type and trauma severity are known to influence treatment preferences, 
each condition included two types of trauma: (1) a single trauma suffered in 
adulthood and (2) multiple traumas suffered during childhood. We expected 
a comorbid diagnosis to generate a lower therapist preference for exposure 
and the patient’s preference for exposure a higher therapist preference for the 
treatment. As to the therapist factors, we expected more training in exposure, 
higher credibility ratings and fewer perceived barriers to be associated with a 
higher preference for exposure therapy, with male therapists having a stronger 
preference for exposure than female therapists.
METHOD
Participants
A total of 296 trauma experts took part in our study conducted during the 
2008 Annual NtVP Conference (the ‘Nederlandstalige Vereniging voor 
Psychotrauma’; the Dutch-Flemish Association for Psychotrauma). Forty-
one participants (13.8%) did not consent to their contribution being used for 
research purposes. The final sample thus consisted of 255 participants: 84 
men and 167 women (with four respondents not specifying their sex), with an 
average age of 48.83 (SD = 9.83). All participants were trauma professionals. 
The majority (45.9%) noted psychologist/psychotherapist as their primary 
profession, 12.5% were psychiatrists/physicians, 14.9% social workers/social 
psychiatric nurses, and 26.7% indicated another profession (e.g. researcher or 
policy maker). For the experiment, the participants were randomised to two 
conditions 145 participants were allocated to Condition 1 (100 women; mean 
age 48.83, SD = 9.95) and 110 participants to Condition 2 (67 women, mean 
age 48.65, SD = 9.71). The participants in the two conditions did not differ 
with regard to sex, age or range of profession.
Materials
Treatment descriptions
In the first part of the study, we explored the various therapist variables for all 
four treatments: the two trauma-focused interventions (1a) imaginal exposure 
(IE) and (1b) EMDR, and the two nontrauma-focused therapies (2a) psychop-
harmacological treatment (medication) and (2b) (present-centred) supportive 
counselling. To ensure that all participants had the same conceptualizations 
of the treatments, for each treatment a description was read out to the partic-
ipants (see Appendix A), with the treatment descriptions corresponding in 
terms of length and sentence structures. So as not to influence the participants, 
the accounts did not contain any information about the known (side) effects of 
the various treatments. Second, all participants were shown clinical examples 
in the form of four 1-min videotaped therapist-patient interactions featuring 
the same female actors for each treatment.
Case presentations. For a description of the patient cases used in the experi-
mental part of our study we refer to Appendix B. 
 
Cases 1 and 2: comorbidity. Participants were shown brief video record-
ings specifically produced for this study featuring two female PTSD patients 
(played by different actresses who were not involved in any other aspect of the 
study): one having experienced a single trauma (road traffic accident) in adult-
hood and one having suffered sexual abuse in childhood. The recordings were 
similar in nature and conveyed relevant information about the trauma and 
PTSD symptoms according to DSM-IV criteria (APA, 2000). Depending on the 
study condition, the two patients also showed comorbid depressive symptoms 
in a supplemented scene in accordance with the DSM-IV criteria for a Major 
Depressive Episode (APA, 2000). Cases 3 and 4: patient preference. Two 
similarly structured video recordings showed a female PTSD patient having 
suffered a single trauma (robbery) in adulthood and a patient having been 
subjected to childhood physical and psychological abuse. Apart from convey-
ing information about the respective traumas and PTSD symptoms (DSM-IV; 
APA, 2000), again depending on the study condition, the tapes also showed 
scenes with the patient expressing a preference for trauma-focused therapy 
(IE or EMDR) or a preference for nontrauma-focused therapy (medication or 
supportive counselling).
Study conditions
In Condition 1, participants were shown Case 1 without comorbid depression 
and Case 2 with comorbid depression, while the participants in Condition 2 
were presented with Case 1 showing comorbid depression and Case 2 without 
comorbid depression. Likewise, in Condition 1, participants saw Case 3 with 
a trauma-focused therapy preference and Case 4 with a nontrauma-focused 
therapy preference, and the participants in Condition 2 Case 3 with a nontrau-
ma-focused therapy preference and Case 4 with a trauma-focused therapy 
preference (see Scheme 1 for a schematic overview).
Measures
Demographics
All participants were asked to state their age, sex and main profession.
Treatment use
For each of the four treatment options the participants indicated to what 
extent they offered the treatment in question (‘I use this treatment to treat 
PTSD’) on a 10-point scale (1 = Never, 10 = Always).
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Trauma Manipulation
Condition 1 Condition 2
Case 1 Single trauma in 
adulthood
Comorbidity: No depression Depression
Case 2 Multiple trauma 
during childhood
Comorbidity: Depression No depression
Case 3 Single trauma in 
adulthood
Preference: Trauma-focused Nontrauma-focused
Case 4 Multiple trauma 
during childhood
Preference: Nontrauma-focused Trauma-focused
Scheme 1. Schematic overview of study conditions 
Training
They similarly rated the quality of their training (‘I received a good training  
in this treatment for PTSD’; 1 = Does not apply to me at all; 10 = Fully applies 
to me).
Treatment credibility
Participants responded to five statements about credibility of each of the four 
treatment options as based on the Credibility Scale (CS; Addis & Carpenter, 
1999): (1) This treatment seems logical to me. (2) This treatment seems scien-
tific to me. (3) If I have a PTSD, I would choose this treatment. (4) This treat-
ment would be effective for most people. (5) If a close friend or relative has 
PTSD, I would recommend this therapy to them.
Perceived barriers
Participants rated five statements about potential barriers to the clinical use of 
the treatments in question, based on the difficulties preventing the implemen-
tation of exposure treatment for PTSD as they are mentioned in the literature: 
(1) This treatment has unpleasant (temporary) side effects. (2) As a result of this 
treatment, PTSD symptoms can exacerbate. (3) Patients want this treatment. 
(4) This treatment is only useful for relatively healthy and stable patients, like 
patients with a single trauma, or patients without comorbid disorders. (5) This 
treatment causes dropout.
Treatment suitability
After having viewed each patient case, the participants answered the question 
‘‘How suitable do you think (‘name of treatment’) is for the treatment of this 
patient?’’ for each of the four treatments on a 10-point scale (1 = Not suitable at 
all, 10 = Exceptionally suitable).
Forced choice
Finally, the participants were required to select one of the four treatments for 
the treatment of each particular patient: ‘‘If you were forced to make a choice 
between one of the four treatment options, which would you choose for this 
patient?’’
Procedure
The study formed an integral part of the 2008 NtVP annual conference 
programme. To ensure equal numbers of participants with comparable profes-
sional backgrounds, candidates were stratified based on profession, after which 
the conference organizer randomly assigned them to one of two conditions (and 
hence to two different conference rooms). In a brief introduction the partici-
pants were told the study aimed to investigate health professionals’ attitudes 
towards and utilization of various treatments for PTSD.
The video recordings and questions were all projected on a screen and, using 
a wireless voting system, each participant individually answered the questions 
by pushing the appropriate button(s) of a 10-button keypad. After the partic-
ipants had answered the demographic questions, the explorative survey was 
initiated, with the participants viewing the tapes illustrating the four treat-
ments, after each tape indicating the use of and training in that particular treat-
ment, its perceived credibility and barriers (factors prohibiting its use). Next, 
during the experimental part of the session, the participants viewed the video 
recordings of the four PTSD patient cases, answering the treatment suitability 
items and forced choice question after each case.
At the end of the session, the participants were asked to give permission for 
their data to be used for research and were shortly debriefed. The week after 
the experiment all participants were informed in more detail about the goals of 
the study.
Analyses
Preliminarily assumption testing was performed to check for normality, linear-
ity, univariate and multivariate outliers, homogeneity of variance-covariance 
matrixes, and multicollinearity; no serious violations emerged. 
To evaluate the explorative survey data we performed repeated measures 
analyses and bivariate correlation analyses. For the experimental data we 
used one-way multivariate analyses of variance (MANOVA) for each of the 
four patient cases to identify condition effects on the professionals’ treatment 
suitability/preference ratings, with the scores for IE, EMDR, medication, and 
supportive counselling as the four dependent variables and condition (resp. 
comorbid depression versus no comorbid depression, and patient preference 
trauma-focused versus patient-preference nontrauma-focused) as the independ-
ent variables. Because training, sex, credibility and perceived barriers of IE were 
hypothesized to be related to therapist’s treatment suitability/preference scores, 
we included these variables as covariates in the MANOVAs. To avoid Type-I 
errors, we set alpha at .01 for all analyses.
When do therapists choose exposure therapy?Chapter 2
4342
RESULTS
Explorative survey results
Table 1 shows the means and standard deviations (SDs) for the experts’ 
responses to the four expert variables under study per treatment type.
Table 1. Means and standard deviations (SDs) for the use of, training in, credibility of and perceived 
barriers to the treatment as reported by all consenting trauma experts (n = 255)
Treatment Use
M (SD)
Training
M (SD)
Credibility
M (SD)
Perceived
barriers M (SD)
Imaginal exposure 4.01 (3.11) 3.76 (3.03) 28.75 (10.60) 25.80 (5.71)
EMDR 5.05 (4.02) 4.45 (3.96) 37.86 (9.76) 22.11 (5.96)
Medication 4.53 (3.09) 2.58 (2.70) 22.62 (9.74) 24.87 (5.41)
Supportive 
counselling
6.37 (3.12) 5.54 (3.08) 26.24 (11.29) 18.94 (6.24)
Note. Range for use and training: 1–10; treatment credibility range: 5–50, with higher scores 
reflecting higher treatment credibility; perceived barriers to treatment range: 5–50, with higher 
scores indicating more perceived barriers.
Use
The use differed significantly among treatments (F (3,252) = 36.44, p < .000), 
with contrast analyses showing IE to be significantly less frequently used than 
the other psychological treatments (all F > 4, all p < .001).
Training
Participants also differed in the (level of) training they had received for the four 
treatments (F (3, 252) = 51.91, p < .000), with the contrast analyses revealing 
that they were less (well) trained in IE than in EMDR and supportive counsel-
ling, but better trained in IE than in medication (all F > 4, all p < .01). The use 
of a treatment correlated highly with the level of training in that treatment  
(IE: r = .64; EMDR: r = .78; medication: r = .44; and supportive counselling: r = 
.57; all p < .000).
Treatment credibility
The therapists’ confidence in the treatments differed significantly: (F (3, 251) 
= 95.73, p < .000), with IE being rated as more credible than medication and 
supportive counselling, but as less credible than EMDR (all F > 4, all p < .01). 
As expected, training in and the use of a specific treatment were significantly 
positively related to its perceived credibility (Training: range r = .38–r = .55,  
all p < .000; Use: range r = .46–r = .57, all p < .000; specifically for IE: Training: 
r = .38; Use: r = .57).
Perceived barriers
The barriers the respondents recorded to the use of the treatments also differed 
significantly (F (3,252) = 84.59, p < .000), with the most prohibitive factors 
being reported for IE (all F > 4, all p < .001). In contrast to our hypothesis, use 
and training were relatively unrelated to the perceived barriers to a treatment 
(Training: range r = .03–r = -.11, all p > .08; Use: range r = -.06–r = -.14, all  
p > .02; specifically for IE: Training: r = -.05; Use: r = -.08).
Sex
The male respondents reported offering IE more often than their female  
counterparts (t (249, 1) = -2.66, p < .01), while the other three treatments 
showed no sex-related differences. In line, the men found IE to be more  
credible than the women (t (172, 2) = -.57, p < .000), which difference was  
not observed for the other treatments. No sex-dependent differences were 
found for perceived barriers.
Experimental results
For a schematic overview of the experiment, see also Scheme 1.
Case 1: single trauma in adulthood with and without depression
Table 2 lists the means and SDs for the treatment suitability data for Case 1. 
Comorbid depression had not generated a significant effect on the suitability 
ratings (F (4, 241) = 1.62, p = .17, Wilks’ λ = .97, partial ŋ2 = .03). Training in 
IE did yield a main effect (F (4, 241) = 7.82, p < .001, Wilks’ λ = .89, partial ŋ2 
= .12). Between-subjects effects were found for EMDR (F (1, 244) = 13.07, p < 
.001, partial ŋ2 = .05), and supportive counselling (F (1, 244) = 25.40, p < .001, 
partial ŋ2 = .09). In the total group, training in IE was positively related to the 
use of EMDR (r = .14, N = 255) and negatively to supportive counselling (r = 
-.33, N = 255). 
IE credibility also showed a main effect (F (4, 241) = 23.79, p < .001, Wilks’ 
λ = .72, partial ŋ2 = .28). Between-subjects effects were found for IE (F (1, 244) 
= 77.42, p < .001, partial ŋ2 = .24), EMDR (F (1, 244) = 11.66, p = .001, partial 
ŋ2 = .05) and medication (F (1, 244) = 8.71, p = .003, partial ŋ2 = .03). IE cred-
ibility was positively related to perceived IE suitability (r = .57, N = 255) and 
medication (r = .15, N = 255), and negatively associated with perceived EMDR 
suitability (r = -.17, N = 255). 
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Table 2. Perceived treatment suitability for single adult trauma and multiple childhood trauma with 
and without comorbid depression
Single adult trauma Multiple childhood trauma
No 
depression 
(n = 145)
Depression 
(n = 110)
No 
depression
(n = 110)
Depression 
(n = 145)
M SD M SD M SD M SD
Imaginal exposure 5.59 2.70 5.87 2.35 6.15 2.40 4.81 2.85
EMDR 8.13 2.26 8.00 2.23 7.66 2.16 6.87 2.56
Medication 2.63 1.81 4.80 2.72 3.63 2.28 5.11 2.42
Supportive 
counselling 5.00 2.92 4.64 2.58 5.59 2.51 6.41 2.43
Note. Range scores: 1–10, with higher scores indicating superior perceived treatment suitability.
The forced choice (see Table 3) data revealed a significant difference between 
conditions (χ2 (3, 252) = 18.21, p < .001). In the depression condition medi-
cation was more often chosen, than IE, EMDR and supportive counselling 
relative to the no-depression condition. Post-hoc pairwise analyses revealed a 
significant difference between conditions regarding medication on the one hand 
and IE (χ2 (1, 58) = 14.74, p = .000), EMDR (χ2 (1, 188) = 16.72,  
p = .000) and supportive counselling (χ2 (1, 47) = 11.84, p = .001) on the other.
Table 3. Forced choice: percentage of professionals opting for a treatment as the most preferred 
treatment (comorbidity)
Single adult trauma Multiple childhood trauma
No depression 
(n = 145)
Depression 
(n = 110)
No depression
(n = 110)
Depression 
(n = 145)
Imaginal exposure 17.2 12.7 17.3 23.4
EMDR 69.7 61.8 57.3 39.3
Medication 1.4 15.5 1.8 11.0
Supportive counselling 11.7 10.0 23.6 26.2
Case 2: multiple trauma in childhood with and without depression
Table 2 lists the means and SDs of the therapists’ suitability ratings. For the 
Multiple Childhood Trauma case there was a statistically significant main 
effect of depression on the treatment’s perceived suitability (F (4, 242) = 8.66, 
p < .001, Wilks’ λ = .88, partial ŋ2 = .13). In case of comorbid depression, the 
professionals rated IE (F (1, 245) = 11.35, p < .001, partial ŋ2 = .04) and EMDR 
(F (1, 245) = 9.12, p < .01, partial ŋ2 = .04) as less suitable and medication (F 
(1, 245) = 22.20, p < .001, partial ŋ2 = .08) as more suitable.
Training in IE also showed a main effect (F (4, 242) = 4.58, p < .001, Wilks’ 
λ = .93, partial ŋ2 = .07) with EMDR yielding a between-subjects effect (F (1, 
245) = 11.18, p = .001, partial ŋ2 = .04). Training in IE was positively related to 
EMDR perceived suitability (r = .12, N = 255).
Also, a main effect was found for IE credibility (F (4, 242) = 27.28,  
p < .001, Wilks’ λ = .69, partial ŋ2 = .31) with between-subject effects emerging 
for IE (F (1, 245) = 83.51, p < .001, partial ŋ2 = .25) and EMDR (F (1, 245) = 
18.44, p < .001, partial ŋ2 = .07). IE credibility was positively related to IE suit-
ability (r = .56, N = 255) and negatively to EMDR suitability (r = -.20,  
N = 255).
Perceived barriers to IE also produced a main effect (F (4, 242) = 4.89,  
p = .001, Wilks’ λ = .93, partial ŋ2 = .08), with IE yielding a between-subjects 
effect (F (1, 245) = 16.23, p < .001, partial ŋ2 = .06). The more perceived barri-
ers were mentioned, the less likely participants rated IE as a suitable option  
(r = -.26, N = 255).
Forced choice (see Table 3) again uncovered significant differences between 
conditions (χ2 (3, 252) = 13.13, p = .0004), with post-hoc analyses revealing the 
difference between medication and EMDR to be significant: in the depression 
condition, medication was significantly more preferred than EMDR  
(χ2 (N = 138) = 10.76, p = .001) relative to the no-depression condition.
Case 3: single trauma in adulthood with patient preference
Table 4 shows the means and SDs for the therapist treatment suitability ratings 
for Case 3. The patient’s preference for a particular treatment had a statistically 
significant main effect on the therapists’ judgments (F (4, 242) = 8.18,  
p < .001, Wilks’ λ = .88, partial ŋ2 = .12). Between-subject effects were found for 
IE (F (1, 245) = 26.34, p < .001, partial ŋ2 = .10): when the patient expressed a 
preference for a trauma-focused treatment, either IE or EMDR,  
the therapists judged IE as more suitable.
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Table 4. Perceived treatment suitability for single adult trauma and multiple childhood trauma with 
a known patient preference for a trauma-focused versus a nontrauma-focused intervention
Single adult trauma Multiple childhood trauma
Preference 
for trauma-
focused
therapy 
(n = 145)
Preference for 
nontrauma-
focused
therapy
(n = 110)
Preference 
for trauma-
focused
therapy 
(n = 110)
Preference for 
nontrauma-
focused
therapy
(n = 145)
M SD M SD M SD M SD
Imaginal 
exposure
6.57 2.72 5.56 2.65 6.32 2.19 4.20 2.80
EMDR 8.38 1.91 8.17 1.95 7.93 2.03 6.46 2.83
Medication 2.45 1.68 3.06 2.08 3.13 2.06 3.78 2.24
Supportive 
counselling
4.36 2.70 4.72 2.64 5.00 2.67 6.52 2.42
Note. Range scores: 1–10, with higher scores indicating superior perceived treatment suitability.
Training in IE also showed a main effect (F (4, 242) = 7.78, p < .001, Wilks’ λ 
= .89, partial ŋ2 = .11), with a between-subjects effect for EMDR (F (1, 245) 
= 12.35, p = .001, partial ŋ2 = .05) and supportive counselling (F (1, 245) 
= 27.41, p = .001, partial ŋ2 = .10). Training in IE was positively related to 
EMDR suitability (r = .12, N = 255) and negatively to supportive counselling (r 
= -.14, N = 255).
Also, a main effect was found for IE Credibility (F (4, 242) = 28.97, p < 
.001, Wilks’ λ = .61, partial ŋ2 = .39), with between-subjects effect for IE (F (1, 
245) = 143.16, p < .001, partial ŋ2 = .37) and EMDR (F (1, 245) = 11.10, p < 
.001, partial ŋ2 = .04). IE Credibility was positively related to IE (r = .62, N = 
255) and negatively to EMDR suitability (r = -.14, N = 255).
Again, the forced choice (see Table 5) yielded significant differences between 
conditions (χ2 (3, 252) = 16.81, p = .001), with the post-hoc analyses showing 
the difference between IE and supportive counselling to be significant: when 
the patient expressed a preference for trauma-focused therapy, therapists more 
often opted for IE than for supportive counselling (χ2 (1, 77) = 13.99, p < .000).
Table 5. Forced choice: percentage of professionals choosing a treatment as the most preferred 
treatment option (patient preference)
Single adult trauma Multiple childhood trauma
Trauma-focused 
therapy
(n = 145)
Nontrau-
ma-focused 
therapy
(n = 110)
Trauma-focused 
therapy
(n = 110)
Nontrauma-
focused 
therapy
(n = 145)
Imaginal 
exposure
27.6 12.7 24.5 16.6
EMDR 66.9 68.2 60.0 40.7
Medication .7 3.6 1.8 3.4
Supportive 
counselling
4.8 15.5 13.6 39.3
Case 4: multiple trauma in childhood with patient preference
For means and SDs of preferences for Case 4, see Table 4. The patient’s pref-
erence had a statistically significant effect on the therapists’ treatment suitabil-
ity ratings (F (4, 242) = 17.17, p < .001, Wilks’ λ = .78, partial ŋ2 = .22), with 
between-subject effects for IE (F (1, 245) = 44.07, p < .001, partial ŋ2 = .15), 
EMDR (F (1, 245) = 25.35, p < .001, partial ŋ2 = .09) and supportive counsel-
ling (F (1, 245) = 19.74, p < .001, partial ŋ2 = .08). When the patient expressed 
a preference for a trauma-focused treatment, the therapists judged both IE and 
EMDR as more suitable than supportive counselling.
A main effect was found for IE Credibility (F (4, 242) = 32.16, p < .001, 
Wilks’ λ = .65, partial ŋ2 = .35), with between-subject effects for IE (F (1, 245) 
= 91.18, p < .001, partial ŋ2 = .27) and EMDR (F (1, 245) = 19.25, p < .001, 
partial ŋ2 = .07). IE Credibility was positively related to IE (r = .55, N = 255) 
and negatively to EMDR suitability (r = -.20, N = 255).
Perceived barriers to IE also produced a main effect (F (4, 242) = 6.84, p < 
.001, Wilks’ λ = .90, partial ŋ2 = .10), with between-subject effects for IE (F (1, 
245) = 11.24, p < .001, partial ŋ2 = .04), medication (F (1, 245) = 10.54, p < 
.001, partial ŋ2 = .04) and supportive counselling (F (1, 245) = 12.45, p < .001, 
partial ŋ2 = .05). Perceived barriers to IE was negatively related to IE suitability 
(r = -.23, N = 255) and positively to the suitability ratings of EMDR (r = .21,  
N = 255) and supportive counselling (r = .25, N = 255).
And again the forced choice item (see Table 5) revealed significant differ-
ences between conditions (χ2 (3, 252) = 21.96, p < .001), with post-hoc analyses 
showing the differences between IE and EMDR versus supportive counselling to 
be significant: when the patient expressed a preference for trauma-focused ther-
apy, the therapists opted more frequently for IE (χ2 (1, 123) = 13.69, p < .000) 
or EMDR (χ2 (1,123) = 19.28, p < .001) than for supportive counselling.
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DISCUSSION
In an attempt to find an explanation for the minimal use of imaginal expo-
sure, an evidence based technique, in the treatment of PTSD, we conducted 
an explorative survey among 255 trauma experts practising in Belgium and 
the Netherlands looking at level of training, treatment credibility, perceived 
barriers and the therapist’s sex. Further, we experimentally studied the effect 
of patients’ comorbidity and treatment preferences by randomizing the trauma 
experts to two conditions in which they were presented four video recordings 
of PTSD patients (two single adult trauma and two multiple childhood trauma) 
either with or without comorbid depression and with a preference for trau-
ma-focused or nontrauma-focused treatment. 
We confirmed earlier findings (see Becker et al., 2004) in that only a minor-
ity of the therapists we polled actually used IE to treat their PTSD patients. 
Compared to EMDR and supportive counselling, two other commonly used 
psychological treatments for PTSD, IE was the least-used approach. 
Looking for therapist and patient factors to explain this underutilization, 
we first found that, relative to the two alternative psychological interven-
tions, the participating therapists had received the least training in IE. Given 
that the training in and use of the treatment were highly related for all four 
approaches, we argued that intensifying training in IE might maximize its 
use (see also Sprang et al., 2008). However, in the experimental part of our 
study we found no beneficial effects of superior training in IE on the judg-
ments of and preference for IE. What we did find was that superior training 
in IE was associated with a higher preference for EMDR and a lower prefer-
ence for supportive counselling. In line with the conclusions in the Sprang and 
colleagues study (2008), we suggest that (improved) training in IE does not 
necessarily increase the use of this particular treatment but that it does foster 
the choice for trauma-focused approaches over nontrauma-focused interven-
tions. 
Despite its underuse in our expert cohort, and in contrast to our expecta-
tions, the respondents found IE to be more credible as a PTSD treatment than 
pharmacotherapy or supportive counselling, and, confirming our hypothesis, 
the more training the participants had enjoyed, the more often they offered IE 
in their practice and the more highly they rated its credibility. Interestingly, 
and independent of the presence of a comorbid depression or the patient’s 
preference for a particular treatment, higher IE credibility was consistently 
related to a greater preference for and use of IE. This is in line with treatment 
outcome, a component of treatment credibility, being related to therapists’ 
treatment preferences (Devilly & Huther, 2007). High IE credibility, however, 
did lead to a lower preference for EMDR, suggesting that, unlike training, 
credibility is a treatment-specific factor. To increase therapist confidence in 
IE, and thereby possibly promoting its use, during training it is important 
to emphasize the components that make up the treatment’s credibility, for 
instance by highlighting its rationale and the empirical effects obtained in 
various PTSD populations. Yet, since a therapist’s individual stance towards 
a treatment is another important aspect of treatment credibility, it may also 
be relevant to pay close attention to this aspect, for instance by having the 
therapists experience IE techniques for their own fearful or distressful autobi-
ographic memories during the training sessions. It is our experience that this is 
a very powerful way to increase the credibility of exposure techniques to start-
ing and practising therapists.
Interestingly, the male therapists reported to use IE significantly more 
often than their female colleagues. This does underscore Devilly and Huther’s 
(2007) observation that women tend to view exposure therapy as more 
stressful than men. The men in our cohorts accordingly found IE to be more 
credible than the women. Because treatment credibility strongly influenced 
treatment suitability, the correlation between sex and treatment credibility 
may explain why the factor sex was not significant in the therapists’ choice of 
treatment in our experiment.
Despite the therapists’ relatively high confidence in IE, they did report the 
most barriers for its clinical use relative to the other psychological interven-
tions, which is in accordance with previous research stating that IE, more 
than other trauma approaches, is associated with disadvantages or contrain-
dications (see Becker et al., 2004; Cook et al., 2004). When our ‘victims’ had 
experienced a single trauma in adulthood, the perceived barriers did not play 
a role in the respondents’ choice of IE. However, consistent with previous 
studies (Becker et al., 2004; Cook et al., 2004; Ruscio & Holohan, 2006), fear 
of symptom exacerbation or higher risk of dropout did negatively affect their 
IE preference in the two multiple childhood trauma cases. 
Contrary to previous findings of clinicians reporting fewer barriers to the 
use of exposure when more experienced in the technique (Becker et al., 2004), 
and contrary to our hypothesis, we found that the use of and training in IE 
were relatively unrelated to the obstacles the professionals foresaw. Hence, in 
spite of the evidence against such barriers to IE (see e.g. Cahill et al., 2006), 
our experts tended to persist in their subjective contraindications in the more 
complex PTSD patients, which misperceptions thus need to be explicitly 
addressed in IE training. Additionally or alternatively, to help overcome these 
perceived barriers, exposure programmes may be better tailored to the more 
challenging PTSD patients, similar to Cloitre, Stovall-McClough, Miranda, 
and Chemtob (2004) who offered the survivors of childhood sexual abuse a 
modified exposure programme after the patients had completed skills training 
in affect and interpersonal regulation. 
Overall, in Case 1, the single-trauma-in-adulthood survivor, comorbid 
depression did not change the experts’ preferences for a particular treatment, 
except when they were forced to make a choice, in which case more respond-
ents opted for medication and fewer for psychological treatments, includ-
ing IE, than when judging the same case without comorbidity. In Case 2, the 
victim of childhood sexual abuse, more respondents opted for medication 
and fewer for the two trauma-focused treatments (EMDR and IE) when the 
patient concurrently suffered from depression than when she did not, but here 
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the IE preference rate did not change when they were forced to select the most 
suitable treatment. EMDR preference rates did decrease while the rate for 
medication increased. Note however, that overall psychological treatments 
were still preferred to medicinal treatment.
The patient’s preference for a particular treatment was indeed highly rele-
vant for the therapists’ choice of treatment. When the patient expressed a 
preference for trauma-focused therapy, in all patient cases IE was significantly 
more offered than when the patient preferred nontrauma-focused treatment. 
This finding is also of high clinical relevance in that PTSD patients can play 
an important role in increasing the use of IE. Earlier studies already showed 
that patients tend to prefer psychological treatments to medication (Angelo 
et al., 2008; Cochran et al., 2008; Roy-Byrne et al., 2003), more specifically, 
they prefer CBT, including IE, regardless of the anticipated associated distress 
(Becker et al., 2007; Tarrier et al., 2006). To promote the use of IE in the clin-
ical practice, it may thus be worthwhile to inform PTSD patients better about 
all treatment options, and to encourage clinicians to include the patient’s pref-
erence more explicitly in the treatment decision making process, especially in 
the light of another interesting result we obtained: in contrast to the Becker 
and colleagues (2007) and Tarrier and colleagues (2006) analogue studies 
where patients/respondents preferred exposure to EMDR, we found that, 
regardless of the case and the condition, when therapists were forced to make  
a choice, they preferred EMDR to all other approaches (albeit that this 
tendency was less pronounced in the ‘patient’ with multiple childhood trauma 
who had expressed a preference for nontrauma-focused therapy). Possibly, 
the trauma conference during which we conducted our study had attracted 
relatively more EMDR- than CBT-oriented therapists, which may have biased 
the results. It is, therefore, important that our findings are replicated in other 
therapist cohorts. Alternatively, our finding may also reflect a discrepancy 
between the patients’ preference (favouring exposure over EMDR) and the 
therapist’s first choice (favouring EMDR over exposure), which thus consti-
tutes another important topic for future research, where special attention 
should be paid to identifying the underlying reasons for this discrepancy and 
finding solutions to bring the patient’s preference into line with the choice of 
the therapist who is to deliver the treatment. 
Our study design did not allow us to directly compare the effects for the 
two different trauma types we presented to our expert audience. Nevertheless, 
we did consistently find treatment credibility to play an important role in the 
choice of treatment regardless of trauma type. In contrast, the perceived barri-
ers to a particular treatment were relevant for the therapists’ choice of treat-
ment in the patients who suffered multiple childhood trauma only. Together, 
these findings suggest that when therapists are dealing with more complex 
PTSD patients, the decision-making process is likewise more complex, which 
reflects the current clinical practice, given that there is expert consensus about 
treatment guidelines for ‘simple’ PTSD, but not (yet) for more ‘complex’ 
PTSD (see e.g. Stein et al., 2009). Formulating guidelines for the treatment of 
the latter subgroup will require more randomised controlled studies evaluat-
ing more complex patients as well as consensus among trauma experts.
To our knowledge, ours is the first controlled study into the PTSD-specific 
treatment preferences of trauma professionals. By evaluating both therapist 
and patient variables in a controlled design, we were able to study how these 
factors interact in the treatment decision-making process. By having our study 
incorporated into a conference programme, we could gauge a large number 
of professionals and achieve a high response rate (86.2%). Also, we covered a 
broad range of trauma professionals by including experts from various related 
disciplines all directly involved in the treatment decision-making process 
concerning PTSD victims. For these reasons, we believe that the results of our 
study lend themselves well for generalization to the clinical practice. On the 
other hand, we do not know whether our cohort is representative of other 
professionals working with trauma victims who did not attend this specific 
conference, i.e. whether these health professionals were not or less special-
ized or interested in this area. Therefore, replication of our findings in other 
expert samples (e.g. members of a conference on CBT-related topics) is recom-
mended.
Another point warranting discussion is the lack of a manipulation check. 
Especially in the two cases in which depression was added as a comorbid 
disorder, we have no guarantees that we introduced and represented the factor 
correctly and consistently and are thus unable to say if and to what extent the 
differences we obtained can be safely or fully attributed to the comorbid disor-
der. We would therefore suggest to explicitly check the respondents’ inter-
pretation of the patients’ diagnosis in future investigations. Furthermore, the 
patient cases we presented all featured adult women, which limits the conclu-
sions of our study to this particular population. It would be interesting to 
compare our results with those obtained in adult men and children diagnosed 
with similar and different traumas and comorbidity.
Summing up, we confirmed that, compared to other commonly used PTSD 
treatments, (imaginal) exposure remains an underutilized treatment and 
that trauma professionals are less well trained in exposure-based treatments. 
Patient variables were found to play an important role in the choice of treat-
ment. In case of a comorbid depression, our expert cohort preferred psychop-
harmacotherapy to psychological, trauma-focused approaches, including 
exposure, and when patients expressed a preference for trauma-focused treat-
ment, the experts were more likely to opt for exposure. Therapist characteris-
tics were likewise found to be importantly related to the choice for exposure 
therapy, with the therapist’s confidence in the technique (IE treatment credi-
bility) being the main determining factor. Perceived barriers to exposure (e.g. 
fear of symptom exacerbation and dropout) only correlated negatively to 
exposure preference when PTSD comprised multiple childhood traumas. 
Given that also the trauma professionals we polled were undertrained in 
exposure, that training in exposure was found to be positively related to its use 
and credibility, we recommend encouraging starting professionals and those 
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already working with PTSD victims to seek additional, comprehensive training 
in this proven technique (for training guidelines, also see Litz & Salters-Ped-
neault, 2008). The current results also imply that training should not be solely 
focused on the application of the technique, but also address the generally low 
credibility of and misperceived barriers to the treatment.
APPENDIX A: treatment descriptions
In the original Dutch versions the four treatment descriptions corresponded in 
terms of length and sentence structures. 
1. Imaginal exposure
With imaginal exposure, the patient visits the therapist once a week for a treat-
ment session lasting 60 to 90 minutes. The patient is instructed to close his/
her eyes, and to recount aloud the traumatic event(s) in the first person, in 
the present tense, and as vividly and in as much detail as possible. In the first 
few sessions, the patient is exposed to the less fearful (parts of the) memories. 
Depending on the progress made, in subsequent sessions the patient is gradually 
exposed to the most fearful details of the trauma. Each session is audiotaped 
and a copy handed to the patient with the instruction to listen at home to the 
most recent tape five times a week. 
2. EMDR 
With EMDR (eye movement desensitization and reprocessing), the patient 
visits the therapist once a week for a treatment session lasting 60 to 90 minutes. 
The patient is instructed to hold a distressing image of the traumatic event(s) 
in mind while focusing on a distracting stimulus (e.g. tracking the therapist’s 
finger moving back and forth, or listening to alternating sounds via a headset) 
during several sets of 30 to 45-second intervals. After a set, the therapist asks 
the patient to provide feedback about his/her current thoughts and feelings, 
after which the patient is again instructed to envisage the most prominent and 
distressing image while focusing on the distracting stimulus during another set 
of intervals. 
3. Psychopharmacotherapy
Psychopharmacotherapy entails a regimen of a drug prescribed by a medi-
cal doctor or psychiatrist. The patient is required to visit the attending health 
professional once a week. The therapy will usually consist of an antidepres-
sant, most commonly a selective serotonin reuptake inhibitor (SSRI) like Zoloft 
(sertraline) or Seroxat (paroxetine), the dose of which may be increased for 
several weeks until the optimal dosage has been attained. During the weekly 
visits treatment adherence, treatment effects, dose adjustments and poten-
tial side effects are addressed. The trauma, in terms of event(s) or (in)directly 
related experiences, is not discussed explicitly, nor is explicit advice pertaining 
to trauma processing provided. 
4. Supportive counselling
When receiving supportive counselling, the patient sees a therapist - most 
commonly a qualified psychologist, a social worker or a specialized nurse 
practitioner - once a week. The therapist supports the patient and helps him/
her cope with current daily-life problems, which may or may not be directly 
or indirectly related to the trauma. The topic(s) discussed during the sessions 
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will generally depend on the patient’s input and the most distressing or inhibit-
ing problem at the time. The trauma, in terms of event(s) or (in)directly related 
experiences, is not discussed explicitly, nor is explicit advice pertaining to 
trauma processing provided. However, during the sessions some stress-man-
agement techniques, like breathing exercises or relaxation exercises, may be 
discussed and practised. 
APPENDIX B: case transcriptions
Case 1: single trauma (road traffic accident) suffered during adulthood 
“I just can’t let go of it, even though it happened 7 months ago. I remember I 
was in a hurry; I had some shopping to do. And, because I was reflecting on 
some pressing issues, I wasn’t paying proper attention to the traffic. Suddenly, 
I saw this truck. And I did nothing. I just froze, I couldn’t move. I just sat there 
in the car, waiting, until I heard this enormous ‘Bang’. I don’t remember what 
happened after that. I do remember waking up in the hospital. They told me 
I’d been in a very serious car accident and that I was very lucky to be alive. And 
they were right, because I‘d only broken my arm, and had some shards of glass 
in various parts of my body. Apart from that, I had no other serious injuries. 
At the time, I really felt that I had been very lucky, that I got off well. But a 
week later, I became very restless. I don’t sleep very well. I have very distress-
ing dreams about the accident. The images come flooding into my mind: I am 
back sitting in my car and I see that truck closing in. After these dreams, I wake 
up sweating all over, in utter panic. Since the accident, I have avoided driving. 
I have tried it once, but I flew into a panic and got out of the car immediately. 
It was such a stupid thing to do, just sitting there, freezing up. I keep thinking 
about what I might have done differently. It was all my fault. If I’d paid more 
attention to the traffic, this would never have happened to me!”  
Case 2: multiple trauma (sexual abuse) during childhood
“I’ve been sexually abused by my father when I was a child. It began when I 
was 8 years old. I knew there was something wrong. I was scared to death. It 
continued for 10 years. Until I left home when I was 18. I think I should have 
done more to stop him. I feel dirty and bad because of all these things happen-
ing to me. I’m afraid to leave the house, scared to run into my father. I’m on 
my guard all the time when I’m outside, which is why I live a very isolated 
life, socially. I’ve never told anyone about what happened between my father 
and me. I feel extremely guilty. I’ve never had an intimate relationship and I 
don’t think that I will ever be able to. I think I’ll never be able to really love 
someone. I always sleep with the lights on, always afraid someone’ll come in, 
anxious that someone will be standing beside my bed. I remember the sound 
of my father walking towards my room. I can still feel the pain I felt, during 
everything he did to me. It’s like everything’s happening over and over again.”   
Comorbidity supplement: depression 
“I feel sad. I just seem to be unable to feel any joy or enthusiasm. I’m so very 
tired all the time, lacking all energy from the time I wake up in the morn-
ing to the time I go to bed at night. I am too tired to even make a sandwich. 
Everything is an effort. I feel worthless. Everything seems pointless. It’s not that 
I have actually ever considered committing suicide, but sometimes I lie in bed 
thinking: “If I don’t wake up tomorrow, I wouldn’t mind.” 
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Case 3: single trauma (robbery) in adulthood
“A while ago, I was told to close up the shop where I work together with a 
colleague. We needed to refill the shelves with some new products after clos-
ing time. But I forgot to lock the shop door, so stupid of me. Suddenly, he’s 
there, inside the shop. Afterwards, the police asked me for a description, but I 
couldn’t tell them anything about that man. All I could remember was the gun 
in his hand. He said that if we did what he told us to do, nothing would happen 
to us. He wanted the money that we’d already put away in the safe. I had the 
feeling that it took hours before I managed to type in the code. I was shaking 
all the time. After I’d opened the safe, the man tied our hands and feet with a 
rope and put duct tape over our mouths. The police arrived very soon after. I 
can’t exactly remember what happened at the police station. I can’t recall any 
of the answers I gave to the police officers’ questions. Now, I can’t stop thinking 
about what happened in the shop that day. It feels as if everything’s happening 
all over again; it’s as if everything keeps recurring. The first day I went back to 
work after the robbery, I was on the alert all the time. I kept watching the shop 
door the whole day. I feel so immensely stressed out; I lose my nerve with every 
little sound. I don’t want to think about what’s happened, but I just can’t stop 
the thoughts rushing back. I should’ve locked the door that Saturday night! If I 
had, nothing would’ve happened to me or to my colleague!” 
Case 4: multiple trauma (physical and psychological abuse) during childhood 
“My mother died when I was 4 years old. Not long after she’d died, my father 
started drinking and in the same period he got into a new relationship. That’s 
when everything started to go wrong. My father‘s new partner mistreated me 
and my sister, both mentally and physically. She got extremely angry if we 
didn’t act the way she wanted us to. She kept telling us that we were bad chil-
dren and that our mother had died because of us. If I didn’t do what she told me 
to, she locked me up in a closet, sometimes for more than half a day. My dad 
did nothing to stop her; I’ve always wondered whether he actually knew what 
was going on. I left home when I was 20 and have since seen my father only 
twice. It was terrible. All these painful memories came flooding to my mind. 
I didn’t want that anymore, so I decided to break up with my dad. I’m doing 
fine now. I have a nice job, a nice boyfriend. But still, it’s like I’m restless. I’m 
very cagey, even though I know that I don’t need to be on the ball all the time 
anymore. I get these dreams about her locking me up in the closet again. And 
I hear her shouting at my sister. I want to help my sister but I can’t, I‘m unable 
to get out of the closet and I start panicking. I don’t want this anymore. I want 
to forget everything that’s happened. I also broke up with my sister. I feel awful 
about that because I love her so much, but every time I saw her, she reminded 
me of what happened when we were young. And I couldn’t cope with that any 
longer. I wonder if I’ll ever be able to start my own family. How can I show love 
to my children, love I never got? How can I ever be a good mother?” 
Treatment preference supplement: trauma-focused therapy 
“My therapist told me about the various treatment options. I prefer EMDR 
or exposure. I think it’s going to be difficult, because I need to go through 
everything that happened to me again and I need to talk about all these awful 
incidents. But that is o.k. with me.” 
Treatment preference supplement: no trauma-focused therapy 
“My therapist told me about the various treatment options. I would prefer 
medication or supportive counselling. They sound easier. I don’t want to go 
over my whole history again.”
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Day 1: Amy is in two minds about me keeping a diary this week, but it gives me something to do the next few days while she’s at the treatment centre. Something that gives me purpose – a mission –, the idea that I’m also contributing now that she is 
so brave trying to come to terms with the past, dispelling her demons. 
I feel put at a distance a little, really, it’s between her and the treatment 
team now, no need for me to watch out for my baby sister. How scared 
I was each time I heard the doorbell ringing these past few years! Each 
time dragging my feet, expecting two police officers come to tell me 
that Amy had killed herself. The memories of our father abusing her had 
driven her crazy, driving her to her death. I wonder what she’ll be like 
when she comes home after this first long day away.
Day 2: I was fretting about like an impatient puppy last night, waiting 
for her to return to the hotel, filled with questions about how things 
had gone, firing one question after the other at her. It took me a full 10 
minutes to notice the expression on her face, telling me she didn’t feel 
like talking. She wanted to go out for a walk. We went walking for ages, 
in silence. Me trying to suppress all my questions. And now I’m practi-
cally coming undone. I can’t stop thinking about her. What’s happening 
at the centre? Why doesn’t she want to share things with me? 
Day 3: Been out walking again; quite a nice place here, by the way. Nic-
er than up north in Friesland I have to admit. Today, Amy volunteered 
to tell me about the sessions, how she’d managed to surpass herself, to 
conquer her fears. How she’d allowed the memories to resurface, the 
memories she’d tried to suppress for the past 20 years. How she was 
tired out but still felt strong and empowered. For the first time after a 
long time, I saw a new sense of confidence in the way she looked at me.
Day 4: Visited the museum today; loved the exhibits. I was sudden-
ly overcome by a sense of shame, guilt even, once I realised I hadn’t 
thought of Amy the past few hours, fascinated as I was by all the beau-
tiful Roman artefacts on display. I’m writing this with Amy sleeping in 
the bed next to me. We met in the hotel lobby earlier today and, out of 
the blue, I immediately started telling her about what I’d seen that af-
ternoon, that it had inspired me to maybe pick up my art history studies 
again. I saw tears welling up in her eyes when she told me I had made 
her feel like a sister again instead of a patient to be looked after. 
Day 5: It’s been a long drive but we’re back in Friesland – looking for-
ward to just being sisters again.
62
Chapter 3
Feasibility of  
brief intensive 
exposure therapy  
for PTSD patients  
with childhood  
sexual abuse:  
a brief clinical report
This chapter is based on: Hendriks, L., de Kleine, R. A., van Rees, M., Bult, C., & 
van Minnen, A. (2010). Feasibility of brief intensive exposure therapy for PTSD 
patients with childhood sexual abuse: a brief clinical report. European Journal of 
Psychotraumatology, 1, 5626.
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ABSTRACT
Despite the strong empirical support for the effectiveness of exposure-based 
treatments in ameliorating posttraumatic stress disorder (PTSD), improve-
ment of treatment is wanted given relatively high dropout rates and challenges 
of treating patients with high comorbidity and treatment-interfering stressors. 
The purpose of the current paper is to introduce an intensive exposure treat-
ment programme, illustrated by four case descriptions of PTSD patients, who 
suffered multiple (sexual) traumas in childhood, had high levels of comorbidity 
and psychosocial stressors, and failed to improve during ‘‘regular’’ trauma-fo-
cused treatment programmes. The programme consisted of psychoeduca-
tion, prolonged imaginal exposure, exposure in vivo, exposure by drawings 
combined with narrative reconstructing, and writing assignments about central 
trauma-related cognitions. The treatment included 5 working days with indi-
vidual sessions (in total 30 h of treatment) provided by a team of four thera-
pists. The PTSD symptoms of all patients decreased substantially and the effect 
sizes were large (Cohen’s d resp. 1.5 [pre-post], 2.4 [pre-FU1 month], and 2.3 
[pre-FU3 months]). Also, none of the patients showed symptom worsening or 
dropped out. The evaluation of these four pilot cases suggests that it is possible 
to intensify exposure treatment, even for multiple traumatized PTSD patients 
with high comorbidity. We concluded that the first results of this new, intensive 
exposure programme for PTSD patients with childhood sexual abuse are prom-
ising.
INTRODUCTION
Exposure-based treatments proved to have strong empirical support for their 
effectiveness in ameliorating PTSD and related psychopathology (Powers, 
Halpern, Ferenschak, Gillihan, & Foa, 2010) and are recommended world-
wide in the official treatment of PTSD guidelines (see e.g. International Society 
for Traumatic Stress Studies, ISTSS, Foa, Keane, Friedman, & Cohen, 2009; 
National Institute for Health and Care Excellence Guidelines on PTSD, NICE, 
2005). However, improvement of treatment is wanted, given for instance rela-
tively high dropout rates (36%; Arntz, Tiesema, & Kindt, 2007) and challenges 
of treating patients with high comorbidity and treatment-interfering psychoso-
cial stressors.
Several studies showed that comorbidity and trauma characteristics did 
not influence exposure treatment outcome (Powers et al., 2010; van Minnen, 
Arntz, & Keijsers, 2002). However, irregular attendance at therapy was related 
to treatment outcome (Tarrier, Sommerfield, Pilgrim, & Faragher, 2000). This 
is in line with our clinical experience that patients with high comorbidity and 
psychosocial stressors can profit from exposure but, due to incompliance and 
irregular session attendance, the exposure cannot always be properly dosed. 
That brought us to comprise and intensify the exposure treatment.
Remarkably, although there are intensive brief treatments available for 
patients with other anxiety disorders like obsessive-compulsive disorder (OCD) 
and panic disorder, scarce brief intensive treatments have been developed for 
PTSD. Recently, intensive cognitive behavioural treatment was shown to be 
feasible for the treatment of 14 PTSD patients with single trauma in adulthood 
(Ehlers et al., 2010). Patients received up to 18 h of therapy over a period of 
5–7 working days. No patients dropped out, the treatment was well tolerated 
and was effective; 85.7% of the patients no longer had the diagnoses PTSD at 
posttreatment. Also, a non-controlled study of an intensive treatment, including 
exposure therapy techniques, with multiple traumatized PTSD patients showed 
good treatment outcome results and low dropout rates (3%; Gantt & Tinnin, 
2007).
The present study presents the intensive exposure treatment programme 
illustrated by four case descriptions of PTSD patients who suffered multiple 
(sexual) traumas in childhood, including childhood sexual abuse, physical 
abuse, rape, emotional neglect, and had high levels of comorbidity and psycho-
social stressors including problems with the primary support group, problems 
related to the social environment, occupational problems, and economic prob-
lems. All patients had failed to improve during ‘‘regular’’ one-session per week 
trauma-focused treatment programmes (prolonged exposure or eye movement 
desensitization and reprocessing, EMDR).
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The intensive exposure therapy (IET)
The intensive exposure therapy (IET) programme included 5 working days with 
individual sessions from 08:30 a.m. to 16:30 p.m. (with a few breaks, mean of 
6 h of treatment a day, in total 30 h, 24 h dedicated to the trauma processing). 
All four patients were treated by one team of four therapists.
The treatment mainly followed the prolonged exposure principles of Foa’s 
programme (Foa, Rothbaum, Riggs, & Murdock, 1991), including exposure 
in vivo elements, but also included exposure by drawing a narrative (see also 
Gantt & Tinnin, 2007) and cognitive restructuring.
At the first day, a non-traumatic but anxious childhood event was processed 
to train the patient in the treatment techniques. Every next day, one concrete 
traumatic event identified by the patient as most representative for a certain 
type or period of traumatization, guided by their most intrusive recollections, 
was selected for processing. For processing, the following treatment techniques 
were used every day.
The first technique was psychoeducation about relevant trauma-related 
subjects, respectively, trauma responses including tonic immobility; memory 
including amnesia, dissociation including some grounding techniques; comor-
bidity including the relationship with PTSD-symptoms; and life after treatment. 
The second technique was prolonged imaginal exposure (60–90 min) in which 
the patient was asked to imagine the traumatic event as vividly as possible, with 
closed eyes, in the present time, and as detailed as possible. The third technique 
was exposure by drawings combined with narrative reconstructing. The patient 
drew a picture story (a graphic narrative) of the trauma in which each scene 
was drawn on a separate sheet of paper. Most attention was paid to the draw-
ings of the ‘‘hotspots’’ of the traumatic memory, and patients were instructed 
to include all details of the trauma within the drawings. Besides the draw-
ings of the scenes of the trauma, the patient made a pre- and post-traumatic 
event drawing, in which the patient was relaxed, to bracket the actual trauma. 
Afterward, one of the therapists attached the drawings to a display board and 
‘‘re-presented’’ the narrative to the patient and therapist team. In addition, 
as the fourth technique, the patients were in vivo exposed to trauma-related 
material including, for instance, their diaries, pictures, books, movies, clothes, 
and so on. The final part of treatment consisted of a writing assignment about 
the trauma, especially about central trauma-related cognitions such as ‘‘I am 
a weak person’’ or ‘‘It was my fault that this happened.’’ New views concern-
ing the traumatic event were imparted to regain a sense of control and patients 
were asked to write advice to themselves.
During the evenings and nights, the patients stayed in a hotel to help them 
in limiting interference of psychosocial stressors in the context of their home 
environment. However, there were no restrictions with regard to contact with 
family members or friends.
The four described cases were regular referrals to the Centre for Anxiety 
Disorders. Prior to the baseline measures, the patients were assessed with the 
Mini-International Neuropsychiatric Interview (M.I.N.I.; Sheehan et al., 1998) 
and the Dutch version of the Structural Clinical Interview for DSM-IV Axis 
II disorders (SCID II; First, Gibbon, Spitzer, Williams, & Benjamin, 1997) to 
verify diagnoses. Trauma characteristics, psychiatric treatment history, and 
psychosocial stressors were inquired during a structured interview. The patients 
completed the PTSD symptom scale self-report (PSS-SR; Foa, Riggs, Dancu, & 
Rothbaum, 1993) at pre-treatment (day one), after the therapy (1 week after 
day one), and at two follow-ups (after 1 month and after 3 months). Every 
treatment day, patients rated their level of anxiety concerning the recollection 
processed that day on a 10-point scale (1 = no anxiety, 10 = extreme anxiety) at 
the start of that day and at the end of that day. Furthermore, patients rated the 
experienced burden at the end of every treatment day on a 10-point scale (1 = 
not at all, 10 = extreme high).
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Case examples
Table 1 shows the results for the PSS-SR at pre-treatment, posttreatment and 
follow-ups after 1 and 3 months for the four cases.
Table 1. Statistics for the total PSS-SR and the three PSS-SR subscales (recollections, avoidance, and 
arousal) at pre-treatment, posttreatment, and follow-up after 1 and 3 months for the four cases
Pre-treatment Posttreatment 1 M 3 M
Case one
   PSS-SR 19 27 18 14
   Recollections 9 12 3 0
   Avoidance 4 7 8 10
   Arousal 6 8 7 4
Case two
   PSS-SR 37 10 17 21
   Recollections 12 4 3 5
   Avoidance 14 2 6 8
   Arousal 11 4 8 8
Case three
   PSS-SR 36 8 11 19
   Recollections 15 1 4 6
   Avoidance 13 3 4 8
   Arousal 8 4 3 5
Case four
   PSS-SR 39 27 19 12
   Recollections 11 8 7 3
   Avoidance 12 11 7 4
   Arousal 16 8 5 5
Means (SD)
   PSS-SR 32.8 (9.25) 18.0 (10.42) 16.3 (3.59) 16.5 (4.20)a
   Recollections 11.8 (2.50) 6.3 (4.79) 4.3 (1.89) 3.5 (2.65)
   Avoidance 10.8 (4.57) 5.8 (4.11) 6.3 (1.71) 7.5 (2.52)
   Arousal 10.3 (4.35) 6.0 (2.31) 5.8 (2.22) 5.5 (1.73)
Note. 1 M = follow-up after 1 month; 3 M = follow-up after 3 months; SD = standard deviation.
aCohen’s d resp. 1.5 (pre-post), 2.4 (pre-1 M) and 2.3 (pre-3 M). 
Case one
Diagnostic details
Case one was a 30-year-old woman who reported repeated sexual abuse in 
childhood (starting when she was a 3-year-old until she was a 5-year-old) by her 
stepfather, emotional neglect by her mother who was alcohol addicted (starting 
when she was an 11-year-old), threat with a knife in childhood (10-year-old), 
and a physical assault during adulthood (17-year-old). She met the DSM-IV 
criteria for PSTD, reporting intrusive distressing perceptional recollections, 
emotional numbing, and hyperarousal. She also met the criteria for borderline 
personality disorder, reporting identity disturbance; impulsivity concerning 
eating and substance abuse; affective instability; chronic feelings of emptiness; 
and transient, stress-related paranoid ideation. Finally, she met the criteria for 
alcohol abuse (age of onset 26 years old) and had a history of major depression 
(age of onset 22 years old).
Psychiatric treatment history
The patient’s treatment history consisted of hospitalization in a mental health 
clinic when she was 23 years old because of depression. In addition, she had 
had an outpatient treatment aimed at the borderline personality disorder, which 
she quit because of paranoid symptoms. Also, she engaged in an outpatient 
(one session per week) prolonged exposure programme aimed at the PTSD 
but failed to improve, probably due to low treatment compliance because of 
constantly interfering stressors in her life and avoidance to disclose the most 
distressing details of her traumatic experiences. In addition to the psycholog-
ical treatments, she underwent several pharmacological treatments, including 
two different kinds of selective serotonin reuptake inhibitors (SSRIs), a benzo-
diazepine, an antipsychotic, two different kinds of tetracyclic antidepressants 
(TCAs), and sleep medication, with no results. At the start of the IET, the 
patient was on a stable dose for 2 years of a TCA (Mirtazipine, 45 mg).
The intensive exposure therapy (IET) intervention
At the first day, the IET started with processing a non-traumatic event about 
a situation in which the patient saw her little sister falling in the water and 
saved her. During day two and three, the recollection of the sexual abuse by 
the patient’s stepfather was processed. At the second day, the sexual abuse 
was processed in detail including touching, penetration, and secretive atti-
tude. During the exposure, the patient’s anxiety levels increased to a high level. 
During the exposure, she felt ashamed to disclose explicit details of the sexual 
abuse and refused to do so. However, on the third day, she wanted to complete 
the story and filled in the details she left out the day before. She made detailed 
drawings of explicit sexual acts and during the prolonged exposure her anxiety 
levels decreased. The exposure in vivo mainly consisted of looking at pictures 
of her stepfather. During the writing assignments, she discussed with herself the 
function of drinking alcohol. During day four, the emotional neglect due to her 
mother’s alcohol problems was the central focus. The patient chose the recol-
Feasibility of intensive exposure therapyChapter 3
7170
lection that she came home with her oldest sister while her mother was drunk. 
During day five, the recollection of the moment that her mother’s friend put 
a knife on her sister’s throat was processed. During the writing, she discussed 
with herself her feelings of responsibility toward her sisters and imparted new 
views.
Results
During day two, the level of anxiety when experiencing the recollection of that 
day decreased from 8 toward 5. During day three, the level of anxiety decreased 
from 9 toward 3. At day four, this level decreased from 7 toward 5 and during 
day five, from 8 toward 6. Severity of PTSD symptoms, especially recollections, 
was reduced substantially.
The patient rated the experienced burden at the end of every treatment 
day with an average of 6.6. The patient experienced the IET as confronting 
and tiring; however, she reported that for the first time in life she has positive 
thoughts about her future.
Case two
Diagnostic details
Case two was a 49-year-old woman who reported repeated sexual and physical 
abuse in childhood by her father (during her whole childhood, mainly between 
8 and 16 years old) and repeated sexual and physical abuse in adulthood within 
intimate relationships (mainly as an 18 until 20 years old). She met the DSM-IV 
criteria for PTSD, reporting recurring distressing dreams; intrusive distressing 
recollections; avoidance of thoughts associated with the rapes; inability to recall 
important aspects of the trauma; diminished interest in significant activities; 
feeling of detachment from other, restricted range of affect; sense of foreshort-
ened future; sleeping problems; irritability; difficulty concentrating; hypervig-
ilance; and an exaggerated startle response. Besides that, she met the DMS-IV 
criteria for OCD, specific phobia, panic disorder without agoraphobia, social 
phobia, and bipolar II disorder (age of onset 38 years old). Furthermore, she 
met the criteria for borderline personality disorder, reporting frantic efforts to 
avoid abandonment, a pattern of unstable interpersonal relationships, identity 
disturbance, and affective instability.
Psychiatric treatment history
The patient’s treatment history consisted of an outpatient family therapy, 
hospitalization in a mental health clinic, when she was 35 years old because 
of depression and suicidal behaviour and outpatient treatment aimed at the 
borderline personality disorder. Furthermore, she engaged in several outpa-
tient trauma-focused treatments with no results. All treatments lacked effect. At 
the time of the IET, the patient was using a serotonin-norepinephrine reuptake 
inhibitor (SNRI, Venlafaxine, 75 mg) and was on a stable dose for 3 years.
 
The intensive exposure therapy (IET) intervention
At the first day, the IET started with processing a non-traumatic event about a 
bullying in childhood. During day two, the patient focused on the sexual and 
physical abuse by her father. The patient chose two specific recollections that 
reflected the theme. First, she chose the recollection that her father watched her 
changing a tampon. Second, she chose a specific moment when she was beaten 
by her father. During the exposure, the patient experienced dissociative symp-
toms; however, later on she applied some simple grounding exercises to resist 
the dissociating successfully. During day three, the recollections of the sexual 
abuse during different intimate relationships was processed such as the moment 
that the patient was forced to do oral sex. During day four, the death of the 
patient’s cat was processed. The most important recollection was the moment 
that the patient picked up her cat and felt that all the bones were broken. 
During day five, the patient focused on the death of her mother. The main intru-
sive recollection was a situation in which the mother negatively judged the care 
she received from the patient. The exposure in vivo mainly consisted of looking 
at several pictures and home videos.
Results
During day two, the level of anxiety when experiencing the recollection of 
that day decreased from 10 toward 8. During day three, the level of anxiety 
decreased from 7 toward 2. At day four, this level decreased from 10 toward 7 
and during day five, from 8 toward 5. Severity of PTSD symptoms was reduced. 
At follow-up after 3 months, recollections, arousal, and avoidance reduced 
comparably.
The patient rated the experienced burden at the end of every treatment day 
with an average of 5.6. The patient experienced the IET as confronting and 
tiring; however, she reported she felt save and learned a lot. She valued the 
results of the IET as very good. 
Case three
Diagnostic details
Case three was a 27-year-old woman who reported physical abuse in childhood 
by her father (during her whole childhood, mainly between 8 and 16 years old), 
sexual abuse in childhood by her sister and brother (as a 10 until 12-year-old), 
sexual abuse in childhood by a neighbour (as a 8-year-old), and sexual abuse 
in adulthood (as a 26-year-old). She met the DSM-IV criteria for PSTD report-
ing recurring distressing dreams, intrusive distressing recollections, flashbacks, 
hypervigilance, an exaggerated startle response, trichotillomania, and recur-
rent major depressive episodes in partial remission (age of onset 20 years old). 
Furthermore, she had features of borderline personality disorder, reporting 
frantic efforts to avoid abandonment, identity disturbance, recurrent self-muti-
lating behaviour, and affective instability.
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Psychiatric treatment history
The patient’s treatment history consisted of a day-care treatment where her 
depression was treated effectively, day-care treatment aimed at the personality 
disorder where the patient’s need for PTSD treatment was not met, an outpa-
tient depression treatment, hospitalization in a mental health clinic when she 
was 26 years old, where again the patient’s need for PTSD treatment was not 
met, and hospitalization in a mental health clinic aimed at PTSD when she 
was 27 years old. During this last hospitalization, she had several trauma-fo-
cused EMDR sessions with no results. Besides that, she had several pharma-
cological treatments, consisting of SSRIs and benzodiazepines, with minimal 
results. At the time of the IET, the patient was still under medication using a 
SSRI (Sertraline, 50 mg), a benzodiazepine (Clonazepam, 0.5 mg), and was on a 
stable dose for 1 year.
The intensive exposure therapy (IET) intervention
At the first day, the IET started with a non-traumatic event about being bullied 
during childhood. During day two, the recollection of the sexual abuse by a 
neighbour was processed. The patient chose a specific recollection that reflected 
the theme in which she was on a bicycle and a neighbour touched her vagina. 
During day three, the sexual abuse by her brother and sister was the central 
focus. At the third day, the sexual abuse was processed in detail including pene-
tration. The patient had a tendency to elaborate on non-significant details and 
had trouble narrowing down the traumatic aspects of her experiences. This 
complicated the imaginal exposure. In the exposure by drawings, she was asked 
to draw her hotspots first and fill in the details later, by doing so she was able 
to complete her stories. During day four, she focused on the physical abuse by 
her father. During the writing assignment the central theme was her feelings of 
loneliness and desertedness by mother. During day five, the physical abuse by 
her family members was processed. She exposed herself to several occasions 
of physical abuse of which she only focused on the hotspot. By doing so, she 
condensed a long period of violence in the family into one bound story.
Results
During day two, the level of anxiety when experiencing the recollection of that 
day stayed 7. During day three, the level of anxiety decreased slightly from 8 
toward 7. At day four, this level decreased from 9 toward 7 and during day five, 
from 8 toward 7. Severity of PTSD symptoms was reduced. At follow-up after 3 
months, recollections, arousal, and avoidance reduced comparably.
The patient rated the experienced burden at the end of every treatment 
day with an average of 6.8. She valued the results of the IET as very good and 
reported that she was less numb and felt more powerful during the treatment.
The patient still met the criteria for trichotillomania and was referred else-
where for specialized treatment. Besides that, she was still involved in a post-
care programme of the mental health clinic she was hospitalized in.
Case four
Diagnostic details
Case four was a 32-year-old woman who reported sexual abuse during child-
hood by her sports trainer (as a 13 until 14-year-old) and physical abuse during 
childhood by her father (during her whole childhood). She met the DSM-IV 
criteria for PTSD, reporting recurring intrusive distressing thoughts, recurring 
distressing dreams, flashbacks, avoiding thoughts and activities associated with 
the trauma, diminished interest in significant activities, feeling detached from 
others, restricting range of affect, sleeping problems, irritability, hypervigilance, 
and exaggerated startle response. Furthermore, she met the DSM-IV criteria for 
dissociative disorder not otherwise specified (NOS) and recurrent severe major 
depressive episodes without psychotic features (age of onset 16 years old). 
Psychiatric treatment history 
The patient’s treatment history consisted of an outpatient depression and PTSD 
treatment (EMDR), but she failed to improve due to strong dissociative symp-
toms and an extreme high level of anxiety. In addition to the psychological 
treatments, she underwent several pharmacological treatments, including two 
different kinds of SSRIs, a SNRI, a TCA, an antipsychotic, and a benzodiaze-
pine with no results. At the time of the IET, the patient was on a stable dose of 
two different kinds of antipsychotics (Olanzapine, 10 mg for 1 year; Levome-
promazine, 50 mg for 10 months), a benzodiazepine (Midazolam, 15 mg for 1 
year), and an antiepileptic medication (Lamotrigine, 15 mg for 8 months).
The intensive exposure therapy (IET) intervention
At the first day, the IET started with processing a non-traumatic event about 
the patient’s stay in a hospital during childhood. During day two and three, the 
recollection of the sexual abuse by her sports trainer was processed. The patient 
chose a specific recollection that reflected the theme in which her sports trainer 
lay on her in a car. The patient had a lot of trouble disclosing the details of the 
trauma, her anxiety levels rose high and she experienced dissociative symptoms 
including conversion paralysis and loss of consciousness. Therefore, it took 2 
days to complete the story of the sexual abuse. During day four, it was decided 
to halt the treatment for one part of the day because of the patient’s dissociative 
and fatigue symptoms. Despite these problems, however, she managed to do the 
drawings of the trauma of that day on her own in the hotel. During day five, she 
focused on the violent behaviour of her father as well as the death of her best 
friend. During the writing, she discussed with herself her views during child-
hood and imparted new views concerning the traumatic event.
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Results
Severity of PTSD symptoms was reduced. At follow-up after 3 months, recol-
lections, arousal, and avoidance reduced comparably.
The patient rated the experienced burden at the end of every treatment day 
with an average of 8.3. She reported that she had learned a lot. She experienced 
the treatment as very extensive; however, she was very satisfied with the fixed 
structure. Furthermore, she was satisfied with the effects of the IET.
Because the patient is suffering recurrent severe major depressive episodes, 
the pharmacological treatment, which she received in another mental health 
care centre, was continued after the IET.
Overall results of the intensive exposure therapy (IET)
All patients improved in PTSD symptoms during treatment and the effect sizes 
were large (Cohen’s d resp. 1.5 [pre-post], 2.4 [pre-FU1 month], and 2.3 [pre-
FU3 months]). Overall, treatment effects were most pronounced in decreasing 
re-experiences. What is more, none of the patients showed symptoms worsen-
ing during or after the treatment, none dropped out, and treatment compliance 
and attendance was optimal (100%). Finally, patients themselves experienced 
and rated the IET as an acceptable treatment. These findings indicate that 
the IET was possible and feasible, even in this group of severely traumatized 
patients with high levels of comorbidity. 
However, some important difficulties occurred during the IET. First, it was 
very difficult for some patients to disclose explicit details of their traumas, espe-
cially during the prolonged imaginal exposure. For some patients, avoidance 
of those details was also an obstacle during earlier trauma-focused treatments. 
Our impression was that the exposure by drawing was helpful in overcoming 
this avoidance because the explicit details could be filled in step by step. Also, 
for the therapists it was more visible and thus controllable what was miss-
ing in a specific picture. In addition, some patients needed more time than the 
regular 60–90 min sessions to reveal the traumatic details, which was avail-
able in the IET. Another difficulty was that some patients experienced strong 
dissociative symptoms that complicated the imaginal exposure. In some cases, 
patients resisted the dissociation successfully by applying some simple ground-
ing exercises; in other cases, the technique of imaginal exposure was adapted, 
for instance, by letting patients open their eyes or telling the story from a third 
person perspective. Again, we felt that the exposure by drawings was helpful 
in this respect perhaps because drawing, holding a pencil, has some similarities 
with grounding techniques. Also, the time aspect was important; sometimes we 
just waited a while for the anxiety levels to decrease, the associated dissociation 
to disappear, and could then continue the exposure, which is, in practical sense, 
harder to do during regular 60–90 min sessions.
DISCUSSION
The evaluation of these four pilot cases suggests that it is possible to intensify 
exposure treatment, even for multiple traumatized PTSD patients with high 
comorbidity. The first results are promising; the effect size was good, patients 
showed no symptom worsening, no patients dropped out, and all patients 
complied to all five treatment days and indicated the burden of treatment as 
acceptable. This study confirmed the results of Ehlers’s study (2010) that inten-
sive trauma-focused treatment is possible and feasible, and extended those 
results to patients with sexual abuse in childhood and high comorbidity.
The presented patients who succeeded in IET all failed in weekly dosed 
trauma-focused therapy, implying that it is not per se the treatment in itself 
(exposure technique) that should be improved or adapted but the implementa-
tion and dose of treatment. Especially for those patients with high psychosocial 
stressors, problems of treatment attendance and compliance can be adequately 
solved by presenting them a more intensive way to engage in trauma-focused 
treatments. We also had the impression that the longer sessions within the IET 
helped patients to overcome their avoidance in revealing details of the trauma. 
We also think that providing exposure in several ways (reliving, exposure in 
vivo, drawings) helped patients to overcome difficulties experienced during 
earlier failed treatments (e.g. dissociation).
An important limitation of this study is that at this moment we don’t know 
the long-term effects. It is thinkable that, given the context dependence of 
extinction, fear returns when patients go back to their own daily life context 
(Effting & Kindt, 2007). However, the 3 month follow-up results are promis-
ing. We also felt that the inclusion of exposure in vivo materials such as family 
pictures and home videos helped to broaden the treatment context. However, 
future studies should focus on long-term effects and relapse. Also, we don’t 
know which elements of the IET were effective and what the most optimal 
order of the five IET techniques is. Future research should study those issues.
Other limitations are that this was a small, non-controlled study with 
limited outcome measures. Future controlled studies could compare this new 
treatment with existing regular treatments such as prolonged exposure, or with 
adapted treatment programmes for PTSD-patients who suffered sexual abuse 
in childhood such as Skills Training in Affective and Interpersonal Regulation 
(STAIR; Cloitre et al., 2010).
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CONCLUSION
To conclude, the first results of this new, intensive exposure treatment 
programme showed that this is a promising approach. Patients who failed  
to improve during regular trauma-focused treatments did improve substantially 
during the IET. Treatment attendance and compliance was optimal,  
there was no symptom worsening, and none of the patients dropped out.  
What is more, patients were satisfied with the programme and found the  
treatment acceptable.
This study showed that intensive exposure therapy is feasible and possible, 
even for PTSD patients who suffered repeated childhood sexual abuse and  
had high levels of comorbidity. Maybe this intensive treatment is even more 
indicated for this group of patients, because it prevents stressful daily life  
events to interfere with the treatment and helps them overcome severe avoid-
ance behaviour.
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Prepared speech:  Welcome all! I so vividly remember the smells leaving the treat-ment centre for the last time, the sultriness after the summer shower, having completed the trauma treatment. Successfully, 
finally! A year has passed, and I just want to say: Thank you for keep-
ing faith in me despite me having gone in and out of therapy. Each 
time fighting those images, images that kept creeping up on me, not 
forgiving myself for letting myself end up in this loverboy situation. 
Each time I was admitted, and started a new treatment, I tried to learn 
to process all that I’d gone through, to learn to no longer avoid every 
situation that reminded me of these horrendous times. I tried, a little, 
briefly, before withdrawing again, hating myself for not being able to 
conquer my fears.
Until last year. I’d decided to make a final attempt and to brazenly 
commit myself to face my memories and to expose myself to all the 
situations I’d been avoiding for all these years. The interventions were 
similar to those of the earlier treatments. I was asked to close my eyes 
and recall out loud and in detail the most difficult episodes and to 
confront rather than avoid scary situations outside, all part of everyday 
life. But this time I persevered, feeling that I was gaining ground, inch 
by inch. 
I’ve thought long and hard about what it was that happened that 
time around. The therapists suggested it may have been the high 
intensity of the exposure sessions, their close succession that left 
less room for avoidance behaviours between sessions. I think this 
may well have played a role. But I think there was another difference. 
For the first time I was held accountable for my own actions. The ball 
was in my court, or rather, I could play or not play along. The thera-
pists explained the pros and cons of working through key events but 
still let me decide when and which to tackle. And after each session 
I simply went home, to my place! I know some of you thought it all 
sounded a bit harsh. As if I was left to fend for myself despite me being 
so desperately low. But that’s not what happened at all. I was being 
acknowledged more than ever before. I was no longer being treated as 
a patient in need of protection but as a woman who was trying to cope 
with her PTSD and making her own decisions. I’ve since hardly had any 
intrusive memories, I’ve taken up work again and been getting out, as 
most of you know. Doing nice things, like this lunch with you, guys. I 
raise my glass, to you, for your unconditional support and your faith in 
me… and the regained faith in myself!
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Chapter 4
Intensive prolonged 
exposure therapy for 
chronic PTSD patients 
following multiple 
trauma and multiple 
treatment attempts
This chapter is based on: Hendriks, L., de Kleine, R. A., Broekman, T. G., Hendriks, 
G. J., & van Minnen, A. (2018). Intensive prolonged exposure therapy for chronic 
PTSD patients following multiple trauma and multiple treatment attempts. 
European Journal of Psychotraumatology, 9, 1425574.
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ABSTRACT
Suboptimal response and high dropout rates leave room for improvement of 
trauma-focused treatment (TFT) effectiveness in ameliorating posttraumatic 
stress disorder (PTSD) symptoms. The main purpose of the present trial was 
to explore the effectiveness and safety of intensive prolonged exposure (iPE) 
targeting chronic PTSD patients with a likely diagnosis of ICD-11 complex 
PTSD following multiple interpersonal trauma and a history of multiple treat-
ment attempts. Participants (N = 73) received iPE in 12 × 90-minute sessions 
over four days (intensive phase) followed by four weekly 90-minute booster 
prolonged exposure (PE) sessions (booster phase). The primary outcomes, clini-
cian-rated severity of PTSD symptoms, and diagnostic status (Clinician-Ad-
ministered PTSD Scale; CAPS-IV) were assessed at baseline, posttreatment, and 
at three and six months. Treatment response trajectories were identified and 
predictors of these trajectories explored. Mixed model repeated measures anal-
ysis of CAPS-IV scores showed a baseline-to-posttreatment decrease in PTSD 
symptom severity (p < .001) that persisted during the three and six-month 
follow-ups with large effect sizes (Cohen’s d > 1.2); 71% of the participants 
responded. None of the participants dropped out during the intensive phase 
and only 5% during the booster phase. Adverse events were extremely low and 
only a minority showed symptom exacerbation. Cluster analysis demonstrated 
four treatment response trajectories: Fast responders (13%), Slow responders 
(26%), Partial responders (32%), and Non-responders (29%). Living condition 
and between-session fear habituation were found to predict outcome. Partici-
pants living alone were more likely to belong to the Partial responders than to 
the Non-responders cluster, and participants showing more between-session 
fear habituation were more likely to belong to the Fast responders than to the 
Non-responders cluster. The results of this open study suggest that iPE can be 
effective in PTSD patients with multiple interpersonal trauma and after multiple 
previous treatment attempts. In addition, in this chronic PTSD population iPE 
was safe.
INTRODUCTION
Trauma-focused treatment (TFT) programmes have strong empirical support 
for their effectiveness in ameliorating posttraumatic stress disorder (PTSD) 
symptoms (Cusack et al., 2016). Still, a systematic review of response in anxiety 
related disorders showed that the average response rate for PTSD is approxi-
mately 60% (Loerinc et al., 2015), although it needs to be noted that definitions 
of treatment response varied greatly across studies. In addition to this subopti-
mal response, dropout rates in regular TFT programmes are high. A meta-analy-
sis investigating dropout from PTSD treatment, including TFT programmes and 
supportive counselling (Imel, Laska, Jakupcak, & Simpson, 2013), estimated 
that, on average, 18% of patients drop out, with percentages varying signifi-
cantly across studies and rates running up to 52%, although definitions  
of dropout differed among the studies.
To improve both response and dropout, TFT programmes have been 
augmented in various ways (de Kleine, Rothbaum, & van Minnen, 2013; Kehle-
Forbes et al., 2013). However, these modifications have not resulted in clini-
cally significant improvement of either outcome or dropout rates. A relatively 
new strategy is to deliver the treatment sessions in a highly intensive format 
(Hendriks, de Kleine, Hendriks, & van Minnen, 2016; Rauch & Rothbaum, 
2016), with patients attending multiple sessions within a compact period of 
time (e.g. within one week) instead of weekly sessions over the course of several 
months. The main argument for intensifying TFT is the expectation that it will 
improve both outcome and dropout.
Indeed, a higher session frequency resulted in faster recovery in psycho-
therapy programmes in general (Erekson, Lambert, & Eggett, 2015). Regard-
ing TFT programmes for PTSD, more specifically cognitive processing therapy 
(CPT) or prolonged exposure (PE), higher session frequencies were associated 
with significantly greater PTSD symptom amelioration even when controlling 
for the amount of sessions (Gutner, Suvak, Sloan, & Resick, 2016). The authors 
suggested that intensifying TFT may help reduce avoidance of confronting the 
details of (situations related to) the trauma memories. More theoretically, results 
from animal studies about fear extinction learning (i.e. the development of new 
associations with the stimulus that inhibits the manifestation of the original fear 
memory and the presumed mechanism of action of exposure therapy; see for an 
overview Fitzgerald, Seemann, & Maren, 2014) showed that once extinction 
learning is initiated in a massed way, further extinction learning is more effective 
when trials are spaced (Cain, Blouin, & Barad, 2003).
Additionally, highly intensive treatments may improve dropout rates in the 
treatment of PTSD. For instance, in the meta-analysis of Imel and colleagues 
(2013), variability in dropout rates across studies was associated with the 
number of sessions delivered. That is, in treatment programmes that encom-
passed more (weekly) sessions, patients were more likely to drop out. This 
suggests that shorter treatment durations might prove superior in retaining 
patients. While treatment dropout is generally considered a negative outcome, 
a recent study found that some patients that prematurely ended CPT or PE 
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nevertheless showed significant PTSD symptom amelioration, although 
having attended more treatment sessions was associated with better treatment 
outcomes (Szafranski, Smith, Gros, & Resick, 2017). These findings suggest 
that, while it is important that treatment duration is kept as short as possible to 
prevent dropout and improve treatment outcome, the total number of treat-
ment sessions should not be reduced.
Although abovementioned studies suggest that a condensed TFT deliv-
ery format is a plausible strategy to improve response and reduce dropout, 
the effectiveness of these so-called intensive TFT programmes is still largely 
unknown. One study used a brief imaginal exposure therapy (five daily 
50-minute sessions) to determine the augmentation effects of methylene blue 
versus placebo and compared outcomes to a waiting list condition that was 
later converted into TFT delivered twice weekly. The study provided prelim-
inary evidence that intensive imaginal exposure was effective, with results 
being comparable to those obtained with regular treatment with twice weekly 
sessions (Zoellner et al., 2017). To our knowledge, only one randomised 
controlled trial (RCT) directly compared intensive TFT with TFT delivered in 
weekly sessions. This study by Ehlers and colleagues (2014) showed that an 
18-hour intensive cognitive therapy delivered within one week showed faster 
symptom reduction and was equally effective in ameliorating PTSD symptoms 
as regular weekly cognitive therapy for patients suffering from PTSD following 
a single trauma in adulthood. Additionally, the dropout rate for the intensive 
programme was remarkably low (3%), however, it must be mentioned that the 
regular weekly cognitive therapy showed a comparable low dropout rate. The 
authors emphasized that intensive TFT is of interest when treatment needs to be 
conducted within a short period of time or when patients themselves indicate a 
preference for condensed treatment. However, the effectiveness of highly inten-
sive TFT for more complex patient populations, such as patients with a history 
of multiple childhood trauma or patients meeting the symptoms of the ICD-11 
diagnosis of complex PTSD as proposed by the World Health Organization 
(WHO; Maercker et al., 2013) that includes PTSD symptoms as well as distur-
bances in affect dysregulation, negative self-concept, and interpersonal prob-
lems, is still largely unknown.
There is a lot of discussion about the treatment of this so-called complex 
PTSD group, with some clinicians and researchers highlighting the importance 
of tailoring treatments to this population, for example by providing sequen-
tial or multicomponent therapies instead of stand-alone TFT (Cloitre, 2015). 
Unlike intensive TFT, this would imply treatments being lengthened rather than 
shortened. Others argue that the evidence for these sequential or multicompo-
nent interventions for complex PTSD patients is weak (de Jongh et al., 2016). 
To bridge the knowledge gap concerning the effectiveness of TFT for more 
complex patient populations, we developed a highly intensive TFT programme 
for those patients with a likely diagnosis of ICD-11 complex PTSD after multi-
ple interpersonal trauma that had a history of multiple treatment attempts as 
a next step in their treatment. The intervention is offered in a massed format 
of 12 × 90-minute sessions during four days and is based on PE, a first line 
treatment for PTSD (Powers, Halpern, Ferenschak, Gillihan, & Foa, 2010) 
and recommended in available treatment guidelines (e.g. International Society 
for Traumatic Stress Studies, ISTSS, Foa, Keane, Friedman, & Cohen, 2009; 
National Institute for Health and Care Excellence Guidelines on PTSD, NICE, 
2005).
In standard weekly TFT programmes, patients characteristics are not found 
to be stable predictors of treatment outcome (Ehlers et al., 2013; Ehring et al., 
2014; Powers et al., 2010; van Minnen, Arntz, & Keijsers, 2002; van Minnen, 
Harned, Zoellner, & Mills, 2012) and findings concerning (early) treatment 
process variables, such as fear habituation, are inconsistent (Bluett, Zoellner, & 
Feeny, 2014; Sripada & Rauch, 2015; van Minnen & Hagenaars, 2002). This 
variability might be explained by the fact that in most studies prediction anal-
yses of associations were performed in entire and thus heterogeneous samples. 
In response to this methodology, researchers recently identified several distinct 
trajectories of treatment response based on change patterns, suggesting there 
are disparate, more homogeneous, response groups that might have differential 
predictors (Allan, Gros, Myers, Korte, & Acierno, 2017; Clapp, Kemp, Cox, & 
Tuerk, 2016; Galovski et al., 2016; Stein, Dickstein, Schuster, Litz, & Resick, 
2012).
The main purpose of the present open clinical trial was to investigate 
whether the highly intensive prolonged exposure (iPE) programme would 
decrease PTSD symptoms and dropout rates. Additionally, and taking into 
account clinician-perceived barriers to PE in terms of serious adverse events and 
symptom exacerbation (van Minnen, Hendriks, & Olff, 2010), we also eval-
uated treatment safety. Finally, to examine which patients might benefit most 
from this iPE programme, we aimed to identify distinct treatment response 
trajectories and explored predictors of these response patterns.
METHOD
Participants
Participants (N = 73) were regular referrals to a Dutch outpatient mental health 
clinic specialized in the treatment of anxiety disorders (Figure 1). Inclusion 
criteria were: (a) age ≥ 18 years; (b) history of multiple interpersonal trau-
mas (repeated sexual abuse and/or repeated physical abuse); (c) meeting full 
DSM-IV-TR (APA, 2000) diagnostic criteria for PTSD established with the Clini-
cian-Administered PTSD Scale (CAPS-IV; Blake et al., 1995); and (d) history of 
multiple treatment attempts. Exclusion criteria were: (a) suicide attempt within 
eight weeks prior to study entry (i.e. suicidality without imminent threat was not 
an exclusion criterion); (b) inability to speak and write Dutch; (c) severe intel-
lectual impairment defined as an estimated IQ of 70 or less; and (d) comorbid 
medical conditions requiring more immediate care. Participants were allowed 
to take psychotropic medication; those on medication (76.7%) were asked to 
remain on a stable dosage.
Effectiveness of intensive exposure therapyChapter 4
8786
160  Assessed for eligibility
77 Eligible for trial
83 Excluded
 26 Did not meet full PTSD  
  criteria on CAPS-IV
 7 Never previously received 
   PTSD treatment
 17 Met exclusion criteria 
 4 Involved in another 
  research trial
 3 Requested EAS
 26 Did not continue
4 Did not continue 
73 Entered into iPE and were  
 included into assessments  
 trajectory 
73 Completed intensive phase
69 Completed intensive phase 
 and at least 2 out of 4  
 booster sessions
69 Completed posttreatment
63 Completed 3-mo follow-up 
59 Completed 6-mo follow-up 
73 Included in analysis
Treatment
The iPE therapy programme (see Hendriks, de Kleine, van Rees, Bult, & van 
Minnen, 2010) was based on Foa’s PE protocol (Foa, Hembree, & Roth-
baum, 2007) with the difference that, instead of weekly sessions, the inter-
vention was delivered in a highly intensive format. Treatment started with a 
90-minute session aimed at psycho-education and case conceptualization, i.e. 
establishing a hierarchy of the four most relevant traumatic experiences. The 
intensive phase consisted of four treatment days delivered within one week. 
On each of the four treatment days, the participants received three daily indi-
vidual 90-minute sessions (4.5 hours of treatment per day). Every day, session 
1 comprised prolonged imaginal exposure during which the participant was 
asked to recount aloud the traumatic memory as detailed and vividly as possi-
ble, with closed eyes and in the present tense. Session 2 comprised exposure 
with the participant being instructed to draw the scene(s) of the hotspots of the 
traumatic memory, each scene on a separate sheet of paper, including all anxie-
ty-provoking details of the hotspots in the drawing (similarly to the instructions 
during the imaginal exposure). Session 3 included exposure in vivo to trau-
ma-related situations and material. During this intensive phase, patients did not 
receive any homework assignments because of time constraints. After the inten-
sive phase, participants received four weekly 90-minute PE booster sessions in 
combination with homework assignments (booster phase) to promote a sound 
translation and generalization of treatment outcomes to other contexts and 
everyday life. These booster sessions each comprised prolonged imaginal expo-
sure and exposure in vivo, with homework assignments consisting of listening 
to the audiotaped imaginal exposure of the previous booster session, draw-
ing the scene(s) of the hotspots of the same traumatic memory, and continuing 
exposure in vivo as practiced during the previous booster session, all on a daily 
basis.
Figure 1. Flow diagram of patient recruitment and trial progress
Note. CAPS-IV = Clinician-Administered PTSD Scale; EAS = euthanasia or assisted suicide; iPE = 
intensive prolonged exposure; mo = month; PTSD = posttraumatic stress disorder.  
Procedure
This study was an open clinical trial and recruitment took place between 2012 
and 2015 (registered at trialregister.nl; NTR5931). Patients completed a screen-
ing with a therapist who assessed trauma characteristics, PTSD diagnosis using 
the CAPS-IV (Blake et al., 1995), psychiatric treatment history, and suicidality 
using the M.I.N.I. (Sheehan et al., 1998), to determine the inclusion and exclu-
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sion criteria. The DSM-IV Axis I diagnoses of any comorbid disorders were 
also assessed with the M.I.N.I. (Sheehan et al., 1998). Eligible patients were 
invited to participate in the study. Participants signed informed consent and 
completed the baseline assessment.
Measures
The participants’ demographic characteristics were recorded at baseline. Clini-
cian-administered PTSD diagnostic status and symptom severity (past week 
version), as well as self-reported PTSD symptom severity, were evaluated at 
baseline, posttreatment (one week after the last booster session), and at three- 
and six-month follow-up. In addition, self-reported PTSD symptom severity 
was assessed at each booster session.
Primary outcome
Trained independent research assistants (BSc or MSc in Psychology) inter-
viewed participants using the CAPS-IV (Blake et al., 1995), a clinician-rated 
structured interview developed to test for symptom severity as well as the 
presence of a PTSD diagnosis. The CAPS-IV has excellent internal consistency 
(Cronbach’s α = .94) and interrater diagnostic agreement (Blake et al., 1995). 
Interrater reliability for a PTSD diagnosis was k = 0.92, and r = 0.99 for the 
total severity score in our study (based on 10% randomly selected interviews). 
Self-reported PTSD severity was monitored using the Dutch translation of the 
PTSD Symptom Scale, Self-Report (PSS-SR; Foa, Riggs, Dancu, & Rothbaum, 
1993), a 17-item questionnaire to rate the frequency of PTSD symptoms. The 
internal consistency has been shown to be high (Cronbach’s α = .91; Foa et al., 
1993) and the Dutch version has also shown to have good internal consistency 
(Mol et al., 2005).
Dropout, adversities and symptom exacerbation
Dropout was recorded by the therapist; treatment completion was defined as 
having completed the intensive phase of the treatment (four weekdays) and at 
least two of the four booster sessions. Serious adverse events defined as any 
medical occurrence that results in death, is life-threatening, requires inpa-
tient hospitalization, results in persistent or significant disability/incapacity, 
or requires intervention to prevent permanent impairment, were reported. 
Furthermore, participants reported suicidal ideation, self-harm, aggressive 
behaviour, and the sense of losing control on an 11-point Likert scale ranging 
from ‘no, not at all’ (0) to ‘yes, very much’ (10), at baseline and at the end of 
the intensive phase. Symptom exacerbation was assessed by calculating PSS-SR 
difference scores from baseline to booster 1 (deterioration during intensive 
phase), from baseline to posttreatment (deterioration during the treatment 
including the booster phase), and from baseline to the six-month follow-up. 
Symptom exacerbation was defined as an increase of 7 or more points on the 
PSS-SR (Doane, Feeny, & Zoellner, 2010).
Potential predictors
Potential predictors of treatment outcome were measured at baseline or early 
treatment and all variables were treated as continuous variables, unless other-
wise indicated. Potential predictors were assigned to one of three domains:  
(1) the demographic domain: age, educational level (primary, secondary, voca-
tional, higher vocational education, or university), and living condition (as 
a categorical variable: living alone vs. together with partner or other people 
like children or parents); (2) the clinical domain: PTSD symptom severity as 
assessed using the PSS-SR (Foa et al., 1993), depressive symptom severity as 
measured with the Beck Depression Inventory (BDI-II; Beck, Ward, Mendel-
son, Mock, & Erbaugh, 1961), dissociative symptom severity as assessed using 
the Dissociative Experiences Scale (DES; Bernstein & Putnam, 1986), current 
severity of borderline personality disorder manifestations as measured with the 
Borderline Personality Disorder symptom checklist (BPD-47 symptom check-
list; Arntz et al., 2003), and psychoactive medication use (as a categorical 
variable: yes, no); and (3) the fear habituation domain: fear activation during 
the first exposure session, calculated as the highest given Subjective Units of 
Distress (SUD) rating (SUD peak) on a 0–10 point scale (no anxiety to maxi-
mum anxiety), within-session fear habituation during the first session, calcu-
lated as SUD peak minus the latest SUD rating at the end of the first exposure 
session, and between-session fear habituation, calculated as the difference 
between SUD peak scores from the first and second imaginal exposure session 
(Rauch, Foa, Furr, & Filip, 2004; van Minnen & Hagenaars, 2002).
Therapist training and treatment fidelity
All participants were treated by a team of qualified clinicians holding a master’s 
degree in clinical psychology who were trained in PE therapy for PTSD; all 
participated in twice-weekly group supervision sessions with a senior thera-
pist (AVM). Therapist adherence to the treatment protocol was verified during 
the supervision sessions and all deviations from the treatment protocol during 
the intensive phase were documented and reported by the therapists after each 
session. The treatment protocol had been violated (e.g. no complete exposure 
during a session) in 2.1% of all treatment sessions (N = 876).
Data analysis
Treatment effect
A mixed models procedure for repeated measures analysis was conducted with 
statistical software (SPSS 22; IBM SPSS) to analyse scores on the CAPS-IV and 
PSS-SR with time (baseline, posttreatment, three- and six-month follow-up) as 
the main fixed effect and an unstructured covariance matrix for the repeated 
factor time. Effect sizes were calculated for all analyses and interpreted using 
Cohen’s (1988) criteria. Response on the CAPS-IV (decrease from baseline of ≥ 
10), loss of diagnosis (response + no longer meeting ‘1/2’ symptom criteria and 
CAPS-IV severity score < 45), and remission (loss of diagnosis and CAPS-IV 
severity score < 20) were calculated (Schnurr & Lunney, 2016). Also, response 
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and remission rates on the PSS-SR were computed, where response was defined 
as a decrease from baseline on the PSS-SR of 7 or more points (Doane et al., 
2010). Loss of diagnosis was defined as a PSS-SR severity score ≤ 20, and remis-
sion was defined as a PSS-SR severity score < 10 (Cooper et al., 2017).
Clustering analysis
To investigate change patterns during distinct stages of the treatment, classi-
fication was based on response at four different time frames to establish: (1) 
response to the intensive phase, before the first booster session; (2) response 
during the booster phase as determined by averaging the scores of the four 
booster sessions to reflect the process during the booster phase; (3) posttreat-
ment response; and (4) response at follow-up as established by averaging the 
scores of the two follow-up assessments. In accordance, four difference scores 
of self-reported PTSD were computed: baseline score minus booster 1 score 
(d1); baseline score minus mean score of booster 1 to 4 (d2); baseline score 
minus posttreatment score (d3); and baseline score minus the mean score 
of the three- and six-month follow-ups (d4). To deal with 17 missing values 
(6.2%) of these difference scores, multiple imputation was applied (Basagaña, 
Barrera-Gómez, Benet, Antó, & Garcia-Aymerich, 2013) using the R soft-
ware package developed by Buuren and Groothuis-Oudshoorn (MICE; 2011) 
to obtain 100 imputed data sets. On these datasets, k-Means cluster analysis 
(Steinley, 2006) was carried out using the R software package developed by 
Barrera-Gómez and Basagaña (MICLUST; 2013) to identify clusters of simi-
lar patterns of PSS-SR scores. In k-Means clustering an iterative process real-
locates participants to a certain number of clusters in order to minimize the 
within-cluster variance. A squared Euclidean distance metric was calculated to 
distribute two-way, two-mode data (N objects each having measurements on 
d1 to d4) into clusters such that the distance for any object and the centroid of 
its respective cluster is at least as small as the distances to the centroids of the 
remaining clusters. To gain insight into response patterns beyond response or 
non-response, we allowed the number of clusters to vary between 3 and 6 and 
identified the optimal number using CritCF as a goodness of fit measure to eval-
uate the quality of each partition (Breaban & Luchian, 2011). After the final 
selection of clusters based on CritCF, participants were allocated to the clus-
ter they were assigned to in most of the imputed data sets. As a final step, the 
clusters were interpreted in terms of average response (decrease from baseline 
on the PSS-SR of 7 or more points; Doane et al., 2010), loss of diagnosis, and 
remission (respectively defined as PSS-SR ≤ 20 and PSS-SR < 10; Cooper et al., 
2017).
Prediction analysis
Multinomial logistic regression analyses were conducted with statistical soft-
ware (SPSS 22; IBM SPSS) to investigate associations between potentially 
predictive variables and cluster (as a nominal dependent variable with more 
than two categories). Due to the explorative nature of the prediction analysis, 
we aimed at generating (instead of testing) hypotheses regarding the associa-
tions between potential predictive variables and the clusters. In line with previ-
ous work exploring predictors of outcome, potential predictors were classified 
into different domains and a stepwise procedure was used for each predic-
tor domain (de Kleine, Hendriks, Smits, Broekman, & van Minnen, 2014; 
Fournier et al., 2009). In step 1, a model including all variables for a given 
domain was tested. The terms that were significant at p < .20 were retained in 
step 2, where these residual variables for this specific domain were tested again. 
Subsequently, step 3 retained the terms from step 2 that were significant at p < 
.10, and step 4 retained the terms from step 3 that were significant at p < .05. 
Finally, all terms that were significant at p < .05 at step 4 (within each domain) 
were included in a final model (assessing predictors across all domains).
RESULTS
Figure 1 shows the participant flow through the study. The characteristics of 
the study population are presented in Table 1. From April 2012 through August 
2015, 73 participants completed the baseline assessment and started iPE. All 
participants had experienced multiple interpersonal trauma, with the majority 
reporting childhood (at age ≤ 16 years) abuse: 71.2% childhood sexual abuse 
and 63.0% childhood physical abuse. The participants were characterized by 
a current medium to high suicide risk, severe posttraumatic, depressive, and 
dissociative symptoms, and manifestations of borderline personality disor-
der. All reported symptoms of complex PTSD (WHO ICD-11 criteria; Cloitre, 
Garvert, Brewin, Bryant, & Maercker, 2013), i.e. affect dysregulation, negative 
self-concept, and interpersonal problems.
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Table 1. Characteristics of the study population (N=73)
Characteristics 
Age in years, mean (SD), range 35.9 (11.3), 19–63
Sex, n
    Male 10
    Female 63
Education, n (%)
    Primary education 0 (0.0)
    Secondary education 18 (24.7)
    Vocational education 24 (32.9)
    Higher vocational education 25 (34.2)
    University 6 (8.2)
Living condition, n (%) 
    Alone 31 (42.5)
    Together 42 (57.5)
Trauma history, n (%)
    Childhood, ≤ 16 years
Multiple sexual abuse 52 (71.2)
Multiple physical abuse 46 (63.0)
    Adulthood, >16 years
Multiple sexual abuse 31 (42.5)
Multiple physical abuse 42 (57.5)
Time since trauma in years, mean (SD), range 28.2 (12.0), 6–59
Current medium or high suicide risk, n (%) 33 (48.5) a)
CAPS-IV baseline, mean (SD), range 85.1 (17.2), 41–128
PSS-SR baseline, mean (SD), range 33.3 (6.5), 18–46 b)
BDI-II baseline, mean (SD), range 30.6 (11.1), 0–51 b)
DES baseline, mean (SD), range 22.7 (13.3), 0–56 c)
DES baseline, score above clinical cut-off d), n (%) 20 (32.8) c)
BPD-47 baseline, mean (SD), range 103.7 (27.2), 51–203 b)
BPD-47 subscales baseline, mean (SD), range
    Affect dysregulation e) 32.3 (9.0), 19–64 b)
    Negative self-concept f) 20.1 (6.0), 8–36 b)
    Interpersonal problems g) 7.4 (3.1), 3–15 b)
Axis I and II comorbidity (current), n (%) 68 (93.2)
    1-2 comorbid disorder 45 (61.6)
    ≥ 3 comorbid disorders 23 (31.5)
Comorbid depressive disorder, n (%) 50 (68.5)
At least one comorbid anxiety disorder, n (%) 23 (31.5)
At least one comorbid personality disorder, n (%) 35 (47.9)
Receiving psychotropic medication, n (%) 56 (76.7)
Duration of PTSD in years, mean (SD), range 10.6 (9.7), 1–40
 
Note. BDI-II = Beck Depression Inventory Second Edition; BPD-47 = Borderline Personality Disor-
der Checklist; CAPS-IV = Clinician-Administered PTSD Scale; DES = Dissociative Experiences 
Scale; PSS-SR = PTSD Symptom Scale, Self-Report; PTSD = posttraumatic stress disorder. 
a) N = 68, b) N = 69, c) N = 61, d) Clinical cut-off defined as a DES severity score of 25 (Boon & Draijer, 
1993)., e) Sum score of the ‘Mood’, ‘Impulsivity’ and ‘Anger’ subscales., f) As measured by the ‘Iden-
tity/Self-concept’ subscale. , g) As measured by the ‘Relationships’ subscale. 
Treatment effects
The mixed model analysis revealed a main effect of time on both the CAPS-IV 
(F(3,63) = 38.58, p < .001) and the PSS-SR scores (F(3,60) = 35.84, p < .001). 
There was a decrease in CAPS-IV and PSS-SR scores between baseline and post-
treatment that persisted during the three- and six-month follow-ups with large 
effect sizes (Table 2), reflecting an improvement of clinically observed as well as 
self-reported PTSD symptoms.
Table 2. Primary outcomes at baseline, posttreatment, 3 and 6-month follow-up a) 
Outcome Baseline Posttreatment 3-month follow-up 6-month follow-up
CAPS-IV, mean (SD) 85.1 (17.2) 55.0 (30.8) 50.9 (32.9) 49.6 (30.9)
     Effect size NA 1.21 1.30 b) 1.42 b)
PSS-SR, mean (SD) 33.3 (6.5) 21.7 (11.6) 21.1 (12.5) 20.3 (12.7)
     Effect size NA 1.23 1.23 b) 1.29 b)
 
Note. CAPS-IV = Clinician-Administered PTSD Scale; PSS-SR = PTSD Symptom Scale, Self-Report. 
a) All outcomes reflect the estimated marginal mean from the mixed model analysis. Effect sizes are 
Cohen d based on estimated data from the mixed model analysis. 
b) Effect sizes are based on follow-up compared to baseline scores.
Response and remission rates with regard to PTSD symptoms are listed in Table 
3. Fifty-two participants (71.2%) showed posttreatment response,  
22 (30.1%) a loss of diagnosis, and 10 (13.7%) achieved posttreatment remis-
sion according to the CAPS-IV. A chi-square goodness-of-fit test indicated that 
both loss of diagnosis and remission percentages had further improved: loss of 
diagnosis at the six-month follow-up χ2(1) = 7.92, p = .005, and remission at 
the three- and six-month follow-ups, χ2(1) = 5.68, p = .017. Based on self-re-
ported PTSD symptoms (PSS-SR), 43 participants (58.9%) showed posttreat-
ment response, 29 (39.7%) a loss of diagnosis, and 10 (13.7%) having achieved 
posttreatment remission. A chi-square goodness-of-fit test indicated that 
PSS-SR remission percentages had further improved at three months (χ2(1) = 
4.17, p = .041) and at six months (χ2(1) = 5.68, p = .017).
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Table 3. Observed response, loss of diagnosis, and remission rates according to the CAPS-IV and 
PSS-SR
Outcome Posttreatment 3-month follow-up 6-month follow-up
CAPS-IV a)
     Response, n (%) 52 (71.2) 54 (74.0) 58 (79.5)
     Loss of diagnosis, n (%) 22 (30.1) 29 (39.7) 33 (45.2)
     Remission, n (%) 10 (13.7) 17 (23.3) 17 (23.3)
PSS-SR b)
     Response, n (%) 43 (58.9) 44 (60.3) 47 (64.4)
     Loss of diagnosis, n (%) 29 (39.7) 31 (42.5) 34 (46.6)
     Remission, n (%) 10 (13.7) 16 (21.9) 17 (23.3)
 
Note. CAPS-IV = Clinician-Administered PTSD Scale; PSS-SR = PTSD Symptom Scale, Self-Report. 
a) Response defined as decrease from baseline ≥ 10 points; loss of diagnosis defined as response 
plus no longer meeting ‘1/2’ symptom criteria plus a severity score < 45; remission defined as loss 
of diagnosis plus a severity score < 20 (Schnurr & Lunney, 2016). 
b) Response defined as a decrease from baseline ≥ 7 points (Doane et al., 2010); loss of diagnosis 
defined as a severity score ≤ 20; remission defined as a severity score < 10 (Cooper et al., 2017).
Dropout, adversities, and symptom exacerbation
None of the participants dropped out during the intensive phase and 95% 
completed the treatment as defined as the intensive phase and at least two 
booster sessions. During the iPE, a single serious adverse event, a psychiatric 
hospitalization aimed at suicide prevention, occurred. Paired-samples t-tests 
showed no differences from baseline to the end of the intensive phase in self-re-
ported suicidal ideation (baseline M = 2.3, SD = 2.8; post M = 2.2, SD = 3.1), 
self-harm (baseline M = .8, SD = 2.0; post M = .9, SD = 2.2), or aggressive 
behaviour (baseline M = .2, SD = .9; post M = .2, SD = 1.1). Sense of losing 
control decreased from baseline (M = 4.5, SD = 3.0) to the end of the intensive 
phase (M = 2.7, SD = 2.8), with the difference, 1.73, BCa 95% CI [.97, 2.50] 
being significant t(66) = 4.52, p < .001 and representing a medium effect size, d 
= 0.59.
Two participants (2.7%) reported symptom exacerbation on the PSS-SR 
from baseline to booster 1 (with one participant showing an increase of 7 and 
the other an increase of 10 points), a third participant from baseline to post-
treatment (1.4%, increase of 17 points), while a fourth participant reported 
symptom exacerbation from baseline to six-month follow-up (1.4%, increase 
of 8 points).
Clustering analysis
Due to missing baseline scores on the PSS-SR, it was not possible to calcu-
late difference scores for four participants who were, therefore, excluded 
from the cluster analyses. Use of the CritCF criterion resulted in four clus-
ters: Fast responders (n = 9), Slow responders (n = 18), Partial responders 
(n = 22), Non-responders (n = 20). The Fast responders cluster consisted of 
participants showing self-reported response and a loss of diagnosis immedi-
ately after the intensive phase, i.e. before starting the booster phase (average 
decrease of 19.8 on the PSS-SR, PSS-SR Mbefore booster phase = 15.7), who addition-
ally showed a second PSS-SR decrease during the booster phase into remission 
(average decrease of 29.4 on the PSS-SR from baseline, PSS-SR Mafter booster phase 
= 6.0). Participants in the Slow responders cluster reported no response after 
the intensive phase (average decrease of 5.7 on the PSS-SR, PSS-SR Mbefore booster 
phase = 27.1), but did show a PSS-SR response during the booster phase (average 
decrease of 17.9 on the PSS-SR from baseline) and a loss of diagnosis (PSS-SR 
Mafter booster phase = 14.9). Participants classified in the Partial responders clus-
ter strictly reported no PSS-SR response during the intensive phase (average 
decrease of 6.9 on the PSS-SR, PSS-SR Mbefore booster phase = 26.4). However, their 
trajectory is characterized by a PSS-SR response during the booster phase (aver-
age decrease of 9.5 on the PSS-SR from baseline, PSS-SR Mafter booster phase = 23.7) 
and further decreasing PSS-SR scores during the follow-up period to a loss 
of diagnosis (PSS-SR M6 month follow-up = 18.7). Finally, participants classified as 
Non-responders had no change in PSS-SR scores at all (average increase of 2.2 
on the PSS-SR from baseline to intensive phase, PSS-SR Mbefore booster phase = 35.2, 
average increase of 0.9 on the PSS-SR from baseline to posttreatment, PSS-SR 
Mafter booster phase = 33.9). Figure 2 shows the longitudinal trajectories of the aver-
age PSS-SR scores within each cluster.
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iPE        Boosters   Post                            3 FU                           6 FU 
Figure 2. Average PTSD Symptom Scale, Self-Report (PSS-SR) scores before, during, and after 
treatment within each cluster
Note. iPE = intensive prolonged exposure; Post = Posttreatment; PSS-SR = PTSD Symptom Scale, 
Self-Report; 3 FU = 3-month follow-up; 6 FU = 6-month follow-up. Average scores are based on 
completed assessments. 
Prediction analysis
Supplementary data are available (see Appendix), providing the results of the 
stepwise analyses for each of the three domains: demographic characteristics, 
clinical characteristics, and fear habituation characteristics. Regarding the 
demographic characteristics, living condition was significantly associated with 
the Partial responders cluster, predicting whether participants belonged to the 
Partial responders cluster or to the Non-responders cluster, b = -1.86, Wald 
χ2(1) = 7.27, p = .007, indicating that participants living alone were more likely 
to belong to the Partial responders cluster than to the Non-responders cluster. 
Within the clinical characteristics domain, no variables were significantly asso-
ciated with clusters. Results showed that, within the fear habituation charac-
teristics domain, between-session fear habituation was significantly associated 
with the Fast responders cluster. Between-session fear habituation predicted 
whether participants belonged to the Fast responders cluster (M = 1.42; 95% 
CI, -.09–2.92) or the Non-responders cluster (M = .04; 95% CI, -.53–.61), b 
= .65, Wald χ2 (1) = 4.06, p = .044, indicating that participants showing more 
between-session fear habituation between the first and second imaginal expo-
sure session were more likely to belong to the Fast responders cluster than to 
the Non-responders cluster. 
Both significant terms were included in a final model aimed at testing the 
associations between each variable with cluster while controlling for the other 
variable (Table 4). Living condition, b = -1.89, Wald χ2(1) = 7.34, p = .007, 
and between-session fear habituation, b = .76, Wald χ2(1) = 3.85, p = .050, 
remained significant predictive variables.
Table 4. Final model with all significant predictors from the domain models
95% CI for Odds Ratio
Predictor b (SE) a Lower Odds Ratio Upper
Cluster Fast responders
Living condition 1.19 (1.27) .27 3.29 39.69
Between-session fear 
habituation .76 (.39)**** 1.00 2.13 4.54
Cluster Slow responders
Living condition -.65 (.71) .13 .52 2.09
Between-session fear 
habituation -.06 (.25) .58 .94 1.53
Cluster Partial responders
Living condition -1.89 (.70)*** .04 .15 .59
Between-session fear 
habituations -.22 (.23) .51 .80 1.26
 
Note. SE = standard error.  
a) b-values represent unstandardized beta coefficients predicting the chance to belong to one of 
the specified clusters relative to the Non-responders cluster. 
* p < .20; ** p < .10; *** p < .05; **** p = .05. 
DISCUSSION
Overall, this study suggests, in line with previous RCTs (Ehlers et al., 2014; 
Zoellner et al., 2017), that PE delivered in an intensive format is effective for 
PTSD patients. This is especially noteworthy given that our sample mainly 
consisted of patients who had experienced multiple childhood trauma and 
reported symptoms of ICD-11 complex PTSD, expanding the evidence base 
for the effectiveness of intensive TFT to a more complex patient population. 
Additionally, all patients had received previous treatments that had proven 
unsuccessful. Several studies indicate that regular treatment attendance (Tarrier, 
Sommerfield, Pilgrim, & Faragher, 2000) and a higher frequency of sessions 
(Gutner et al., 2016), especially early in the treatment, enhances treatment 
outcome. One possible explanation for these findings is that some PSTD 
patients have more trouble overcoming their avoidance behaviour and, there-
fore, are in need of a compact treatment programme instead of weekly stand-
ard TFT that leave the patients more room to engage in avoidance behaviour 
between sessions. However, the results of our trial cannot support this conclu-
sion due to the lack of a control group. Future controlled studies that moni-
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tor action readiness to change avoidance before and during iPE and booster 
sessions are needed.
Arguably, the lack of effect in previous treatments might (also) be associated 
with the high dropout rates, running up to 52% for conventional PTSD inter-
ventions (Imel et al., 2013). In the present study, all participants completed the 
intensive phase and few patients (5%) left the booster phase prematurely. Again, 
overcoming avoidance behaviour by delivering TFT treatment within a short 
time frame may be the key mechanism underlying this results, considering that 
early dropouts are also assumed to prematurely discontinue treatment to avoid 
their traumatic memories (Szafranski et al., 2017). Although the low dropout 
rate in this study might point to the fact that intensive TFT can prevent dropout, 
we may also have included a select population of patients for whom intensive 
treatment is acceptable, which limits the generalizability of our results.
Besides investigating the effects of iPE, it is important to address potential 
risks of massed treatments. A first concern here is that results achieved in a 
short time might not be maintained in the long run, with relapse as a result. We, 
however, found that the posttreatment PTSD symptom amelioration persisted 
up to six months. Second, TFT programmes may evoke serious adverse events 
or symptom exacerbations (Becker, Zayfert, & Anderson, 2004; van Minnen 
et al., 2010) and these risks are assumed to be higher in intensive treatment 
programmes and in more vulnerable PTSD patients with ICD-11 complex 
PTSD symptoms such as the present population. We found no evidence for this 
assumption. Our patients showed no serious adverse events during the iPE in 
terms of suicide attempts and self-reported PTSD symptom exacerbation was 
rare (< 3%). Only one serious adverse event occurred in terms of a hospitaliza-
tion aimed at suicide prevention. The low incidence of serious adverse events 
and symptom exacerbation contributes to the growing evidence that TFTs are 
safe (Larsen, Stirman, Smith, & Resick, 2016), also if they are delivered in a 
massed format.
The effectiveness, low dropout rate, and safety of intensive TFT challenges 
(some) clinicians’ beliefs that complex PTSD patients need tailored treatment 
that includes an initial stabilization phase of emotion regulation skills train-
ing (Cloitre, 2015; Dorrepaal et al., 2013). The results of the present study 
provide preliminary evidence that intensive stand-alone TFT (without any 
preparatory or additional module(s)) and, more specifically, stand-alone inten-
sive exposure, is effective and safe for PTSD patients with a likely diagnosis of 
ICD-11 complex PTSD. Our results may then contribute to the identification of 
commonalities (in this case exposure) in the treatment of PTSD and help us to 
distinguish the most effective treatment components, enabling us to improve the 
effectiveness of existing TFT programmes (Schnyder et al., 2015).
Although the response rate we obtained (71%) was comparable to the 
average rate of 60% found in a systematic review (Loerinc et al., 2015), as 
well as to the response rates of studies with patient populations compara-
ble to ours based on trauma characteristics (Bohus et al., 2013; Cloitre et 
al., 2010; Schnurr et al., 2007), not all participants improved to the same 
degree. Our cluster analyses revealed four distinct trajectories based on change 
patterns: Fast, Slow, Partial, and Non-responders. Similar distinct response 
groups were also found by other researchers (Allan et al., 2017; Clapp et al., 
2016; Galovski et al., 2016; Stein et al., 2012). We observed that for a small 
proportion of responders (13%) PTSD symptoms decreased immediately after 
completing the four days of iPE, i.e. before starting the four-week booster 
phase in which exposure was expanded to the full variety of contexts (Fast 
responders). The high dose of PE offered within a short time frame may be the 
key mechanism underlying the gains in this subgroup. This would be in line 
with previous research showing that a higher frequency of sessions, especially 
early in the treatment, enhances treatment outcome (Gutner et al., 2016). 
Next, we observed that 26% of the responders who had not improved during 
the intensive phase did show a major decrease in PTSD symptoms during 
the booster phase (Slow responders). There are several possible explanations 
for this finding. First, this slow response trajectory may indicate that these 
patients needed more sessions, which is in line with previous findings show-
ing that some patients need additional sessions to benefit from PE (Foa et al., 
2005). Additionally or alternatively, the improvement in this subgroup might 
not necessarily result from the added exposure but rather from the spacing 
of the additional exposure sessions during the booster phase. Animal stud-
ies (see Fitzgerald et al., 2014) showed that, once initiated in a massed way, 
extinction learning is boosted when subsequent trials are spaced (Cain et al., 
2003). Third, the patients in this cluster may have needed exposure in a variety 
of contexts such as the home environment. It has been suggested that greater 
variability in terms of exposure contexts promotes generalization, resulting 
in better treatment outcomes in anxious patients (Craske, Treanor, Conway, 
Zbozinek, & Vervliet, 2014). In the third cluster (Partial responders), 32% of 
the patients showed a partial improvement both during the intensive and the 
booster phase. This distinct group was also found by others (Galovski et al., 
2016; Taylor et al., 2001). It is uncertain whether here full recovery can be 
achieved with additional therapy. Finally, of all our participants, 29% showed 
no response to treatment (Non-responders), reporting severe PTSD symptoms 
at all time points. As other studies recorded a similar non-responders clus-
ter (Allan et al., 2017; Stein et al., 2012), this raises the question whether, for 
some patients, extinction learning is not feasible (Lissek et al., 2005).
From a clinical perspective, it would be worthwhile if we could determine 
in advance which patient is likely and which patient is unlikely to respond to 
iPE. We found that the patients showing more between-session fear habitua-
tion between the first and second imaginal exposure session were more likely 
to belong to the Fast responders cluster than to the Non-responders cluster. 
This is consistent with previous findings (e.g. Cooper, Clifton, & Feeny, 2017) 
in which between-session fear habituation, but not within-session fear habit-
uation, was found to be related to treatment outcome. Although replication is 
needed, our finding does suggest that a lack of habituation to anxiety during 
the early stage of iPE treatment can be used to detect those patients that are 
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unlikely to benefit from exposure-based treatment. Also, patients living alone 
were more likely to belong to the Partial responders cluster than to the Non-re-
sponders cluster, which result is in contrast to previous findings (Ehlers et al., 
2013; Tarrier et al., 2000; van Minnen et al., 2002). However, it is possible 
that in our highly affected PTSD population, the presence of a partner helps 
maintain PTSD-related avoidance behaviour. Interestingly, none of the clinical 
variables were found to be predictors of treatment response. This is promising 
as it suggests that even patients with (severe) comorbidity might benefit from 
intensive TFT programmes like ours. Together, these findings suggest that, 
contrary to what clinicians generally assume, several baseline demographic 
and clinical variables do not interfere with treatment and are thus no robust 
contra-indicators of (intensive) TFT interventions. We rather found that early 
treatment process variables were better predictors of treatment success.
Because our study lacks a control group and had no randomised design, 
our findings warrant replication in a randomised controlled design. Addition-
ally, the results of the exploratory cluster and prediction analyses should be 
interpreted with caution given the low number of participants per cluster. Also, 
although our participants had a history of multiple treatment attempts, we did 
not use a standard measure to quantify the degree of treatment resistance per 
participant (Dunlop, Kaye, Youngner, & Rothbaum, 2014). Another limita-
tion is that we assessed suicidal ideation, self-harm, aggressive behaviour, and 
a sense of losing control with Likert scales rather than validated measures. 
Furthermore, we based therapist adherence on self-reports instead of video 
observation. Lastly, we used the DSM-IV-TR (APA, 2000) diagnostic criteria 
for PTSD and not the DSM-5 (APA, 2013). However, recent research showed 
that the CAPS-IV diagnosis closely corresponds to the CAPS-5 diagnosis, with 
most patients diagnosed according to the DSM-IV criteria also meeting the 
DSM-5 criteria for PTSD (Weathers et al., 2018). We therefore assume that our 
results also apply to PTSD populations diagnosed using the DSM-5 criteria. 
Showing the effectiveness of intensive TFT for PTSD, Ehlers and colleagues 
(2014) emphasized that an intensive TFT is of interest when treatment needs 
to be conducted within a short period of time or when patients prefer a 
condensed treatment. Our results expand these implications, suggesting that 
intensive TFT is a feasible next step in the treatment of chronic PTSD patients 
with a likely diagnosis of ICD-11 complex PTSD following multiple inter-
personal trauma and a history of multiple treatment attempts. However, also 
within our intensive TFT programme not all participants improved and future 
research regarding other next step options is needed.
 
CONCLUSION
Although randomised controlled trials are needed to establish the effective-
ness of iPE, this open study suggests that iPE is both effective and safe in PTSD 
patients having suffered multiple interpersonal childhood trauma and reporting 
ICD-11 complex PTSD symptoms. Despite previous treatment attempts being 
unsuccessful, 71% of the patients showed partial or complete response during 
iPE, with results being maintained up to six months. Serious adverse events and 
symptom exacerbation were rare and dropout very low.
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APPENDIX: supplementary data
Stepwise analysis of demographic characteristics domain
95% CI for Odds Ratio
Predictor b (SE) a Lower Odds Ratio Upper
Step 1,2
Cluster Fast responders
     Age -.01 (.04) .92 .99 1.07
     Educational level -.49 (.45) .26 .62 1.48
     Living condition 1.16 (1.20) .30 3.18 33.53
Cluster Slow responders
     Age -.05 (.03)* .89 .95 1.02
     Educational level -.37 (.37) .33 .69 1.44
     Living condition -.34 (.74) .17 .71 3.05
Cluster Partial responders
     Age .01 (.03) .95 1.01 1.08
     Educational level -.54 (.39)* .27 .59 1.25
     Living condition -1.77 (.71)*** .04 .17 .69
Step 3,4
Cluster Fast responders
     Living condition .98 (1.18) .26 2.67 26.92
Cluster Slow responders
     Living condition -.65 (.71) .13 .52 2.10
Cluster Partial responders
     Living condition -1.86 (.70)*** .04 .16 .60
 
Note. SE = standard error.  
 
a) b-values represent unstandardized beta coefficients predicting the chance to belong to one of 
the specified clusters relative to the Non-responders cluster. 
* p < .20; ** p < .10; *** p < .05.
Stepwise analysis of clinical characteristics domain
95% CI for Odds Ratio
Predictor b (SE) a Lower Odds Ratio Upper
Step 1
Cluster Fast responders
     PSS-SR .10 (.08) .94 1.11 1.30
     BDI-II .04 (.06) .92 1.04 1.18
     DES -.05 (.04) .88 .95 1.04
     BPD-47 -.05 (.03)** .90 .95 1.00
     Psychoactive medication -2.60 (1.22)*** .01 .07 .82
Cluster Slow responders
     PSS-SR .03 (.06) .91 1.03 1.16
     BDI-II -.05 (.04) .88 .95 1.04
     DES -.05 (.03)* .89 .95 1.01
     BPD-47 .03 (.02)* .99 1.03 1.07
     Psychoactive medication 1.10 (.94) .48 3.01 18.94
Cluster Partial responders
     PSS-SR .05 (.06) .94 1.05 1.19
     BDI-II -.03 (.04) .90 .97 1.05
     DES -.03 (.03) .92 .98 1.03
     BPD-47 -.02 (.02) .94 .98 1.02
     Psychoactive medication .42 (.91) .26 1.52 9.09
Step 2
Cluster Fast responders
     DES -.05 (.04) .88 .95 1.03
     BPD-47 -.03 (.02)* .93 .97 1.01
     Psychoactive medication -1.94 (1.00)** .02 .14 1.02
Cluster Slow responders
     DES -.05 (.03)** .89 .95 1.01
     BPD-47 .02 (.02) .99 1.02 1.05
     Psychoactive medication .75 (.87) .39 2.12 11.56
Cluster Partial responders
     DES -.02 (.03) .93 .98 1.03
     BPD-47 -.03 (.02)* .94 .98 1.01
     Psychoactive medication .35 (.86) .27 1.42 7.62
Step 3,4
Cluster Fast responders
     DES -.07 (.04)** .86 .93 1.00
     Psychoactive medication -1.45 (.89)* .04 .24 1.35
Cluster Slow responders
     DES -.03 (.03)* .92 .97 1.02
     Psychoactive medication .47 (.83) .32 1.59 8.05
Cluster Partial responders
     DES -.04 (.03)** .91 .96 1.01
     Psychoactive medication .68 (.82) .39 1.97 9.92
 
Note. BDI-II = Beck Depression Inventory Second Edition; BPD-47 = Borderline Personality Disorder 
Checklist; DES = Dissociative Experiences Scale; PSS-SR = PTSD Symptom Scale, Self-Report; SE = 
standard error. a) b-values represent unstandardized beta coefficients predicting the chance to belong 
to one of the specified clusters relative to the Non-responders cluster. * p < .20; ** p < .10; *** p < .05.
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Stepwise analysis of fear habituation characteristics domain
95% CI for Odds Ratio
Predictor b (SE) a Lower Odds Ratio Upper
Step 1
Cluster Fast responders
     SUD peak 1.63 (1.04)* .66 5.09 39.07
     Within-session fear habituation .27 (.22) .85 1.31 2.03
     Between-session fear habituation .59 (.44)* .77 1.81 4.25
Cluster Slow responders
     SUD peak -.33 (.29) .41 .72 1.26
     Within-session fear habituation .17 (.16) .86 1.19 1.64
     Between-session fear habituation .03 (.30) .58 1.03 1.84
Cluster Partial responders
     SUD peak -.13 (.28) .51 .88 1.54
     Within-session fear habituation .00 (.17) .73 1.00 1.39
     Between-session fear habituation -.16 (.31) .47 .85 1.55
Step 2
Cluster Fast responders
     SUD peak 1.61 (1.02)* .68 4.99 36.83
     Between-session fear habituation .82 (.38)*** 1.08 2.28 4.81
Cluster Slow responders
     SUD peak -.30 (.28) .42 .74 1.29
     Between-session fear habituation .11 (.29) .64 1.12 1.95
Cluster Partial responders
     SUD peak -.13 (.29) .50 .88 1.55
     Between-session fear habituation -.15 (.30) .48 .86 1.54
Step 3, 4
Cluster Fast responders
     Between-session fear habituation .65 (.32)*** 1.02 1.91 3.58
Cluster Slow responders
     Between-session fear habituation -.06 (.25) .58 .95 1.54
Cluster Partial responders
     Between-session fear habituation -.21 (.23) .52 .81 1.28
Note. SE = standard error; SUD = subjective units of distress. 
a) b-values represent unstandardized beta coefficients predicting the chance to belong to one of 
the specified clusters relative to the Non-responders cluster. 
* p < .20; ** p < .10; *** p < .05.
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During the intake interviewTherapist: ‘From your medical files I understand that you’ve seen a psychologist before. When was the first time you’ve sought help?’
Hannah (aged 15 years): ‘When I was 8. I was doing really bad at the 
time. I was constantly fighting with me mum, beating up classmates, 
driving teachers up the wall.’
Therapist: ‘What happened next?’
Hannah: ‘I ended up in the system, going from one institution to the 
next, from ward to ward. They turned me inside out, thought I had 
ADHD or some kind of behavioural disorder or something. Sometimes 
I got some play therapy, a couple of sessions. Only this year I got to 
see a psychologist who referred me to you guys.’
Therapist: ‘How did things go with the therapist then?’
Hannah: ‘He asked me! He was the first one to ever ask me. Just like 
that: Have you had some bad things happening to you, something 
traumatic? And then I told him, told someone about it for the first time 
ever … that my father had abused me, had been having sex with me. 
For years. Ever since I was 6. And though it stopped when I went to 
high school, that it was still happening in me head, driving me mad, 
bonkers, crazy.’
After the interview
Had to get away. Be on my own for a bit. No colleagues. Away from it 
all, in the lavatory. I’m fumbling with a piece of toilet paper. Did I really 
hear this? A child walking around with such a big secret for so long? 
That we keep expecting an 8-year-old to tell us of their own accord 
that they are being sexually molested? Instead of us asking them about 
this real possibility? I feel the tears welling up; the paper is no use, I’m 
bawling my eyes out while I actually feel outrage.
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Chapter 5
Intensive prolonged 
exposure treatment for 
adolescent complex 
posttraumatic stress 
disorder: a single-trial 
design
This chapter is based on: Hendriks, L., de Kleine, R. A., Heyvaert, M., Becker, E. S., 
Hendriks, G. J., & van Minnen, A. (2017). Intensive prolonged exposure treatment 
for adolescent complex posttraumatic stress disorder: a single-trial design. Jour-
nal of Child Psychology and Psychiatry, 58, 1229-1238.
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ABSTRACT
The current study evaluated the effectiveness and safety of intensive prolonged 
exposure (PE) targeting adolescent patients with complex posttraumatic 
stress disorder (PTSD) and comorbid disorders following multiple interper-
sonal trauma. Ten adolescents meeting full diagnostic criteria for PTSD were 
recruited from a specialized outpatient mental health clinic and offered a stand-
ardized intensive PE. The intensive PE consisted of three daily 90-min expo-
sure sessions delivered on five consecutive weekdays, followed by 3 weekly 
90-min booster sessions. In a single-trial design, the participants were randomly 
allocated to one of five baseline lengths (4–8 weeks) before starting the inten-
sive PE. Before, during, and after intensive PE completion, self-reported PTSD 
symptom severity was assessed weekly as a primary outcome (a total of 21 
measurements). Furthermore, clinician-administered PTSD diagnostic status 
and symptom severity (primary outcome), as well as self-reported comorbid 
symptoms (secondary outcomes), were assessed at four single time points (base-
line-to-6-month follow-up). Time-series analyses showed that self-reported 
PTSD symptom severity significantly declined following treatment (p = .002). 
Pre-postgroup analyses demonstrated significant reductions of clinician-admin-
istered PTSD symptom severity and self-reported comorbidity that persisted 
during the 3- and 6-month follow-ups (all ps < .05), where 80% of adoles-
cents had reached diagnostic remission of PTSD. There was neither treatment 
dropout nor any adverse events. The results of this first proof of concept trial 
suggest that intensive PE can be effective and safe in an adolescent population 
with complex PTSD, although the gains achieved need to be confirmed in a 
randomised controlled trial.
INTRODUCTION
Posttraumatic stress disorder (PTSD) is a severe and very debilitating disorder. 
A meta-analysis evaluating 43 independent samples showed that the overall 
PTSD rate in trauma-exposed children and adolescents was 15.9%, with chil-
dren and adolescents having been exposed to interpersonal trauma, for example 
sexual and physical abuse, showing the highest risk (Alisic et al., 2014).
In clinical guidelines across the world, trauma-focused therapy (TFT) is consid-
ered the first-line treatment for these children and adolescents (International Soci-
ety for Traumatic Stress Studies, ISTSS, Foa, Keane, Friedman, & Cohen, 2009; 
National Institute for Health and Care Excellence Guidelines on PTSD, NICE, 
2005). A recent meta-analysis evaluating 14 studies describing the effects of PTSD 
treatments in children and adolescents indeed concluded that TFT provided the 
best evidence of effectiveness (Gillies, Taylor, Gray, O’Brien, & D’Abrew, 2013). 
Proven effective TFT protocols include the trauma-focused cognitive behavioural 
therapy (TF-CBT) of Cohen, Mannarino, and Deblinger (2006), comprising grad-
ual exposure and other trauma-focused techniques (e.g. cognitive processing), and 
the prolonged exposure (PE) protocol by Foa, McLean, Capaldi, and Rosenfield 
(2013). In both protocols, treatment is delivered in weekly sessions over the course 
of several months.
Given that most RCTs thus far focused on the effectiveness of TFT for children 
or adolescents with PTSD following single trauma exposure (Gillies et al., 2013), 
the effectiveness of such programmes for young patients having suffered multiple 
trauma is still largely unknown. There is also only limited research available about 
the effectiveness of TFT in young populations showing symptoms of complex 
PTSD, such as affect dysregulation, negative self-concept, and interpersonal prob-
lems, or in populations showing other comorbid symptoms (Smith et al., 2013).
In response to this research gap, it has recently been suggested that, for 
safety reasons, in clinical practice, a phase-based approach, in which a stabilis-
ing phase is offered prior to starting the trauma-focused treatment phase, would 
be advisable for this group of complex PTSD patients (Leenarts, Diehle, Dore-
leijers, Jansma, & Lindauer, 2013). This recommendation was partly based on 
the incorporation of additional modules (e.g. affective coping techniques) in the 
most researched TF-CBT protocol of Cohen and colleagues (2006); however, 
the effects of those additional modules have not been clarified (Leenarts et al., 
2013). Furthermore, as a stand-alone treatment, PE is underutilized in clinical 
practice in general and clinicians perceive barriers to the treatment in terms of 
dropout, adverse events, and symptom exacerbation (van Minnen, Hendriks, & 
Olff, 2010).
Because it is especially children and adolescents who are exposed to inter-
personal trauma that are most likely to develop PTSD, it is of paramount 
importance to establish TFT effectiveness in paediatric patients with complex 
PTSD following interpersonal traumas. Furthermore, in view of the recent 
suggestions of a phase-based approach and the lack of evidence supporting its 
benefits, it would be interesting to learn whether stand-alone TFT, that is with-
out any stabilising phase or additional module(s), is safe for this population.
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A factor that stands in the way of an effective treatment of PTSD in adoles-
cents is premature discontinuation. Dropout rates were as high as 33% in the 
studies using Cohen’s TF-CBT protocol (Cohen, Mannarino, & Iyengar, 2011) 
and 21% for PE (Gilboa-Schechtman et al., 2010). A plausible explanation 
for these high dropout rates is lengthy treatment duration, which increases 
the likelihood of dropout. This would be in line with a meta-analysis of PTSD 
effect studies that showed that dropout among adult patients increased with 
increasing numbers of (weekly) sessions, and thus longer therapy duration 
(Imel, Laska, Jakupcak, & Simpson, 2013), warranting the assumption that 
premature termination may be prevented by treatments that offer sessions in a 
shorter period of time. Intensive TFT programmes for adults with PTSD have 
recently been developed and tested, and one RCT found that intensive cognitive 
therapy delivered within a 1-week timeframe was equally effective in reduc-
ing PTSD symptoms as a regular weekly-based protocol (Ehlers et al., 2014). 
Other studies were exploratory and also showed that intensive TFT reduced 
PTSD symptoms (Hendriks, de Kleine, Hendriks, & van Minnen, 2016). More 
importantly, very few patients left the programmes early and adverse events did 
not occur. There are two uncontrolled PTSD studies that showed an intensive 
TFT delivered in the course of 4 weeks to be effective in reducing self-reported 
and clinician-rated PTSD symptoms in children and adolescents having experi-
enced multiple interpersonal traumas (Matulis, Resick, Rosner, & Steil, 2014; 
Silverstone, Greenspan, Silverstone, Sawa, & Linder, 2016). Although these 
initial outcomes are encouraging, the effectiveness of intensive TFT for paediat-
ric PTSD populations needs to be further established.
The purpose of the present study accordingly was to investigate the effec-
tiveness and safety of an intensive PE therapy for adolescents in an experi-
mental design that controlled for time effects. The programme was specifically 
developed for adolescents who developed PTSD due to multiple interpersonal 
traumas and who show high levels of complex PTSD symptoms as well as 
fulfilling criteria for other comorbid disorders. We hypothesized that our inten-
sive PE would ameliorate their PTSD symptoms, as well as depressive, general 
anxiety, and dissociative symptoms, and second, that it would be low in drop-
out and safe.
METHODS
The trial design was approved by the medical ethics committee of the Radboud 
University Medical Centre and registered in the Dutch trial register with 
number NTR4301 (trialregister.nl).
Participants
The participants (N = 10) were regular referrals to a Dutch outpatient mental 
health clinic specialized in the treatment of anxiety disorders who were 
recruited between 2013 and 2014 (see participant flow diagram, Figure 1). 
Inclusion criteria were (a) age 12–18 years; (b) history of multiple interpersonal 
trauma; (c) meeting full DSM-IV-TR (APA, 2000) diagnostic criteria for PTSD 
established through the Kiddie-Schedule for Affective Disorders and Schizo-
phrenia-Present and Lifetime Version PTSD section (K-SADS-PL-PTSD; Kauf-
man et al., 1997); (d) written informed adolescent and (if under 18) parental 
consent. Exclusion criteria were (a) suicide attempt within 8 weeks prior to 
study entry (i.e. suicidality without imminent threat was not an exclusion crite-
rion); (b) inability to speak and write Dutch; (c) mental retardation (IQ ≤ 70); 
(d) changes in psychoactive medication within 8 weeks prior to enrolment; (e) 
ongoing trauma by a caregiver who is part of the child’s current primary-care 
system; (f) current DSM-IV PTSD diagnosis of the caregiver when involved 
in the child’s current treatment as established with the Mini-International 
Neuropsychiatric Interview (M.I.N.I.; Sheehan et al., 1998) as well as a clinical 
cut-off score of ≥20 on the PTSD self-report symptom scale (PSS-SR; Foa, 1995; 
Foa, Riggs, Dancu, & Rothbaum, 1993).
In view of our aims, the presence of complex PTSD or other comorbid disor-
ders was no exclusion criterion. The DSM-IV Axis I diagnoses of any comorbid 
disorders were assessed with the K-SADS-PL (Kaufman et al., 1997).
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Figure 1. Flow diagram of participant recruitment and trial progress
Note. BDI-II = Beck Depression Inventory Second Edition; BPD-47 Diss = Paranoid/dissociation 
subscale of the Borderline Personality Disorder symptom checklist; iPE = intensive prolonged 
exposure therapy, first five treatment days in one week; K-SADS-PL = PTSD section (current 
episode) of the Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Life-
time Version; PTSD = Posttraumatic stress disorder; SCARED = Screen for Child Anxiety Related 
Emotional Disorders; UCLA PTSD-RI = UCLA PTSD Reaction Index.  
Treatment
Our intensive PE therapy programme was largely based on Foa’s PE proto-
col (Foa, Hembree, & Rothbaum, 2007), with the difference that, instead of 
weekly sessions, the intervention was delivered in five successive weekdays 
(of the same week) and comprised a total of 15 PE sessions. Each of the five 
treatment days, the adolescents received three individual, manualized 90-min 
sessions. The first of these daily sessions comprised prolonged imaginal expo-
sure during which the participant was asked to recount aloud the traumatic 
memory as vividly as possible, with closed eyes, in the present tense, and as 
detailed as possible. The second session concerned exposure by drawing in 
that the participants were instructed to draw the scene(s) of the trauma-mem-
ory hotspots and to include all anxiety-provoking details of this hotspot in the 
drawing. The third session of the day involved exposure in vivo, where partic-
ipants were exposed to trauma-related material and situations. As an add-on 
to the manualized PE treatment, parents attended daily sessions involving 
psychoeducation and social support skill training, which we included based 
on the work of Thrasher, Power, Morant, Marks, and Dalgleish (2010) that 
showed that social support in dealing with the effects of trauma is predictive 
of better treatment gains. Parents were trained to improve the quality of their 
social support when responding to the adolescent sharing the trauma narra-
tive with the aim to reduce the adolescent’s trauma-related avoidance behav-
iour. The parent sessions were for the greater part conducted in the absence of 
the adolescents but at the end of the session, the adolescent was invited to also 
attend and share the traumatic narrative (s)he had processed that day with his/
her parent(s) to provide them with the opportunity to apply their newly learned 
skills. One week after treatment completion, the adolescents received up to 3 
weekly 90-min PE booster sessions within 1 month.
All participants were treated by a team of qualified therapists who were 
specially trained in PE; all had twice weekly group supervision from a senior 
therapist (AVM) for the duration of the trial.
Primary outcome measures
Self-reported PTSD severity over the last week was monitored using the Univer-
sity of California at Los Angeles PTSD Reaction Index (UCLA PTSD-RI; 
Steinberg, Brymer, Decker, & Pynoos, 2004), adolescent version. This 22-item 
self-report scale has been shown to have good to excellent internal consist-
ency reliability (Cronbach’s alpha between .88 and .91) and convergent valid-
ity (Steinberg et al., 2013). Clinician-administered PTSD diagnostic status and 
symptom severity were measured by independent trained assessors, in accord-
ance with the PTSD section (current episode) of the K-SADS-PL (Kaufman et 
al., 1997), whose interrater agreement is high, while its test-retest reliability κ 
coefficients represent good agreement (Kaufman et al., 1997).
 
  Enrolment & intervention Measurement series 
 Time-series design 
(weekly UCLA 
PTSD-RI) 
Single time points  
(K-SADS-PL, BDI-
II, SCARED, BPD-
47 Diss) 
Enrolment  
 
 Assessed for  
  eligibility (N=15) 
 
 Eligible for Trial  
  (N=11)  
 
 Randomly allocated  
  to 1 out of 5 baseline 
  lengths  (N=10) 
 
  
 Baseline phase  
(4-8 weekly 
measurements) 
 
 
 Baseline (one  
 week before  
 treatment) 
  
  
   
   
iPE (completers N=10) 
 
 
 
Intervention phase, 
consisting of: 
 Treatment  
  (5 weekly   
  measurements) 
 
 
 Posttreatment  
 (after iPE before 
 boosters sessions;   
 N=10) 
 
 
Booster session 1 
 
Booster session 2 
 
Booster session 3 
 
  
   
  Posttreatment  
  (4-8 weekly   
   measurements) 
 
   
  
 
 
 
 Follow-up phase  
(4 measurements; 
3 months after 
treatment 
completion) 
3-month follow- 
up (N=10) 
 
   
  6-month follow- 
up (N=10) 
 
 
 Analysed with 
randomisation tests 
and combining p 
values (N=10) 
Analysed with 
Wilcoxon Signed 
Rank Tests (N=10) 
 
Not suitable, 
no PTSD 
(N=4) 
 
Did not want 
to involve 
parents (N=1) 
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Secondary outcome measures
Comorbid symptoms 
Severity of depressive symptoms was assessed with the Beck Depression Inven-
tory (BDI-II; Beck, Ward, Mendelson, Mock, & Erbaugh, 1961), a 21-item 
self-report questionnaire with high internal consistency (a mean Cronbach’s 
alpha of .86; Beck, Steer, & Garbin, 1988). General anxiety symptoms were 
quantified using the 69-item self-report Screen for Child Anxiety-Related 
Emotional Disorders (SCARED), a measure showing good internal consistency 
(Cronbach’s alpha between .74 and .93), test–retest reliability, and discrimi-
native validity (Birmaher et al., 1997). Dissociative symptoms were evaluated 
with the eight-item ‘Paranoid/Dissociation’ subscale of the Borderline Personal-
ity Disorder symptom checklist (BPD-47 symptom checklist; Arntz & Dreessen, 
1992), which self-report questionnaire (full version) has shown excellent inter-
nal consistency (Cronbach’s alpha = .94; Arntz et al., 2003).
Dropout and safety
Dropout was recorded by the therapist and adverse events were monitored by 
self-report. Participants reported suicidal ideation, self-harm, and aggressive 
behaviour on an 11-point Likert scale ranging from ‘no, not at all’ (0) to ‘yes, 
very much’ (10), while the use of alcohol and illicit or prescription drugs, crisis 
contacts with mental health providers, and psychiatric hospitalization were 
reported dichotomously (yes/no). 
Design
As is shown in Figure 1, two different measurement series were performed: a 
time-series design that comprised frequent self-reports, and four single time 
points (baseline, posttreatment, 3-, and 6-month follow-up) that comprised a 
clinician-administered interview as well as self-report measures. 
Time-series design
This time-series design is an ideal experimental strategy for evaluating a novel 
treatment approach, like our intensive PE, as it allows both the intervention 
process and outcome to be evaluated (Morgan & Morgan, 2001).
The severity of self-reported PTSD symptoms was assessed repeatedly: 
during the baseline phase and then continued during the intervention phase 
(weekly, 17 times in total). Baseline length varied between 4 and 8 weeks, 
with participants being randomly allocated to one of five baseline lengths (two 
participants per length). The intervention phase comprised a 5-week treatment 
phase (five consecutive weekdays of intensive PE, 1 week without treatment, 
and 3 weeks with weekly booster sessions) and a posttreatment phase that also 
varied from 4 to 8 weeks. Symptoms were further assessed (weekly, four meas-
urements) during a 1-month follow-up phase, 3 months after treatment comple-
tion. Within this design, PTSD symptom severity scores during the intervention 
phase are compared with baseline scores. 
Single time points
Clinician-administered PTSD diagnostic status and symptom severity, as well 
as self-reported comorbid symptoms, were evaluated at baseline (1 week before 
treatment), posttreatment (after intensive PE completion and before booster 
sessions), and at a 3-month and 6-month follow-up.
Data analysis
Time-series design
A randomisation test was conducted for each participant. Randomisation tests 
are nonparametric significance tests that are valid for single-case designs, with-
out making distributional assumptions (Heyvaert & Onghena, 2014; Onghena 
& Edgington, 2005). The a priori null hypothesis for the randomisation test 
was that intensive PE has no effect: participant responses are independent of the 
condition (i.e. ‘baseline’ vs. ‘intensive PE’) under which they are observed. The 
alternative hypothesis was that there are positive effects of the intensive PE on 
the UCLA PTSD-RI (directional, one-tailed), whereby a lower UCLA PTSD-RI 
scale score is expected in the intervention phase (B), compared to the baseline 
phase (A), for each participant. In accordance with this alternative hypothesis, 
the difference between the means for the baseline and intervention phase was 
applied as test statistic for the randomisation test: T = A – B. The incorporation 
of randomisation for each within-subject experimental design concerned the 
moment of phase change (i.e. the start of the intervention phase), resulting in 
five design possibilities: AAAAABBBBBBBBBBBB, AAAAAABBBBBBBBBBB, 
AAAAAAABBBBBBBBBB, AAAAAAAABBBBBBBBB, and 
AAAAAAAAABBBBBBBB.1
The test statistic was calculated based on the data collected for each partici-
pant. For instance, for participant 1, the following UCLA PTSD-RI total scores 
were collected for the different time points in the A phase: 37; 31; 32; 30; and 
36 and B phase: 17; 20; 15; 15; 16; 17; 17; 15; 16; 18; 20; and 15. Accordingly, 
the observed test statistic for participant 1 was ((37 + 31 + 32 + 30 + 36)/5) – 
((17 + 20 + 15 + 15 + 16 + 17 + 17 + 15 + 16 + 18 + 20 + 15)/12) = 16.45. Next, 
for each participant, the test statistic was calculated for all five design possi-
bilities. These five test statistics were then sorted in ascending order, reflect-
ing the randomisation distribution under the null hypothesis. Following up on 
the example, for participant 1, the test statistics for the five possible permuta-
tions were 16.45, 13.77, 12.60, 10.69, and 9.14, respectively. The proportion 
of possible test statistic values that is as extreme as or even more extreme than 
the value of the test statistic based on the collected data is calculated and used 
to define the individual p value of the randomisation test (Heyvaert & Ongh-
ena, 2014; Onghena & Edgington, 2005). The 10 individual p values that were 
1 Note that for the first design possibility, the A phase consists of five measurement occasions 
although the baseline for the first permutation consisted of 4 weeks. The measurement occasion on 
the first day of the fifth week was also labelled ‘A’ because the UCLA PTSD-RI, completed the first 
day of each week, assessed PTSD symptoms within the last week and an intervention effect during 
the actual intensive PE phase (first week) was not expected.
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the outcomes from the randomisation tests were afterwards combined using 
the additive method (Edgington, 1972; Onghena & Edgington, 2005), and 
analysed with the R software package developed by Bulté and Onghena (SCDA 
package; Bulté & Onghena, 2013).
Single time points
Analyses were conducted with statistical software (SPSS 22; IBM SPSS). Base-
line scores on the measures assessing PTSD severity, depressive symptoms, 
general anxiety, and dissociative symptoms were compared with the posttreat-
ment and 3- and 6-month follow-up scores using the nonparametric Wilcoxon 
signed rank tests because general assumptions for parametric testing were 
violated. Effect sizes were calculated with the formula r = Z / √N, where N is 
the number of observations, and indicated using Cohen’s (1988) criteria (.1 = 
small effect; .3 = medium effect; and .5 = large effect).
RESULTS
Sample characteristics
Our sample consisted of eight girls and two boys with a mean age of 15.90 
years (SD = 1.52, RANGE 13–18). Table 1 shows their baseline demographic, 
trauma, and clinical characteristics. All 10 had experienced multiple interper-
sonal traumas in the past: seven multiple sexual abuse (for six at age ≤ 12 years) 
and nine multiple violent (nonsexual) assaults (for eight at age ≤ 12 years). All 
reported affect dysregulation, negative self-concept, and interpersonal prob-
lems (BPD-47 subscales), resembling criteria for complex PTSD as proposed by 
the WHO ICD-11 (Cloitre, Garvert, Brewin, Bryant, & Maercker, 2013). Nine 
participants met criteria for a comorbid disorder: depressive disorder (n = 7) 
with some also reporting psychotic features (n = 2), other anxiety disorder(s) 
(n = 9), eating disorders (n = 3), conversion disorder (n = 1), autism spectrum 
disorder (n = 1), and alcohol dependence (n = 1). In addition, six participants 
reported suicidal ideations and four (urges of) self-harming behaviour.
Table 1. Sample characteristics 
Characteristics (N = 10)
Education, No. (%)
Lower level secondary school 5 (50)
Intermediate / higher level secondary school 4 (40)
Lower level tertiary education 1 (10)
Trauma history, No. (%)
Multiple sexual abuse 7 (70)
Multiple violent (nonsexual) assault 9 (90)
Emotional abuse 10 (100)
Neglect 8 (80)
Time since trauma in years, mean (SD), range 9.30 (3.89), 1–13
UCLA PTSD-RI baseline, mean (SD), range 48.30 (6.50), 37–61
BPD-47 subscales baseline, mean (SD), range
         Affect dysregulation a) 36.80 (10.56), 22–60
         Negative self-concept b) 21.30 (6.20), 12–29
         Interpersonal problems c) 8.30 (2.11), 6–13
Total amount of comorbid disorders, mean (SD), range 2.50 (1.27), 0–4
Axis I comorbidity (current), No. (%) 9 (90)
           1-2 comorbid disorder 3 (30)
           ≥ 3 comorbid disorders 6 (60)
Comorbid depressive disorder, No. (%) 7 (70)
Receiving psychotropic medication, No. (%) 6 (60)
Total treatment history d) in months, mean (SD), range 30.40 (28.32), 4–96
 
Note. BPD-47 = Borderline Personality Disorder Checklist; UCLA PTSD-RI = UCLA PTSD Reaction Index. 
a) Sum score of the ‘Mood’, ‘Impulsivity’ and ‘Anger’ subscales. 
b) As measured by the ‘Identity/Self-concept’ subscale.  
c) As measured by the ‘Relationships’ subscale. 
d) Mental-health care treatment history.
Primary outcomes
Self-reported PTSD severity
The individual graphs (Figure 2) show the UCLA PTSD-RI scores for all 10 
participants during the baseline (A), intervention (B), and follow-up (C) phases. 
Visual inspection suggests that PTSD symptoms decreased in the interven-
tion phase and that UCLA PTSD-RI follow-up scores are lower compared to 
the baseline values in all but one participant (participant 10). The results of the 
time-series analysis are displayed in Table S1 (see Appendix A).
Applying Edgington’s (1972) additive method, the combined p value across 
all 10 participants showed a statistically significant decrease of PTSD symptoms 
(p = .002). Together, our results show that PTSD symptoms were significantly 
lowered by the intensive PE.
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Figure 2. Primary outcome 
variable: weekly measures 
of PTSD symptom sever-
ity (total UCLA PTSD-RI 
scores) across the baseline 
(A), intervention (B) and 
follow up (C) phases
Note. x-axis = measure-
ment occasions; y-axis = 
outcome scores; phases 
are divided by vertical 
lines.
PTSD diagnostic status and symptom severity (clinician-administered 
interview)
Table 2 lists the descriptive statistics. There was a significant baseline-to-post-
treatment reduction in K-SADS-PL-PTSD section total scores (z = -2.81, p 
= .005) with a large effect size (r = .63), as well as for baseline-to-3-month 
follow-up (z = -2.81, p = .005, r = .63) and 6-month follow-up (z = -2.81, p 
= .005, r = .63). The number of adolescents meeting the K-SADS-PL-PTSD 
diagnosis decreased from 10 to 6 (40% remission) from baseline to posttreat-
ment and from 10 to 2 (80% remission) from baseline to follow-up at 3 and 6 
months.
Table 2. Means, medians, and SDs for Wilcoxon signed rank tests for the primary and secondary 
outcomes (N = 10).  
Baseline Posttreatment 3-month follow-up 6-month follow-up
Mean Median SD Mean Median SD Mean Median SD Mean Median SD
K-SADS-PL 31.60 32.00 3.10 26.40* 26.00 4.12 23.20* 23.00 3.55 23.30* 22.00 4.99
BDI-II 32.50 35.50 14.97 21.70* 20.50 14.94 20.10* 21.00 13.76 17.00* 12.00 13.40
SCARED 71.40 79.00 27.99 45.20* 51.50 22.39 37.70* 44.00 24.87 41.50* 45.50 25.27
BPD-47 Diss 21.90 22.00 7.06 14.30* 12.50 5.54 13.10* 11.00 6.45 12.50* 11.00 5.93
Note. BDI-II = Beck Depression Inventory Second Edition; BPD-47 Diss = Paranoid/dissociation 
subscale of the Borderline Personality Disorder symptom checklist; K-SADS-PL = PTSD section 
(current episode) of the Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and 
Lifetime Version; SCARED = Screen for Child Anxiety-Related Emotional Disorders.  
* p ≤ .05 compared to baseline.
Secondary outcomes
Comorbid symptoms
Table 2 lists the descriptive statistics. There was a significant reduction in 
depressive symptoms (BDI-II total scores) from baseline to posttreatment (z = 
-2.24, p = .025) with a large effect size (r = .50) as well as to the 3-month (z = 
-2.65, p = .008, r = .59) and 6-month follow-ups (z = -2.81, p = .005, r = .63). 
Furthermore, there was a significant baseline-to-posttreatment reduction in 
general anxiety symptoms (SCARED total scores; z = -2.40, p = .017) with a 
large effect size (r = .54), as well for the baseline-to-3-month (z = -2.70, p = 
.007, r = .60) and 6-month follow-ups (z = -2.50, p = .013, r = .56). We also 
computed a significant reduction in dissociative symptoms (BPD-47, paranoid/
dissociation subsection score) from baseline to posttreatment (z = -2.81, p = 
.005) with a large effect size (r = .63), as well as to the 3-month (z = -2.60, p = 
.009, r = .58) and 6- month follow-ups (z = -2.61, p = .009, r = .58).
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Dropout and safety
None of the participants dropped out of the treatment and no adversities 
(suicidal behaviour, crisis contact, or psychiatric hospitalization) occurred 
during the intervention phase. In addition, none of the participants showed 
increased PTSD symptoms (see Figure 2 for the individual graphs). There were 
(nonsignificant) reductions in suicidal ideation (baseline M = 3.00, post M = 
2.20), self-harm (baseline M = 2.20, post M = 1.00), and aggressive behav-
iour (baseline M = 0.20, post M = 0.00), and none of the participants reported 
having abused alcohol, drugs, or prescription medication during the interven-
tion phase.
DISCUSSION
Our results of this first proof of concept trial investigating an intensive PE ther-
apy programme targeting adolescents (aged 12–18 years, N = 10) with complex 
PTSD and comorbid disorders, suggest that the intervention was effective in 
reducing PTSD symptoms and achieving remission of PTSD diagnosis. In addi-
tion, in line with the results of the open studies into intensive TFT (Matulis et 
al., 2014; Silverstone et al., 2016), symptoms declined within a short period of 
time, with our study showing gains persisting over time (6 months) as well. Our 
results were also in agreement with studies showing the effectiveness of week-
ly-based PE in adolescents with PTSD after single trauma (Gilboa-Schechtman 
et al., 2010) and expand the evidence base on the effectiveness of PE for adoles-
cents having suffered multiple interpersonal traumas before the age of 12 and 
who show more complex pathology indicative of complex PTSD as well as 
high levels of comorbid disorders (Foa et al., 2013). In addition, along with the 
PTSD symptom reduction, also symptoms of depression, general anxiety, and 
dissociation were reduced significantly, even though these were not directly 
addressed in the treatment. The amelioration of comorbid depressive symp-
toms we observed is consistent with the findings of a meta-analysis evaluating 
the effectiveness of TFT on symptoms of PTSD and comorbid depression in 
children and adolescents (Lenz & Hollenbaugh, 2015), which showed TFT to 
be more effective in reducing depressive symptoms than other (nontrauma-fo-
cused) treatments. Lastly, our data are also in line with studies in adult PTSD 
populations that consistently found that secondary symptoms decreased along 
with the PTSD symptoms with exposure-based treatments (van Minnen, Zoell-
ner, Harned, & Mills, 2015).
One of the reasons that prompted us to develop a short and intensive PE 
programme for adolescents was to prevent dropout. The fact that, despite 
their complex PTSD and comorbid problems, all 10 participants completed 
the programme shows that intensive PE does just that, whereas dropout rates 
in other studies treating children and adolescents with PTSD for longer peri-
ods were relatively high (Cohen et al., 2011; Gilboa-Schechtman et al., 2010). 
Moreover, given that, on average, 18% of adult PTSD patients drops out of 
treatment (Imel et al., 2013), with some studies reporting rates as high as 52%, 
and that dropout rates range from 28% up to 75% for paediatric outpatient 
mental health care in general (de Haan, Boon, de Jong, Hoeve, & Vermeiren, 
2013), our results, if corroborated, have important clinical implications. Even 
though some clinicians are concerned that with its quick succession of trau-
ma-focused interventions, intensive PE treatment may worsen symptoms or 
induce adverse events (Tarrier et al., 1999), the results of our trial show that, 
despite the massed sessions, our intensive PE protocol was safe and did not 
cause any adverse events.
In addition, by achieving significant symptom reduction in adolescents in 
just 1 week, intensive PE, if implemented soon after the trauma, may reduce the 
likelihood of developing the severe long-term consequences typically associated 
with PTSD (Kessler, 2000), such as the increased risk of revictimization (Risser, 
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Hetzel-Riggin, Thomsen, & McCanne, 2006) or suicidal attempts (Wilcox, 
Storr, & Breslau, 2009), while, ideally, further benefits of rapid symptom 
reduction, such as a timely return to school and prevention of developmental 
stagnation, may be anticipated.
As to limitations, obviously the small sample size must be mentioned. The 
small sample size does restrict the generalizability of our findings (Gliner, 
Morgan, & Harmon, 2000), although the sample is highly representative of 
adolescents with complex PTSD, as typically seen in clinical practice. Further-
more, it was not possible to replicate the intervention by offering the treat-
ment again separated by an adequate washout period, as is typically done in 
experimental studies (Onghena & Edgington, 2005), which lowers the external 
validity of our findings as well. Another limitation is that no control or placebo 
treatment was offered to indicate that the observed treatment effects were treat-
ment specific instead of ‘attention alone’. Note, however, that all adolescents 
already received mental health care treatment (with an average of 2.5 years of 
treatment) when entering the intensive PE, which suggests that it is unlikely that 
the findings should be attributed to placebo or nonspecific effects of treatment 
(rather than exposure effects). We further point out that, although we did not 
offer additional nontrauma-focused modules to the adolescents, the intensive 
PE did include parent sessions, the effects of which we have not elucidated. 
Dismantling studies will need to establish whether parent sessions are criti-
cal to intensive PE outcome. Another limitation is that the chosen design with 
weekly repeated assessments is vulnerable to carryover effects; however, visual 
inspection of the results provides no clear indication for those test effects in the 
current study.
The treatment outcomes we obtained and the absence of dropout and 
adverse events may have important implications for clinical practice as together 
these results expand the effectiveness of TFT – or more specifically PE – for 
young PTSD patients suffering from more complex pathology as a result of 
multiple interpersonal trauma. Importantly, our intervention did not include 
any nontrauma-focused techniques, showing that, despite hesitations of clini-
cians (Allen & Johnson, 2011; van Minnen et al., 2010), intensive TFT can be 
effectively and safely applied in adolescent populations with complex PTSD and 
comorbid mental problems. Our work thus contrasts with the recommendation 
to start treatment with a stabilising phase before initiating TFT especially when 
traumas were repeated and interpersonal or when patients are suffering from 
complex PTSD psychopathology (Leenarts et al., 2013).
Although the cohort size is small, with our results we are, to our knowledge, 
the first to demonstrate the effectiveness and safety of a stand-alone intensive 
PE treatment targeting a complex paediatric PTSD population and with the 
favourable results of this first proof of concept trial offering strong support for 
a randomised controlled study.
APPENDIX: results of the time-series analysis
Table S1. Results of the time-series analysis. Differences between the means for the baseline and 
intervention phases (A – B) are presented for one dependent variable (i.e. UCLA PTSD-RI)
Participant Observed test 
statistic
(A – B) a)
Test statistics for the four other 
design possibilities
(A – B) a)
1 16.45 9.14 10.69 12.60 13.77
2 21.77 21.21 21.46 21.53 21.75
3 24.79 22.81 22.82 22.99 23.06
4 37.42 30.44 32.36 34.29 34.40
5 13.97 11.56 12.27 12.82 14.60 b)
6 17.23 14.01 16.21 16.58 17.06
7 23.01 15.50 16.91 17.39 20.67
8 41.51 31.38 34.55 35.69 38.49
9 24.46 20.87 22.45 23.56 24.61 b)
10 5.15 0.74 0.86 1.20 3.11
a) Difference between the means for the baseline and intervention phases; b) Test statistic values are 
as large as or larger than the observed test statistic.
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Brave:
‘I’m here to get help, not to downplay my traumas.’
‘Well, you can’t help me if you don’t ask me about it, now can you?’
‘Let’s get cracking, then, with this exposure. Things’ve already 
happened to me, so I’ve managed to get through the worst bit already, 
haven’t I?’ 
‘It’s so awfully hard and at the same time such a relief when they keep 
asking you to tell more, go deeper, helping you to acknowledge that 
part of yourself.’
‘I was standing there, in the warm afternoon sun, looking at my family 
home where other people have been living for ages, thinking: I want to 
live, I have a right to live.’
‘My symptoms haven’t improved. So disappointing! But at least I can 
say that I’ve tried confronting things. And funnily enough, that’s meant 
something, has given me some new strength.’ 
‘I’m having a tattoo, to really close this chapter of my life. […]   
Yeah, yeah, of course I‘ll ask my mother, no worries.’
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Summary and integration of the findings
The studies presented in this dissertation were all aimed at improving the 
delivery and, accordingly, the accessibility and acceptability of trauma-fo-
cused treatment (TFT) for patients struggling with posttraumatic stress disor-
der (PTSD). Notwithstanding their status as first-line treatments for PTSD and 
their proven effects, not all PTSD patients benefit from the current TFT proto-
cols, with large groups of patients dropping out, while many eligible patients 
do not even receive TFT to begin with. Accordingly, there is an urgent need 
for new treatment strategies that achieve better outcomes in terms of last-
ing symptom amelioration in patients not (sufficiently) responding to existing 
TFT programmes and that help reduce dropout rates and widen the accessi-
bility of the approach. One such relatively new strategy is to deliver the treat-
ment sessions in a highly intensive format, with patients attending multiple 
sessions within a compact period of time rather that weekly sessions over the 
course of several months. The main arguments for intensifying TFT are that 
the massed format seems a feasible next-step solution for patients not benefit-
ing from regularly dosed interventions, that it will enhance treatment accepta-
bility and thus prevent patients from leaving the programme prematurely, and 
that it will make treatment more accessible for more complex patients who 
are regularly ruled out for TFT because many clinicians still have hesitations 
about the safety. To learn more about (the lack of) TFT accessibility, we first 
examined when and why therapists opt for or rule out this guideline treatment 
for patients with PTSD. Furthermore, we investigated the effectiveness and 
safety of intensive TFT in an adult patient sample. Given the large proportion 
of patients who, having been exposed to multiple interpersonal trauma during 
their childhood, are in need of timely and effective treatment, we also inves-
tigated the effectiveness and safety of intensive TFT in an adolescent patient 
sample. In this concluding chapter, the results of these studies will be summa-
rised and discussed. Also, the clinical implications of our findings will be put 
forward while, lastly, the limitations of the studies are presented and directions 
for future research considered.  
When and why do therapists opt for or rule out TFT for PTSD? 
In the paper presented in Chapter 2 (van Minnen, Hendriks, & Olff, 2010) we 
reported the results of an exploratory survey and experimental study designed 
to investigate when and why therapists choose (not) to offer TFT and, more 
specifically, prolonged exposure (PE). The 255 trauma professionals taking 
part in this study were asked whether they used PE in their therapy practice, 
were trained in this treatment approach, regarded exposure as credible, and 
perceived barriers in offering PE-based protocols. In the experimental part of 
the study, the respondents were randomised to two conditions in which they 
were presented with four cases (two having developed PTSD after single adult 
trauma and two following multiple childhood trauma) in which the patients’ 
comorbidity (with or without depression) and treatment preferences were 
manipulated. The therapists were asked to what extent they deemed the differ-
ent treatment options suited for each of these four patients. The results of our 
survey confirmed earlier findings (Becker, Zayfert, & Anderson, 2004) in that 
PE is underutilised, with the majority of professionals being undertrained in 
the technique. The cases in the experimental part of the study, revealed that 
patient factors indeed influenced the therapists’ choice of therapy. In the case 
with comorbid depression, PE was significantly less preferred than medication. 
Furthermore, the technique was significantly more likely to be offered when 
patients expressed a preference for TFT. Therapist factors were also found to 
be related to treatment preferences, with confidence in the effectiveness of the 
technique being positively related to the therapists’ preference for PE. Perceived 
barriers to PE, such as a fear of symptom exacerbation and dropout, were nega-
tively related to the perceived suitability of the treatment when patients had 
suffered multiple traumas in childhood. 
Asked which treatments they used to treat PTSD patients, only a minority of 
the therapists indicated to use PE rather than eye movement desensitisation and 
reprocessing (EMDR) and supportive counselling. Relative to the other two 
psychological interventions, the trauma specialists had received the least train-
ing in PE, which suggests that more and better training in PE might promote 
its use. However, based on the choices the respondents made in the four cases, 
which were not different for those trained in PE, we expect no beneficial effects 
of more PE training on therapist judgments of and preference for PE, which is 
in line with the conclusions of Sprang and colleagues (2008) that simply offer-
ing (more) training in PE does not necessarily increase the use of the treatment.
Despite the therapists’ relatively high confidence in PE, they did report the 
most barriers for its clinical use relative to the other psychological interven-
tions, which is in accordance with previous research stating that PE, more than 
other trauma approaches, is associated with disadvantages or contraindications 
(Becker et al., 2004; Cook, Schnurr, & Foa, 2004). These perceived barriers 
did not play a role in the respondents’ choice of PE for the scenario describing 
a single trauma in adulthood. However, and consistent with previous studies 
(Becker et al., 2004; Cook et al., 2004; Ruscio & Holohan, 2006), their fear of 
symptom exacerbation or the higher risk of dropout did negatively affect their 
preference for PE in the two multiple childhood trauma scenarios. Hence, in 
spite of the evidence disproving these concerns and claims (see e.g. Cahill, Foa, 
Hembree, Marshall, & Nacash, 2006; van Minnen, Harned, Zoellner, & Mills, 
2012), our trauma professionals tended to persist in their subjective estimation 
of danger in the case of more complex PTSD patients.
In sum, patient variables indeed play an important role in the choice of 
treatment. The findings presented suggest that when therapists are dealing 
with more complex PTSD patients, the decision-making process is likewise 
more complex, which reflects the current clinical practice where there is expert 
consensus about treatment guidelines for PTSD but not (yet) for complex PTSD 
(see e.g. de Jongh et al., 2016; position paper on complex PTSD in adults Inter-
national Society for Traumatic Stress Studies, ISTSS, Guidelines Committee, 
2018; Stein et al., 2009). Several therapist characteristics were also importantly 
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related to the choice of PE, with the therapist’s confidence in the technique 
(trust and belief in PE) being the main determining factor. Finally, perceived 
barriers to exposure (e.g. fear of symptom exacerbation and dropout) only 
correlated negatively to exposure preference when PTSD had developed after 
multiple childhood traumas. Although the experimental part of the study 
reported in Chapter 2 (van Minnen et al., 2010) solely focused on treatment 
decisions for adults with PTSD, the results can in all probability be extended 
to children and adolescents with PTSD. Some researchers recommend starting 
treatment with a skill training phase before initiating TFT in young patients 
with complex PTSD (Leenarts, Diehle, Doreleijers, Jansma, & Lindauer, 2013; 
position paper on complex PTSD in children and adolescents ISTSS Guide-
lines Committee, 2018). There are also clinicians who believe that, in general, 
it is too difficult for children to share their most upsetting traumatic memo-
ries (a standard part of TFT), perceiving them as more vulnerable than adult 
patients even though empirical evidence for both these assumptions are lack-
ing. Apparently, patient characteristics that are indicative of complex PTSD, 
such as multiple interpersonal (childhood) trauma and comorbidity, appear to 
act as confounders in the treatment decision-making process for both adult and 
younger patients.
Is a highly intensive prolonged exposure programme feasible, effective and 
safe for adult patients with complex PTSD?
In a feasibility study presented in Chapter 3, the intensive prolonged exposure 
(iPE) programme in which a total of 24 hours is dedicated to trauma processing 
was introduced and illustrated using four cases of PTSD patients (Hendriks, de 
Kleine, van Rees, Bult, & van Minnen, 2010). The iPE is an intensive one-week 
programme consisting of daily sessions of prolonged imaginal exposure, expo-
sure by drawing with the participant being instructed to draw the scene(s) of 
the hotspots of the traumatic memory, and exposure in vivo to trauma-re-
lated situations and materials. The patients being the first to receive the treat-
ment were those that therapists tend to rule out for TFT (see Chapter 2; van 
Minnen et al., 2010) in that they had all suffered multiple (sexual) traumas in 
childhood, had high levels of comorbidity and psychosocial stressors, as well 
as a history of multiple (regular TFT) treatment attempts. A key component 
of the newly developed iPE programme is therapist rotation, where the patient 
is treated by several therapists. At treatment completion, the PTSD symptoms 
of all four patients had decreased substantially and the effect sizes were large. 
Importantly, none of the participants showed symptom worsening or dropped 
out, and all rated the iPE as an acceptable treatment. These first results were 
very promising, with the favourable outcomes evidently supporting replication 
in a larger cohort of complex PTSD patients.
In Chapter 4 (Hendriks, de Kleine, Broekman, Hendriks, & van Minnen, 
2018) the results of a larger open clinical trial were presented, in which we 
were able to treat 73 chronic PTSD patients with symptoms of ICD-11 complex 
PTSD following multiple interpersonal trauma and a history of multiple treat-
ment attempts using a slightly adapted iPE protocol. Although the partici-
pants still received 24 hours of TFT, we had learned from the feasibility study 
(Chapter 3; Hendriks et al., 2010) that the time patients were able to spend 
on practising exposure techniques in a broader variety of contexts (e.g. their 
home environment) was limited, which is why they were now offered 18 hours 
during the intensive treatment phase (four days within one week), while the 
remaining 6 hours were spread across the following four weeks. These four 
weekly 90-minute booster sessions were aimed at facilitating the generalisation 
of what the participants had learned during the intensive treatment phase. One 
week after the last booster session, patients showed a baseline-to-posttreat-
ment decrease in PTSD symptom severity that, despite the frequently voiced 
doubts about the maintenance of treatment effects, persisted during the 3- and 
6-month follow-ups, with large effect sizes (Cohen’s d > 1.2). The maintenance 
of the iPE gains may be enhanced by the patient’s exposure to trauma-related 
situations in a broad variety of contexts outside the therapy room, supporting 
previous research findings about the context-dependency of extinction learning 
that prompted the postulation that, to prevent relapse, intensive TFT should be 
delivered within multiple daily, real-life contexts (Vervliet, Craske, & Hermans, 
2013). The posttreatment response rate we obtained was 71%. In contrast to 
the high dropout reported in previous studies (Imel, Laska, Jakupcak, & Simp-
son, 2013), which is assumed to stem from participants’ avoidance of their 
traumatic memories (Szafranski, Smith, Gros, & Resick, 2017), all participants 
completed the intensive phase of the iPE protocol, with only 5% dropping out 
during the booster phase. What is more, adverse events were extremely low and 
symptom exacerbation rare (<3%). Arguably, with the proposed massed, inten-
sive format PTSD patients that normally leave weekly-based TFT prematurely 
can be reached, making TFT more accessible for a larger group of patients, and, 
despite widely held fears, also those with complex PTSD and comorbid mental 
health issues. 
Our results are in line with previous research investigating the effects of 
outpatient TFT delivered in an intensive format in PTSD patients having 
suffered a single or two discrete adulthood traumas (Ehlers et al., 2010; Ehlers 
et al., 2014) as well as with the available empirical evidence in more complex 
patients populations (Blount, Cigrang, Foa, Ford, & Peterson, 2014; Gantt & 
Tinnin, 2007; Lande, Banks Williams, Francis, Gragnani, & Morin, 2011) at 
the time our study was designed. Since then, many intensive TFT programmes 
for PTSD were launched, illustrating that intensive treatment formats are 
worldwide regarded as a valuable next step towards improving TFT. One of 
these recent programmes found preliminary evidence of the effectiveness of 
intensive imaginal exposure, with gains being comparable to those obtained 
with regular treatment consisting of twice weekly sessions (Zoellner et al., 
2017). Another pilot study (Bongaerts, van Minnen, & de Jongh, 2017) testing 
an intensive EMDR therapy in seven PTSD patients with complex PTSD result-
ing from childhood sexual abuse, physical abuse, and/or work and combat-re-
lated trauma, reported large effect sizes and no dropout. In a larger open trial, 
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the same research group (van Woudenberg et al., 2018) demonstrated the 
effectiveness of intensive TFT combining PE and EMDR for patients having 
developed PTSD after multiple traumas, obtaining a significant decline in PTSD 
symptom severity with minimal dropout. Comparing the outcomes obtained 
in patients having received intensive cognitive therapy with matched control 
cases having received weekly treatment, all in routine clinical practice, Murray, 
El-Leithy, and Billings (2017) found the intensive group to show the larger 
improvement of PTSD symptoms. However, because their routine clinical prac-
tice study did not allow for randomisation, differences in the patients’ ages and 
time since the trauma suggest a selection bias in who chose or was offered the 
intensive treatment. This selection bias was driven by the authors’ assumptions 
that patients with more failed treatment attempts and more comorbid disorders 
are possibly less hopeful and more avoidant, affecting their readiness to take 
part in an intensive treatment. An open study testing an intensive individual 
imaginal exposure combined with group in vivo exposure therapy in 49 veter-
ans with PTSD, reported large improvements in PTSD and depression symp-
toms in two weeks and notably lower dropout rates compared to regular PTSD 
treatment (Yasinski, Sherrill, Maples-Keller, Rauch, & Rothbaum, 2018). In a 
randomised controlled trial (RCT), comparing the effectiveness of intensive PE, 
regularly spaced PE, present-centred therapy, and a minimal contact control 
group in military personnel with PTSD, Foa and colleagues (2018) found 
the intensive PE format to be superior to the minimal contact condition and 
non-inferior to the spaced PE and present-centred therapies. Although there 
are as yet no indications that treatment response to intensive TFT is superior to 
that recorded for conventional weekly based TFTs, more RCTs are needed to 
confirm or expand these early findings. In sum, so far, massed programmes do 
appear to speed up the amelioration of PTSD (and comorbid) symptoms and 
reduce dropout rates.
Given that the patients participating in our studies all had experienced 
multiple childhood traumas and had self-reported symptoms of ICD-11 
complex PTSD, and a history of several unsuccessful treatment attempts, we 
expanded the evidence base for the effectiveness of intensive TFT in single 
trauma patients (Ehlers et al., 2010; Ehlers et al., 2014). Additionally, our 
results do not support the assumption (Murray et al., 2017) that these more 
complex patients are less willing to engage in intensive TFT. Several studies 
indicate that regular treatment attendance (Tarrier, Sommerfield, Pilgrim, & 
Faragher, 2000) and a higher frequency of sessions (Gutner, Suvak, Sloan, & 
Resick, 2016), especially early on in the treatment, enhance treatment outcome. 
It is conceivable here that some PSTD patients have more trouble overcom-
ing their avoidance behaviour and hence benefit from a compact treatment 
programme because weekly TFT leaves them more room to engage in avoid-
ance behaviour between sessions. However, the results of our trial and the 
greater part of the other studies on intensive TFT cannot fully support this 
conclusion due to the lack of control arms. Although our results showed that 
intensive TFT is feasible for PTSD patients presenting with complex PTSD 
symptoms and multiple failed treatment attempts, we do not know whether we 
unwittingly selected those patients who already were more willing to try the 
new approach.
As to the safety of iPE, many clinicians are afraid that TFT may evoke 
serious adverse events or symptom exacerbations (Becker et al., 2004; Frueh, 
Cusack, Grubaugh, Sauvageot, & Wells, 2006; Chapter 2; van Minnen et 
al., 2010) and these risks are assumed to be higher for massed, intensive 
programmes and more vulnerable patients reporting ICD-11 complex PTSD 
symptoms (Cook et al., 2004; Ruscio & Holohan, 2006). Treating patients 
with such complex symptoms, we found no evidence for this assumption. 
The low incidence of serious adverse events and symptom exacerbations we 
recorded contributes to the growing evidence that TFT is safe in ‘high-risk’ 
patients (Larsen, Stirman, Smith, & Resick, 2016), also if the treatment is deliv-
ered in a massed format. 
Summing up, although we have as yet not conducted an RCT and cannot 
claim that iPE is superior to conventional weekly based TFT in terms of 
response, the intensive programme does speed up the reduction of PTSD symp-
toms, lowers dropout, and improves accessibility. Besides suggesting that 
iPE is effective, our open studies moreover indicate that it is safe for patients 
having suffered multiple interpersonal childhood trauma and reporting ICD-11 
complex PTSD symptoms. Despite previous unsuccessful TFTs, the majority of 
the iPE participants showed partial or complete response during and after treat-
ment, with results being maintained up to six months, while serious adverse 
events and symptom exacerbation were rare and dropout minimal. 
Is a highly intensive prolonged exposure programme feasible, effective and 
safe in adolescent patients with complex PTSD and comorbid disorders 
following multiple interpersonal trauma?  
Wondering whether the positive results in adults with complex PTSD would 
also be achievable in younger patients, in the study presented in Chapter 5 
(Hendriks, de Kleine, Heyvaert, Becker, Hendriks, & van Minnen, 2017) we 
reported on the results of a single-trial design, an experimental strategy with 
adolescents being randomly allocated to one of five baseline lengths before 
starting the iPE. All 10 participants had developed complex PTSD due to multi-
ple interpersonal trauma and showed high levels of comorbid disorders. As an 
add-on to the iPE, parents attended five sessions involving social support skill 
training. Parents were trained to improve the quality of their social support 
when responding to the adolescent sharing the trauma hotspots with the aim to 
reduce the adolescent’s trauma-related avoidance behaviour. Time-series analy-
ses showed that self-reported PTSD symptom severity had significantly declined 
following iPE, while pre-post group analyses revealed significant reductions 
in clinician-rated PTSD symptom severity with a large effect size already after 
completion of the intensive phase (i.e. before the start of the booster sessions). 
Despite the often raised doubts about the long-term effect of condensed treat-
ments, the reductions in PTSD symptoms persisted during the 3- and 6-month 
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follow-ups, with 80% of our adolescent participants having reached diag-
nostic remission of PTSD as established through the PTSD section of the 
Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Life-
time Version (K-SADS-PL-PTSD; Kaufman et al., 1997). Notably, the pre-post 
analyses showed that self-reported symptoms of depression, general anxiety, 
and dissociation had also significantly decreased, all yielding large effect sizes, 
with the gains again being maintained during the 3- and 6-month follow-ups. 
Also noteworthy is that none of the participants dropped out, none showed 
PTSD symptom exacerbation, while no adverse events (suicidal behaviour, 
crisis contact, or psychiatric hospitalisation) occurred and there were (nonsig-
nificant) reductions in suicidal ideation, self-harm, and aggressive behaviour.
Again, our results confirmed previous findings and were supported by 
more recent studies. Similarly to other open studies investigating the effects of 
intensive TFT delivered in the course of four weeks in children and adolescents 
with PTSD after multiple interpersonal trauma (Matulis, Resick, Rosner, & 
Steil, 2014; Silverstone, Greenspan, Silverstone, Sawa, & Linder, 2016), PTSD 
symptoms ameliorated within a short period of time. The fact that none of our 
young patients dropped out of the programme prematurely is consistent with 
the results of a systematic review and meta-analysis about intensive CBT for 
anxiety disorders including PTSD in children that showed that, compared to 
regular CBT, dropout was consistently lower in the intensive protocols (Öst, 
& Ollendick, 2017). Finally, the results of our study showed that iPE was 
safe in that it did not exacerbate PTSD or comorbid symptoms nor induced 
any adverse events. Importantly, our iPE did not comprise a stabilising phase 
or additional skill training techniques as has been recommended by some 
researchers, showing that, despite clinicians’ concerns (Allen & Johnsons, 
2011; Chapter 2; van Minnen et al., 2010) intensive TFT can be safely applied 
as a stand-alone treatment in an adolescent population with complex PTSD.
What is even more promising is that the rapid reduction of PTSD symp-
toms, attained within a single week of iPE, shows the programme’s potential for 
implementation at a young age. Untreated, PTSD in children and adolescents 
is likely to take a chronic course, making them more vulnerable to the severe 
long-term consequences typically associated with PTSD (Kessler, 2000). PTSD 
in youngsters is associated with an increased risk of experiencing additional 
traumatic events (Risser, Hetzel-Riggin, Thomsen, & McCanne, 2006), devel-
oping other mental health disorders such as a range of anxiety and affective 
disorders (Bolton, O’Ryan, Udwin, Boyle, & Yule, 2000), and an increased risk 
of suicidal attempts (Wilcox, Storr, & Breslau, 2009). In addition, untreated 
childhood and adolescent PTSD has been related to social and educational 
problems (Makley & Falcone, 2010). Persistent PTSD-associated avoidance 
behaviour may prevent children and adolescents from attending school regu-
larly or making and maintaining adequate social contacts, imposing serious 
restrictions on their daily functioning and compromising their general develop-
ment. This makes a rapid amelioration of PTSD symptoms crucial. Rather than 
the more extended weekly TFT programmes, iPE will help decrease avoidance 
behaviour in as short a period as possible, thereby potentially minimising the 
adverse effects on the youngsters’ cognitive and socioemotional development. 
Altogether, it is of the utmost importance not to postpone or unnecessarily 
stretch the treatment of PTSD in younger patients. 
In summary, although the cohort size was small, we were able to replicate 
the positive outcomes of our iPE trial with adult patients in younger patients 
with complex PTSD, providing the first evidence of the effectiveness and safety 
of this massed stand-alone TFT in a paediatric population with complex PTSD.
Limitations 
There are some general limitations that need to be taken into consideration. 
First, our treatment studies investigating the effects of iPE all lacked a control 
group, while the study with adult PTSD patients had no randomised design. 
Thus, with regard to the latter study, we are not able to draw the firm conclu-
sion that the changes observed in our adult patients are all attributable to the 
iPE rather than to other factors. Also, in both studies, we may have included a 
select group of adult and adolescent patients particularly motivated to partic-
ipate in a new treatment programme or for whom intensive treatment was 
acceptable, which limits the generalisability of our findings. In the study with 
adolescent patients, we adopted an experimental design, with participants 
being randomised to baseline lengths (Morgan & Morgan, 2001), allowing 
us to attribute the effects to the iPE itself. However, the small sample size still 
restricts the generalisability of the findings (Gliner, Morgan, & Harmon, 2000). 
Still and despite these critical observations, it can safely be claimed that both 
our samples are highly representative of patients with complex PTSD seen in 
daily clinical practice.
Second, due to the timeline of the studies presented, we adhered to the diag-
nostic criteria for PTSD as described in the DSM-IV-TR (APA, 2000) for inclu-
sion and treatment evaluation (as measured with the Clinician-Administered 
PTSD Scale, CAPS-IV; Blake et al., 1995) instead of the DSM-5 criteria (APA, 
2013). Also after the start of our studies, the CAPS was revised to correspond 
with the DSM-5 criteria (CAPS-5). Nevertheless, recent research has shown 
that the results obtained with the CAPS-IV are very similar to those obtained 
with the CAPS-5, while most patients diagnosed according to the DSM-IV 
criteria also meet the DSM-5 criteria for PTSD (Weathers et al., 2018). We 
hence assume that our results will also apply to PTSD populations diagnosed 
using the DSM-5 criteria.
Third, we were particularly interested in the effect of iPE in patients who 
had failed to improve during previous regular PTSD-guideline treatments. 
Although all our adult and most adolescent participants had a history of multi-
ple treatment attempts, we did not use a standard measure to quantify the 
degree of treatment resistance per participant (Dunlop, Kaye, Youngner, & 
Rothbaum, 2014). 
Lastly, although we provided a stand-alone TFT, the iPE for adolescents 
did include five additional parent sessions. We did not establish whether these 
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sessions were critical to the improvements the adolescents attained. Disman-
tling studies are needed to demonstrate the precise role of parent sessions in the 
iPE outcomes of young patients.
Clinical implications
The results obtained may have important implications for clinical practice as 
they provide (preliminary) evidence that for both adult and adolescent patients 
struggling with complex PTSD, trauma-focused therapy can indeed be success-
fully shortened and may be preferable to longer protocols. Besides this evidence 
for the effectiveness of intensive TFT in these more complex PTSD groups that 
tend not to be offered TFT, let alone intensive PE, the therapist rotation model 
that was introduced offers additional opportunities for iPE delivery and will 
hopefully help amend the underutilisation of this guideline approach precisely 
in these target populations.
Intensive TFT reduces overall treatment duration for complex PTSD patients
With the research presented in this dissertation we acted in consonance to the 
recent international NICE guideline (2018, p. 25) to further explore the effec-
tiveness of trauma-focused interventions for PTSD patients that may have 
additional needs, including those with complex PTSD. The effectiveness, low 
dropout rate, and safety of the iPE protocol described in Chapters 3 (Hendriks 
et al., 2010), 4 (Hendriks et al., 2018), and 5 (Hendriks et al., 2017) showed 
that not only PE but also intensive PE is feasible in populations with complex 
PTSD and comorbid mental problems, with, importantly, all gains being 
achieved without the addition of any nontrauma-focused techniques despite 
the hesitations of many clinicians (Chapter 2; van Minnen et al., 2010). The 
iPE results obtained clearly challenge the beliefs that complex PTSD patients 
need tailored treatment, most notably sequenced treatment in which the first 
treatment aims to reduce symptoms uniquely associated with complex PTSD, 
prolonging treatment duration for these patients. Our work thus contrasts the 
recommendations to have TFT for adult (Cloitre, 2015; Dorrepaal et al., 2013) 
and adolescent (Leenarts et al., 2013) PTSD patients be preceded by such a skill 
training phase especially when traumas were repeated or patients present with 
(more) comorbid disorders. Our results corroborate other recent findings of 
studies comparing pre-post differences for different PTSD patients groups that 
a history of childhood sexual abuse (Wagenmans, van Minnen, Sleijpen, & de 
Jongh, 2018) or the presence of dissociative symptoms (Zoet, Wagenmans, van 
Minnen, & de Jongh, 2018) has no impact on the outcome of intensive TFT 
without a prior skill training phase. Contributing to the ongoing debate about 
the issue of the treatment of complex PTSD (Cloitre et al., 2012; de Jongh et 
al., 2016), recent research and the studies presented in this dissertation endorse 
the effectiveness of stand-alone TFT in complex PTSD populations, thereby 
detracting from the claim that TFT must be preceded by a skill training phase. 
As to the additional argument that a skill training phase will diminish drop-
out from TFT in patients with complex PTSD (Cloitre et al., 2012), there was 
found that dropout rates in studies investigating the effects of sequenced treat-
ment were generally high (de Jongh et al., 2016) especially during the skill 
training phase itself (Cloitre et al., 2010). Without spending time and effort on 
a skill training phase aimed at emotion regulation, interpersonal skills or low 
self-esteem, we showed in our studies that no or very few patients dropped out 
during the iPE programmes. We posit that common comorbid conditions to 
PTSD, for instance depressive disorder, dissociative symptoms, or manifesta-
tions of borderline personality disorder, as well as typical symptoms associated 
with complex PTSD such as affect dysregulation, negative self-concept, and 
interpersonal problems, may interfere less with TFT thanks to the short dura-
tion of intensive protocols such as ours. Precluding interference of comorbidity 
might then prevent poor treatment adherence, irregular attendance, and drop-
out, thereby enhancing treatment effectivity. Particularly for complex PTSD 
patients, intensive TFT without any additional precautionary interventions thus 
helps shorten treatment both effectively and safely. Besides these clinical advan-
tages, delivering TFT in a comprised format may also help overcome practical 
problems, enhancing availability for patients living in remote areas and reduc-
ing interference with occupational and social commitments.
Therapist rotation as an answer to the dissemination challenge
Although intensive TFT has been shown to be effective as a stand-alone 
approach to PTSD, effectiveness alone is probably not sufficient to convince 
clinicians to start using the treatment more and most specifically for their 
patients coping with complex PTSD. The objections and fears raised in our 
survey and experimental study (Chapter 2; van Minnen et al., 2010) on PE 
among trauma experts showed us that we cannot expect more training in this 
form of TFT to change their use of this treatment. 
On a more positive note, we hope that the therapist rotation approach as 
introduced in our iPE studies will help foster the dissemination of TFT, espe-
cially in more complex PTSD populations (van Minnen et al., 2018). In this 
novel treatment model, therapists rotate during a patient’s treatment, with 
each therapist delivering several sessions. The first findings are promising. 
When asked about their experiences after participating in a rotation team, the 
therapists indicated that they found the patients more often ready to start the 
TFT. Furthermore, they mentioned that their hesitations about TFT had been 
declined, now estimating it more likely that they would again want to apply 
TFT within a rotation team but also independently in their own practice. They 
also reported they were less likely to drift from the TFT protocol, a common 
problem in the delivery of evidence-based treatments (Waller, 2009), and were 
less hesitant in (consequently) providing trauma-focused techniques. These 
more positive views are likely attributable to the safe context therapist rota-
tion offers the therapist, where the responsibility for the treatment outcome is 
shared. This process bears a parallel to the process the patient is expected to 
undergo: both therapist and patient are exposed to their fears, the therapist to 
the fear of using TFT to treat complex PTSD patients (Grimmett, & Galvin, 
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2015) and the patient to the fear of recalling his or her trauma memories (de 
Kleine, Hendriks, Becker, Broekman, & van Minnen, 2017). However, some 
may argue that a therapist rotation model stands in the way of the develop-
ment of a good therapeutic relationship, widely assumed to be a prerequisite for 
successful TFT (Capaldi, Asnaani, Zandberg, Carpenter, & Foa, 2016). With-
out disclaiming the beneficial effects of a one-to-one relationship, we found 
that the participants to our iPE rated their relationship to the therapists as 
good, including the patients with insecure attachment styles (van Minnen et al., 
2018), a common correlate of complex PTSD (Karatzias et al., 2018). 
All things considered, we hope that the positive findings with iPE using ther-
apist rotation will persuade more clinicians to prescribe and implement TFT, 
thereby widening the accessibility of this guideline treatment, most particularly 
for PTSD patients not responding to standard programmes and those diagnosed 
with complex PTSD who are currently not considered for the TFT approach.
Future directions
The empirical support for the effectiveness of regular weekly-based TFT 
programmes in reducing PTSD is strong (Cusack et al., 2016) and our results 
suggest that when the treatment is delivered in an intensive format, TFT, is a 
feasible and effective next step in the treatment of those patients that do not 
benefit from conventional TFT. However, although response was good and 
dropout negligible, also with our intensive PE programme not all participants 
improved.
Finding out who our (non)responders are and what they need
Although the response rates we obtained (Chapter 4; Hendriks et al., 2018) 
in our adult patients were comparable to the average rate of 60% found in a 
systematic review regarding regular TFT (Loerinc et al., 2015), as well as to 
the rates reported in regular TFT studies with patient populations similar to 
ours in terms of trauma characteristics (Bohus et al., 2013; Cloitre et al., 2010; 
Schnurr et al., 2007), not all participants improved to the same degree. Anal-
ogous to the classes found in other studies investigating patterns of symptom 
change during TFT (e.g. Allan, Gros, Myers, Korte, & Acierno, 2017; Brown et 
al., 2018; Stein, Dickstein, Schuster, Litz, & Resick, 2012), our cluster analy-
ses (Chapter 4; Hendriks et al., 2018) revealed four distinct response trajecto-
ries based on change patterns: fast responders (13%), slow responders (26%), 
partial responders (32%), and non-responders (29%). It would be worthwhile 
if, prior to intensive TFT, we could predict which patient is likely to respond and 
to what degree. Although they are tentative given the small number of partici-
pants per cluster, we posed several hypotheses based on the results of our explor-
atory prediction analyses (Chapter 4; Hendriks et al., 2018). The participants 
showing more fear habituation between the first and second imaginal expo-
sure session were more likely to belong to the fast responders cluster than to 
the non-responders cluster (Chapter 4; Hendriks et al., 2018), which is consist-
ent with previous findings (e.g. Cooper, Clifton, & Feeny, 2017) demonstrating 
between-session fear habituation, but not within-session fear habituation, to be 
related to treatment outcome. These findings then suggest that a lack of habitu-
ation to anxiety during the early stage of intensive TFT can be used to identify 
those patients that are unlikely to benefit from the treatment.
Importantly, in our study none of the iPE participants’ clinical variables were 
found to be predictors of treatment response. Together with the outcomes of 
previous trials with TFT (Ehlers et al., 2013; van Minnen, Arntz, & Keijsers, 
2002; van Minnen et al., 2012), this shows that even patients with (severe) 
PTSD and comorbid (mental-health) issues tolerate and can benefit from (inten-
sive) TFT programmes. Contrary to what clinicians generally assume, base-
line demographic and clinical variables appear to have little value in predicting 
treatment outcome and are thus no robust contra-indicators of (intensive) TFT. 
Instead, we found that early treatment process variables were better predictors 
of treatment success. To move the field forward, future research should focus on 
these early indicators of treatment progress and explore their predictive value 
in distinguishing response trajectories during intensive TFT in larger PTSD 
cohorts.
The different response patterns found in previous and our (Chapter 4; 
Hendriks et al., 2018) research, indicate that the optimal dosage of intensive 
TFT may differ for individual patients. Plausibly, the massed treatment without 
any additional spaced booster sessions will suffice for fast responders, whereas 
the slow responders may need follow-up in terms of a series of more widely 
spaced booster sessions to foster transfer of the gains attained in the therapy 
setting to their home environment (Lang & Craske, 2000). The partial respond-
ers, then, may need more therapy sessions than we provided in our trial to fully 
benefit from iPE, as was suggested in previous research (Foa et al., 2005) or, 
more specifically, more exposure in a broader variety of contexts (including the 
home environment and other relevant settings) as it is likely that a greater varia-
bility of social contexts will facilitate generalisation and thus better, long-lasting 
treatment results (Craske, Hermans, & Vervliet, 2018). Alternatively or addi-
tionally, in (some) partial responders the trauma may have come to be more or 
less integral to their identity (Berntsen, Willert, & Rubin, 2003) at the cost of 
other aspects of their being and individuality, such as being a friend, a parent, 
or an employee. Also these patients may need more exposure sessions in multi-
ple contexts, for instance within the family context or in their work environment 
therefore expanding exposure to situations that facilitate the (re)development 
of other parts of their identity. In short, future research into intensive TFT 
should consider the differential effects of different numbers and distributions 
of sessions, allowing for the possibility that there is no “one size fits all” and 
that certain subgroups of (non)responders are best served by differently dosed 
sessions or extra modules. Using repeated measurements one can then compare 
the effects of additional modules of (differently spaced) sessions in terms of 
amelioration of PTSD (and comorbid) symptoms.
For the non-responders, it remains uncertain whether (full) recovery can be 
achieved by tailoring TFT delivery because extinction learning may not be feasi-
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ble (Lissek et al., 2005). Here, other augmentation strategies facilitating extinc-
tion learning may be more opportune, such as pharmacological enhancement 
targeting the learning mechanisms assumed to underlie the effectiveness of TFT 
(de Kleine, Rothbaum, & van Minnen, 2013).
Shifting our focus to younger PTSD patients
Despite the importance of optimising intensive TFT for (non-responding) adult 
patients, we cannot ignore that a substantial part of these patients (Chapters 
3 & 4; Hendriks et al., 2010; 2018) have been struggling with PTSD symp-
toms for years, having suffered their trauma during childhood or adolescence. 
Regrettably, the vast majority of effect studies in PTSD still focuses on adults, 
even though interventions aimed at ameliorating PTSD symptoms soon after 
their development could reduce the likelihood of individuals developing the 
severe long-term consequences typically associated with PTSD (Kessler, 2000) 
and possibly prevent socioemotional and educational stagnation. Although 
preliminary and obtained in a small cohort, the outcomes reported in Chapter 5 
(Hendriks et al., 2017) show that intensive TFT is effective in adolescents with 
PTSD, meriting future research in larger and younger paediatric PTSD cohorts. 
In order to reach this group at as early a stage as possible, clinicians should be 
attentive to the possibility of trauma in young(er) patients. It is crucial that they 
ask the right questions to uncover any exposure to traumatic events and devel-
oping PTSD symptoms both during the diagnostic process and any ongoing 
treatment. Given the high prevalence of trauma exposure in children (Lindauer 
& de Boer, 2012), with 15.9% of trauma-exposed children overall developing 
PTSD (Alisic et al., 2014), and the potentially serious, pervasive adverse effects 
of untreated PTSD, international guidelines recommend to routinely inquire 
about traumatic experiences and PTSD symptoms during initial health assess-
ments (AACAP, 2010), even if trauma is not the reason for referral. Clinicians 
are advised not to rely solely on a parent or carer for information but directly 
and separately question the child, and, if exposed to traumatic events, screen the 
child for PTSD symptoms (NICE, 2018). Unfortunately, this does not happen 
consistently in routine clinical practice, underscoring the need for clinicians to 
be better informed about the importance of trauma screening in children and 
adolescents and be given easy access to information about and tools to screen 
their younger patients. To illustrate the relevance of this recommendation, the 
adolescents in our iPE study (Chapter 5; Hendriks et al., 2017) had already been 
receiving mental health care for an average of 2.5 years and several of them 
reported that nobody had asked them explicitly about their traumatic experi-
ences. To amend this situation and help clinicians ask the right questions about 
potential childhood trauma and its consequences, together with these children 
we have developed a website (www.rakevragen.nu).  
CONCLUSION
One of the aims of this dissertation was to investigate when therapists elect to 
offer trauma-focused treatments (TFT) for patients with PTSD and when not. 
Patient variables indicative of complex PTSD appear to act as confounders 
in the treatment decision-making process and the findings suggest that when 
therapists are dealing with patients with complex PTSD, the decision-mak-
ing process is likewise more complex. As a result, the delivery of TFT for these 
complex PTSD patients is suboptimal. To improve the delivery of TFT, we 
have developed a condensed, intensive prolonged exposure (iPE) programme 
for both adult and adolescent patients with complex PTSD, where the sessions 
of prolonged exposure are offered within a short timeframe. In our studies we 
focused on PTSD patients not (sufficiently) responding to previous treatments, 
most specifically patients with severe and complex psychopathology who are 
generally not considered for TFT, examining the effects of our iPE both on 
the amelioration of PTSD (and comorbid) symptoms and dropout. Although 
randomised controlled trials are needed to confirm the effectiveness of inten-
sive TFT in general and our iPE in particular, with protocols warranting tailor-
ing to patient subgroups, the outcomes we obtained in our studies suggest 
that iPE is both effective and safe in adults and adolescents having developed 
PTSD after suffering multiple interpersonal trauma in childhood and reporting 
ICD-11 complex PTSD symptoms despite their histories of unsuccessful treat-
ment attempts. Serious adverse events and symptom exacerbation were rare 
and dropout minimal, indicating that the treatment is acceptable and accessible 
for a larger group of patients that leave longer, weekly-based TFT programmes 
prematurely as well as for patients with complex PTSD and comorbid mental-
health issues who are regularly ruled out for TFT. In addition, with both thera-
pists and patients reporting satisfaction with and benefits of the approach, we 
hope that the therapist rotation model we introduced in our iPE programme 
will promote the dissemination and use of (intensive) TFT for both adults and 
adolescents suffering from (complex) PTSD.
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Posttraumatische stressstoornis (PTSS)
Na het zelf of als getuige meemaken van een levensbedreigende gebeurtenis, 
zoals een (dreigende) dood, ernstige verwonding of seksueel geweld, is het 
normaal dat iemand nare herinneringen heeft, zich gespannen voelt of moeite 
heeft om in slaap te vallen. De meeste mensen voelen zich na enkele weken 
beter. Bij sommige mensen blijven klachten die samenhangen met de meege-
maakte gebeurtenis echter bestaan en een deel van hen ontwikkelt een post-
traumatische stressstoornis (PTSS). Mensen die lijden aan PTSS hebben last van 
terugkerende, opdringerige herinneringen aan de traumatische gebeurtenis, ze 
vermijden situaties die hen aan het trauma doen denken, ze hebben meer nega-
tieve gedachten en gevoelens dan mensen zonder PTSS, en last van waakzaam-
heid en schrikachtigheid. Daarnaast hangt het hebben van een PTSS samen met 
een hoger risico op andere psychische stoornissen, suïcide(pogingen) en maat-
schappelijke belemmeringen zoals problemen op school, problemen binnen de 
partnerrelatie en werkeloosheid.
Traumagerichte behandelingen
Gelukkig zijn er effectieve traumagerichte behandelingen voorhanden om 
PTSS-symptomen te verminderen zowel voor volwassenen als jongeren. Trau-
magerichte behandelingen worden meestal in wekelijkse sessies aangeboden en 
duren minimaal enkele maanden. Helaas heeft niet iedereen baat bij de huidige 
behandelingen. Van de volwassen PTSS-patiënten knapt ongeveer 40% niet op 
en stopt gemiddeld 18% voortijdig met de behandeling. Daarnaast zijn trau-
magerichte behandelingen niet voor iedereen toegankelijk. Therapeuten geven 
aan bij sommige patiënten met PTSS geen traumagerichte behandeling voor te 
schrijven omdat ze bang zijn dat een dergelijke behandeling juist voor verslech-
tering zal zorgen. Dit geldt met name voor patiënten die met veel andere 
problematiek te kampen hebben naast de PTSS of voor patiënten die herhaal-
delijk mishandeld of misbruikt zijn in hun jeugd. Bij de huidige traumagerichte 
behandelingen met wekelijkse sessies spelen voor jongeren met PTSS dezelfde 
problemen op het gebied van behandelresultaat, voortijdige behandeluitval en 
toegankelijkheid als bij volwassenen.
Intensieve traumagerichte behandeling 
Er zijn aanwijzingen uit eerder onderzoek dat het intensiveren van traumage-
richte behandelingen effectief is en mogelijk behandeluitval vermindert. Bij een 
intensieve traumagerichte behandeling worden alle behandelsessies aangebo-
den in slechts enkele weken. Het is echter onvoldoende duidelijk of intensieve 
traumagerichte behandelingen ook daadwerkelijk haalbaar en effectief zijn voor 
patiënten met complexere problematiek. Bijvoorbeeld patiënten die een geschie-
denis hebben van herhaaldelijk misbruik of mishandeling in de kindertijd, die 
naast PTSS lijden onder andere psychische stoornissen of die voldoen aan de 
criteria van een zogenoemde complexe PTSS. Patiënten met een complexe PTSS 
hebben niet alleen last van herbelevingen, vermijding, waakzaamheid en schri-
kachtigheid, maar kampen ook met emotieregulatieproblemen, een negatief 
zelfbeeld en problemen in het contact met anderen. Juist voor patiënten met 
complexere problematiek – de doelgroep die in de klinische behandelpraktijk 
nog regelmatig wordt uitgesloten van behandeling – kan een intensieve trauma-
behandeling de toegankelijkheid van zorg mogelijk vergroten. Door de kortere 
duur van een intensieve behandeling is de kans dat andere problematiek inter-
fereert met de behandeling mogelijk kleiner omdat de focus gedurende enkele 
weken alleen op de PTSS-behandeling ligt. 
Het proefschrift
In dit proefschrift onderzochten we voor welke patiënten reguliere PTSS-be-
handelingen met wekelijkse sessies niet toegankelijk zijn doordat therapeuten 
belemmeringen ervaren in het voorschrijven van de traumagerichte behande-
ling. Vervolgens onderzochten we de mogelijkheden en effectiviteit van één 
specifieke traumagerichte behandeling, die ook in de klinische richtlijnen staat, 
namelijk exposuretherapie. Deze behandeling bestaat uit reeds bewezen effec-
tieve exposuretechnieken waarbij de patiënt zich blootstelt aan de herinnerin-
gen aan de traumatische gebeurtenissen en aan de situaties die hem of haar aan 
het  trauma doen denken. Het verschil tussen onze behandeling en de reguliere 
exposuretherapie is dat wij de sessies aanboden in een veel korter tijdsbestek. 
We onderzochten de effecten van deze kortdurende intensieve exposurebehan-
deling op PTSS-symptomen en voortijdige behandeluitval. Ook onderzochten 
we de veiligheid van het intensieve programma, juist binnen een patiëntpopu-
latie met complexere problematiek aan wie in het algemeen minder snel een 
traumagerichte behandeling wordt aangeboden. Daarnaast onderzochten we de 
haalbaarheid en effectiviteit van de intensieve exposurebehandeling bij jongeren 
met PTSS om een inschatting te kunnen maken of het eveneens mogelijk was 
om al op jongere leeftijd (de ernstige gevolgen van) PTSS-symptomen in korte 
tijd te verminderen. 
Wanneer kiezen therapeuten (niet) voor traumagerichte behandeling?
In de studie beschreven in hoofdstuk 2 onderzochten we wanneer therapeu-
ten wel of niet kiezen voor traumagerichte behandeling, meer specifiek voor 
exposuretherapie, voor patiënten met PTSS. We vroegen aan 255 traumaprofes-
sionals of zij exposure gebruikten bij de behandeling van PTSS, of ze getraind 
waren in deze behandelmethode, of ze exposure een logische therapie vonden 
voor de behandeling van PTSS en of ze dachten dat het negatieve effecten kon 
hebben. Uit de resultaten bleek dat exposuretherapie beperkt wordt aanboden 
door therapeuten en zij doorgaans niet getraind zijn in de techniek. De trau-
maprofessionals gaven aan meer belemmeringen in het gebruik van exposure 
te zien dan in andere psychologische interventies. In het tweede deel van deze 
studie kregen de traumaprofessionals filmpjes van vier patiënten met PTSS te 
zien. Twee patiënten ontwikkelden PTSS na een eenmalig trauma in de volwas-
senheid, de twee andere na herhaaldelijk trauma in de kindertijd. Op basis van 
loting werden de professionals toegewezen aan één van twee condities waarbij 
het wel of niet hebben van een andere psychische stoornis en de therapievoor-
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keur van de patiënt varieerden. De professionals werd gevraagd welke behande-
ling zij het beste bij de afzonderlijke patiënten vonden passen. Zij kozen bij de 
patiënten met PTSS en een andere psychische stoornis eerder voor een medica-
menteuze behandeling dan voor exposure. Exposuretherapie werd echter eerder 
aangeboden wanneer patiënten aangaven hier een voorkeur voor te hebben. 
Ook de verschillen tussen therapeuten (zoals geïnventariseerd in het eerste deel 
van de studie) hadden invloed op de uiteindelijke behandelkeuze. Negatieve 
verwachtingen, zoals de angst dat problematiek juist toeneemt of dat er eerder 
gestopt moet worden met de behandeling, hingen samen met het niet voor-
schrijven van exposuretherapie bij patiënten die herhaaldelijk getraumatiseerd 
waren in de kindertijd. Hoewel er geen wetenschappelijke ondersteuning is voor 
deze zorgen, leken de professionals geneigd om vast te houden aan de inschat-
ting dat exposuretherapie negatieve effecten kan hebben wanneer er sprake is 
van complexere problematiek. Er werden hierbij geen verschillen gevonden 
tussen professionals met en zonder training in exposuretherapie. Het simpelweg 
aanbieden van training in exposuretherapie lijkt dus niet de manier om thera-
peuten deze technieken aan te laten bieden.
Is een kortdurende intensieve exposurebehandeling haalbaar, effectief en veilig 
voor volwassen patiënten met complexe PTSS? 
Ondanks de eerste veelbelovende resultaten van intensieve traumagerichte 
behandelingen bij patiënten met PTSS, is het tot op heden onduidelijk of een 
dergelijke intensieve behandelvorm passend is voor patiënten met complexe 
PTSS. Daarom onderzochten wij de haalbaarheid, effectiviteit en veiligheid 
van een intensieve exposurebehandeling juist bij deze doelgroep. In een eerste 
pilotstudie (hoofdstuk 3) werd de intensieve exposurebehandeling gepresen-
teerd aan de hand van vier casussen. De patiënten hadden alle vier een verle-
den van herhaaldelijke (seksuele) trauma’s in de kindertijd, veel verschillende 
psychische stoornissen naast de PTSS en een uitgebreide behandelgeschiedenis 
waarin al verschillende malen geprobeerd was de PTSS-klachten te vermin-
deren. Tijdens de intensieve exposurebehandeling boden we de patiënten in 
totaal 24 uur aan exposuretechnieken aan binnen één week tijd. Deze technie-
ken betroffen imaginaire exposure (waarbij de patiënt herhaaldelijk in detail 
over de traumatische herinnering vertelt), exposure in tekeningen (tekenen van 
de meest angstopwekkende momenten van de traumatische herinnering) en 
exposure in vivo (blootstelling aan situaties die de patiënt vermijdt uit angst 
opnieuw aan het trauma herinnerd te worden). Een belangrijk onderdeel van 
het intensieve programma was therapeutrotatie. De patiënt werd behandeld 
door een team van verschillende therapeuten die elkaar afwisselden. Na afron-
ding van de intensieve behandelweek, waren de PTSS-klachten van alle vier de 
patiënten sterk afgenomen. Geen van hen stopte voortijdig met de behandeling 
en alle vier gaven ze aan dat ze de intensieve exposurebehandeling zwaar maar 
haalbaar vonden. Deze eerste veelbelovende resultaten gaven aanleiding tot 
replicatie van de studie met een grotere groep patiënten met complexe PTSS. 
In hoofdstuk 4 zijn de resultaten beschreven van deze grotere open klinische 
studie. We namen 73 patiënten met PTSS en symptomen van complexe PTSS 
na herhaaldelijk mishandeling en/of misbruik in de studie op. Alle patiënten 
hadden in het verleden al verschillende behandelpogingen ondergaan zonder 
effect. Opnieuw ontvingen de patiënten 24 uur aan exposuretechnieken. We 
hadden in de pilotstudie (hoofdstuk 3) echter geleerd dat in één intensieve week 
de tijd beperkt was om te oefenen in een bredere verscheidenheid aan contex-
ten (bijvoorbeeld in de thuissituatie). In deze vervolgstudie werd daarom 18 
uur aan exposure aangeboden in de intensieve behandelfase (verspreid over vier 
dagen in één week), terwijl de overgebleven zes uur verspreid werden over de 
daaropvolgende vier weken. Gedurende deze vier weken kregen patiënten één 
nabehandelingssessie van negentig minuten per week met als doel datgene wat 
ze geleerd hadden in de intensieve week (verder) te generaliseren naar hun dage-
lijks leven. Na de behandeling was er sprake van een klinisch relevante afname 
van PTSS-symptomen en de resultaten waren er nog steeds bij de vervolgmetin-
gen na drie en zes maanden. Van alle patiënten had 71% baat bij de intensieve 
exposurebehandeling. Iedere patiënt rondde de intensieve fase van de behan-
deling af en slechts 5% stopte eerder met de nabehandelingssessies. Ook leek 
de intensieve exposurebehandeling veilig. Bij minder dan 3% van de patiën-
ten namen de PTSS-symptomen toe en slechts eenmaal kwam het voor dat een 
patiënt moest worden opgenomen na een toename van suïcidale gedachten. 
Kortom, de intensieve exposurebehandeling lijkt een geschikte traumagerichte 
behandeling, ook (of juist) voor patiënten met complexe PTSS en andere psychi-
sche problematiek naast de PTSS-symptomen. Onze studie kan niet aantonen 
dat intensieve traumagerichte behandeling beter is dan reguliere traumagerichte 
behandeling met wekelijkse sessies. Wel toont onze studie aan dat het mogelijk 
is om met een intensievere behandelvorm in kortere tijd de PTSS-symptomen te 
verminderen, voortijdige uitval te reduceren en traumagerichte behandelingen 
toegankelijk te maken voor patiënten met complexere problematiek. 
Is een kortdurende intensieve exposurebehandeling haalbaar, effectief en veilig 
voor jongeren met complexe PTSS? 
Een groot deel van de patiënten met PTSS na een verleden van herhaalde-
lijk seksueel misbruik en/of mishandeling kampt al sinds hun kindertijd met 
deze klachten. Gezien de ernstige gevolgen van een onbehandelde PTSS is het 
belangrijk om traumagerichte behandeling zo snel mogelijk na het ontstaan 
van de PTSS-klachten aan te bieden. In hoofdstuk 5 staan daarom de resulta-
ten beschreven van een studie naar de haalbaarheid, effectiviteit en veiligheid 
van een intensieve exposurebehandeling bij jongeren met PTSS. In een experi-
mentele studie werden tien jongeren op basis van loting ingedeeld in een vari-
erende baseline-periode voorafgaand aan de intensieve exposurebehandeling. 
De jongeren hadden allemaal complexe PTSS ontwikkeld na het meemaken van 
herhaaldelijk seksueel misbruik en/of mishandeling en hadden naast de PTSS 
last van veel verschillende andere psychische stoornissen. De intensieve exposu-
rebehandeling bestond uit één intensieve behandelweek, gevolgd door drie 
wekelijkse nabehandelingssessies. Al na de intensieve behandelingsweek (en dus 
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voorafgaand aan de nabehandelingssessies) was er sprake van een klinisch rele-
vante daling van de PTSS-symptomen. Ook bij deze doelgroep bleven de resul-
taten bestaan bij vervolgmetingen na drie en zes maanden, waarbij 80% van de 
jongeren zelfs niet meer voldeed aan de criteria van een PTSS. Daarnaast namen 
andere psychische problemen, zoals depressieve, algemene angst- en dissocia-
tieve klachten sterk af. Ook deze effecten waren nog aanwezig na drie en na zes 
maanden. Geen enkele jongere staakte voortijdig de behandeling, bij niemand 
namen de PTSS-symptomen toe en er vonden geen incidenten plaats in de vorm 
van suïcidaal gedrag, crisiscontacten of opnames in een psychiatrische kliniek. 
De zeer snelle afname van PTSS-symptomen, namelijk na slechts één week, 
voorkomt dat de klachten van deze jongeren chronisch worden. Door trau-
magerelateerd vermijdingsgedrag in een zo kort mogelijke tijd aan te pakken, 
worden effecten op de cognitieve en sociale-emotionele ontwikkeling gemini-
maliseerd.
Gevolgen voor de klinische praktijk
De resultaten uit de verschillende studies hebben gevolgen voor de klinische 
behandelpraktijk van volwassenen en jongeren met complexe PTSS. Traumage-
richte behandeling lijkt succesvol verkort te kunnen worden en een intensieve 
vorm heeft voor sommige patiënten mogelijk zelfs de voorkeur boven langere 
behandelprotocollen. Daarnaast biedt het gebruikte therapeutrotatie-model 
waarbij therapeuten elkaar afwisselen aanvullende mogelijkheden voor het 
toepassen van traumagerichte technieken bij PTSS-patiënten met complexere 
problematiek.
Behandelduur bij complexe PTSS verkorten in plaats van verlengen 
De effectiviteit, lage behandeluitval en de veiligheid van de intensieve exposu-
rebehandelingen zoals beschreven in hoofdstuk 3, 4 en 5 van dit proefschrift 
laten zien dat intensieve exposurebehandeling haalbaar is voor patiënten met 
complexe PTSS. Ondanks verdeeldheid onder therapeuten en onderzoekers 
over de noodzaak van aanvullende (niet-traumagerichte) technieken in de 
therapie (zie ook hoofdstuk 2), kozen we daar in onze behandeling niet voor. 
Dit biedt een interessant perspectief op het gangbare idee dat patiënten met 
complexe PTSS een aangepaste behandeling nodig hebben, waarbij de trauma-
gerichte technieken worden voorafgegaan door een behandelfase waarbij de 
kenmerken die uniek zijn voor complexe PTSS eerst worden aangepakt. Een 
dergelijke gefaseerde behandeling verlengt de behandeling voor deze doelgroep. 
Onze studies laten echter zien dat juist door de korte duur van een intensieve 
traumagerichte behandeling andere psychische stoornissen en problemen 
samen met de typische kenmerken van complexe PTSS mogelijk minder invloed 
hebben op de PTSS-behandeling. Het intensiveren van traumagerichte tech-
nieken maakt de behandeling voor patiënten met complexe PTSS dus korter in 
plaats van langer.
Therapeutrotatie als manier om traumagerichte behandeling  
toegankelijker te maken
De positieve effecten van intensieve traumagerichte behandelingen zijn waar-
schijnlijk niet voldoende om therapeuten over de streep te trekken deze behan-
deling aan te bieden aan hun patiënten met complexe PTSS. Therapeuten 
hebben bezwaren en angsten met betrekking tot het aanbieden van exposure, 
zo zagen we in de eerste studie in dit proefschrift (hoofdstuk 2), en extra trai-
ning bleek niet genoeg om hen de techniek toch aan te laten bieden. We hopen 
dat het therapeutrotatie-model zoals gebruikt tijdens de intensieve traumage-
richte behandelingen in onze studies de verspreiding en het consequent aanbie-
den van traumagerichte behandelingen kan verbeteren, zelfs (of eigenlijk juist) 
bij de behandeling van patiënten met complexe PTSS. In het therapeutrota-
tie-model wisselen therapeuten elkaar af bij de behandeling van de patiënt, 
waarbij iedere therapeut verschillende sessies geeft. De eerste resultaten van dit 
model zijn veelbelovend. Na gewerkt te hebben met het therapeutrotatie-model 
boden therapeuten hun PTSS-patiënten eerder een traumagerichte behandeling 
aan. Sommige therapeuten en onderzoekers zijn bang dat een therapeutrota-
tie-model de ontwikkeling van een goede therapeutische relatie in de weg staat. 
Zonder de positieve effecten van een één-op-één relatie tussen patiënt en thera-
peut te willen relativeren, kunnen we vermelden dat de deelnemers aan de inten-
sieve exposurebehandeling de therapeutische relatie positief beoordeelden. We 
hopen door de combinatie van de positieve resultaten van de intensieve exposu-
rebehandeling en het gebruik van een therapeutrotatie-model therapeuten te 
kunnen overtuigen om traumagerichte technieken voor te schrijven en aan te 
bieden. Op deze manier kan de toegankelijkheid van traumagerichte technieken 
worden vergroot, in het bijzonder voor de doelgroep met complexere proble-
matiek die nu regelmatig geen behandeling krijgt aangeboden.
Hoe verder?
Ondanks dat het intensiveren van traumagerichte technieken een haalbare en 
effectieve vervolgstap lijkt voor de doelgroep die geen baat heeft bij een stan-
daardbehandeling of die deze niet krijgt aangeboden, knapt ook binnen onze 
studies niet iedereen op. Zo verliep de klachtenverandering in onze studie bij 
volwassenen (hoofdstuk 4) niet bij iedereen op dezelfde manier. Er waren pati-
enten die snel resultaat bemerkten (13%), patiënten die langzamer resultaat 
boekten (26%), patiënten die gedeeltelijke resultaat boekten (32%) en pati-
enten waarbij niets veranderde (29%). Het zou mooi zijn wanneer we voor-
afgaand aan de behandeling zouden weten hoe de patiënt op de behandeling 
zal reageren. We vonden aanwijzingen dat patiënten die een grotere daling 
van angst laten zien tussen de eerste en tweede imaginaire exposuresessie, een 
grotere kans hadden om snel resultaat te boeken. Dit suggereert dat wanneer 
de angst niet zakt aan het begin van de intensieve traumagerichte behandeling 
de patiënt niet zal profiteren van de behandeling. Interessant is dat geen enkele 
klinische variabele (zoals de ernst van de PTSS-klachten of aanvullende psychi-
sche stoornissen) in onze studie het behandelresultaat voorspelde. Kortom, 
Dutch summaryChapter 7
167166
ook patiënten met ernstige PTSS-klachten en aanvullende psychische stoor-
nissen kunnen profiteren van een (intensieve) traumagerichte behandeling, in 
tegenstelling tot wat therapeuten vaak denken. De verschillende patronen van 
klachtverandering wijzen erop dat de optimale dosering van intensieve trauma-
gerichte behandelingen verschillend kan zijn per patiënt. Toekomstig onderzoek 
moet zich richten op het vergelijken van verschillende doseringen van de trau-
magerichte technieken, want er lijkt geen sprake van een one size fits all-behan-
deling. 
Focus op jongere patiënten
Een groot deel van de volwassen patiënten in onze studies (hoofdstuk 3 en 4) 
worstelde al jaren met hun PTSS-klachten. De traumatische ervaringen die 
zij meemaakten, vonden plaats tijdens hun jeugd. Helaas ligt de focus binnen 
PTSS-onderzoek nog altijd op volwassenen. Dat is jammer omdat het inzetten 
van behandeling snel nadat de PTSS-klachten zijn begonnen de ernstige lange-
termijngevolgen die samenhangen met een onbehandelde PTSS kan voorkomen. 
Ook al is de groep jongeren die wij onderzochten klein (hoofdstuk 5), de eerste 
resultaten zijn hoopvol en moedigen ons aan om in de toekomst onderzoek uit 
te voeren met grotere groepen jonge PTSS-patiënten. Om deze groep op tijd te 
bereiken, is het nodig dat therapeuten en andere professionals in de jeugdhulp-
verlening alert zijn op de mogelijkheid dat kinderen en jongeren traumatische 
ervaringen hebben meegemaakt. Het is cruciaal dat de juiste vragen gesteld 
worden aan kinderen en jongeren die in zorg komen om te ontdekken of zij 
PTSS-klachten hebben. Helaas wordt er in de dagelijkse klinische praktijk niet 
consequent naar trauma gevraagd bij deze jonge doelgroep. Dit onderstreept de 
noodzaak om hulpverleners beter te informeren over het belang van traumas-
creening bij kinderen en jongeren en ze toegang te geven tot de juiste informa-
tie en screeningsinstrumenten. De jongeren in onze studie waren gemiddeld 
tweeënhalf jaar in zorg en verschillende van hen gaven aan dat gedurende die 
tijd niemand hen expliciet had gevraagd of ze traumatische ervaringen hadden 
meegemaakt. Om dit te veranderen en hulpverleners te helpen de juiste vragen 
te stellen over traumatische ervaringen, hebben wij samen met deze jongeren de 
website www.rakevragen.nu ontwikkeld. 
CONCLUSIE
Het lijkt erop dat wanneer therapeuten te maken hebben met patiënten met 
complexere problematiek het besluitvormingsproces over een passende behan-
deling eveneens complexer is. Als gevolg hiervan is de toegankelijkheid van 
traumagerichte behandelingen voor deze doelgroep niet optimaal. Om dit 
te verbeteren ontwikkelden wij een intensieve exposurebehandeling voor 
volwassenen en jongeren waarbij sessies werden aangeboden binnen een kort 
tijdsbestek. In onze onderzoeken richtten we ons op PTSS-patiënten die niet 
(voldoende) reageerden op eerdere behandelingen, met name patiënten met 
ernstige en complexe problematiek. We onderzochten de effecten van onze 
intensieve exposurebehandeling op PTSS-klachten, andere psychische stoor-
nissen en behandeluitval. Hoewel grotere gecontroleerde onderzoeken nodig 
zijn om de effectiviteit van intensieve traumagerichte behandelingen in het 
algemeen en onze intensieve exposurebehandeling in het bijzonder te beves-
tigen, zijn de eerste resultaten hoopvol. Intensieve exposurebehandeling lijkt 
effectief en veilig. Dit geldt voor zowel volwassenen als jongeren met complexe 
PTSS-klachten na herhaaldelijk seksueel misbruik en/of mishandeling in de 
kindertijd en met een geschiedenis van mislukte behandelingspogingen. Ernstige 
bijwerkingen en symptoomverergering waren zeldzaam en de uitval was mini-
maal. We hopen daarnaast met het therapeutrotatie-model zoals geïntroduceerd 
in onze studies, waar zowel therapeuten en patiënten tevreden over zijn, de 
verspreiding en het gebruik van (intensieve) traumagerichte behandeling voor 
volwassenen en voor jongeren die lijden aan (complexe) PTSS te verbeteren.
Share Your Story
169168
ABOUT THE AUTHOR
Lotte (1985) was born and raised in Horssen, a small town in Het land van 
Maas en Waal in the Netherlands. After obtaining her Gymnasium diploma 
in 2003 with a science and engineering-based profile, she found she was more 
inspired by the human mind and human behaviour and moved to Nijmegen to 
pursue a degree in Psychology at the Radboud University. Specialising in the 
field of Clinical Psychology, she received her Bachelor degree in 2006 and was 
accepted into the Behavioural Science Research Master’s programme at the 
same university. Having fulfilled her research internship at the Sexual Violence 
department of the Rutgers Nisso Group (now: Rutgers) sexuality knowledge  
centre, she obtained her Master’s degree in Behavioural Science in 2008. After 
spending a year in India to set up educational and microcredit projects for 
the IndianRose foundation, she was persuaded to come back to the Nether-
lands, where she completed a Clinical Psychology Master’s programme at 
the Radboud University, obtaining her Master’s degree in 2011. Interested in 
pursuing a career in clinical practice, in the same year she started working as a 
psychologist at the Overwaal Centre of Expertise for Anxiety Disorders, OCD 
and PTSD (Pro Persona), but, still loving to combine clinical work and science, 
also started a PhD at the Department of Clinical Psychology of the Radboud 
University, working on a research project funded by ZonMw in 2011. 
During her PhD, she and her colleagues focused on intensive (prolonged) 
exposure treatment programmes targeting highly comorbid PTSD popula-
tions, both adolescent and adult patients with a history of multiple interper-
sonal trauma. Throughout her clinical research she engaged in the treatment of 
children and adults with trauma and stressor-related, dissociative and conver-
sion disorders, finishing the Post-Master's Healthcare Training programme and 
registering as a healthcare (GZ) psychologist in 2017, after which, in 2018, she 
started with the 4-year post-licence training programme specialising as a clin-
ical psychologist. Having the firm conviction that research results must have 
relevance for daily clinical practice, she loves spending time sharing her know-
ledge as a teacher at Cure and Care Development and the Radboud Centre for 
Social Sciences, exchanging ideas with colleagues and patients, and present-
ing her work at various national and international conferences and in several 
invited (keynote) lectures. Translating research findings directly into clinical 
practice, Lotte has been actively involved in the implementation of intensive 
exposure treatment programmes for adolescents and adults with PTSD and, 
with the help of trauma-exposed children, has developed a website to help clini-
cians ask the right questions about potential childhood trauma and its conse-
quences, which project was funded by ZonMw (www.rakevragen.nu). 
As for the immediate and longer-term future, Lotte intends to complete 
her post-licence training, working as a clinical psychologist with a focus on 
expanding the Young Overwaal Department where adolescents with PTSD and 
OCD are offered intensive exposure-based treatments, and to conduct research 
on sexual dysfunctions in patients coping with PTSD. Besides work, Lotte 
Share Your Story
171170
hopes to have enough time left to spend on doing other things she loves: making 
music, writing a children’s book, and travelling, most preferably together with 
the people she loves.
Publications by the author
van Minnen, A., Hendriks, L., de Kleine, R. A., Hendriks, G. J., Verhagen, M., & de Jongh, 
A. (2018). Therapist rotation: a novel approach for implementation of trauma-focused 
treatment in post-traumatic stress disorder. European Journal of Psychotraumatology, 9: 
1492836.
Fleurkens, P., Hendriks, L., & van Minnen, A. (2018). Eye Movement Desensitization and 
Reprocessing (EMDR) in a forensic patient with Posttraumatic Stress Disorder (PTSD) 
resulting from homicide: a case study. The Journal of Forensic Psychiatry & Psychology, 
29, 901-913.
Hendriks, L., de Kleine, R. A., Broekman, T. G., Hendriks, G. J., & van Minnen, A. (2018). 
Intensive prolonged exposure therapy for chronic PTSD patients following multiple trauma 
and multiple treatment attempts. European Journal of Psychotraumatology, 9: 1425574.
Hendriks, L., de Kleine, R. A., Heyvaert, M., Becker, E. S., Hendriks, G. J., & van Minnen, 
A. (2017). Intensive prolonged exposure treatment for adolescent complex posttraumatic 
stress disorder: a single-trial design. Journal of Child Psychology and Psychiatry, 58, 1229-
1238. 
Hendriks, L. (2017). Exposure therapie: nieuwe inzichten. Factsheet Vereniging voor 
Gedrags- en Cognitieve therapieën (VGCt).
Hendriks, L. (2017). Antwoord als expert binnen supervisierubriek van het Nederlandstalige 
Vereniging voor Psychotrauma (NtVP)-tijdschrift Cogiscope over traumascreening bij 
kinderen. 
van Minnen, A., de Kleine, R. A., & Hendriks, L. (2017). Richtlijnen bij moeizaam 
verlopende exposurebehandelingen van patiënten met een PTSS. Directieve Therapie, 37, 
43-62. 
Jacobs, P., Hendriks, L., de Kleine, R. A., Neijenhuis, M., Rinck, M., & van Minnen, A. 
(2017). Expliciete en impliciete zelfwaardering bij patiënten met posttraumatische- 
stressstoornis (PTSS). Directieve Therapie, 37, 286-299.
Hendriks, L. (2017). Hoe herken je PTSS bij kinderen en jongeren? Stel rake vragen! GZ-psy-
chologie 9, 28-29.
de Kleine, R. A., Hendriks, L., Becker, E. S., Broekman, T. G., & van Minnen, A. (2017). 
Harm expectancy violation during exposure therapy for posttraumatic stress disorder. 
Journal of Anxiety Disorders, 49, 48-52.
van Minnen, A., de Kleine, R. A., & Hendriks, L. (2017). Richtlijnen bij moeizaam 
verlopende exposurebehandelingen van patiënten met een PTSS. In G. P. J. Keijsers, A. van 
Minnen, M. J. P. M. Verbraak, C. A. L. Hoogduin, en P.M.G. Emmelkamp (red.), Protocol-
laire behandelingen voor volwassenen met Psychische klachten 1-3 (pp. 370-389). Amster-
dam: Uitgeverij Boom.
Hendriks, L. (2016). Antwoord als expert binnen supervisierubriek van het NtVP-tijdschrift 
Cogiscope over de werking van het geheugen.
Hendriks, L. (2016). Position paper: Goede behandeling maar een te lage dosering? 
Geschreven t.b.v. rondetafelgesprek Kamercommissie Ministerie van Volksgezondheid, 
Welzijn en Sport (VWS) ‘Jongeren en hun geestelijke gezondheid’. https://www.tweedeka-
mer.nl/vergaderingen/commissievergaderingen/details?id=2016A02614
Hendriks, L., de Kleine, R. A., Hendriks, G. J., & van Minnen, A. (2016). Intensive cogni-
tive-behavioral treatment of PTSD: An overview of massed outpatient treatment programs. 
In C. R. Martin, V. R. Preedy and V. B. Patel (Eds.), Comprehensive guide to post-traumatic 
stress disorder (pp. 1-16). Cham, Switzerland: Springer International.
Hendriks, L., de Kleine, R. A., van Rees, M., Bult, C., & van Minnen, A. (2010). Feasibility 
of brief intensive exposure therapy for PTSD patients with childhood sexual abuse: a brief 
clinical report. European Journal of Psychotraumatology, 1: 5626.
Hendriks, L., de Kleine, R. A., van Rees, M., & van Minnen, A. (2011). Een alternatieve 
kijk op de therapeutische houding bij de behandeling van PTSS. Directieve Therapie, 31, 
382-397. 
van Minnen, A., Hendriks, L. & Olff, M. (2010). When do trauma experts choose exposure 
therapy for PTSD patients? A controlled study of therapist and patient factors. Behaviour 
Research and Therapy, 48, 312-320. 
Hendriks, L. & Höing, M. (2008). Kwaliteitsinstrumenten voor zelfhulpgroepen seksueel en 
huiselijk geweld. Utrecht: Rutgers Nisso Groep.
Acknowledgement
173172
DANKWOORD (ACKNOWLEDGEMENT)
Er zijn zoveel mensen die een belangrijke rol in mijn leven hebben gespeeld de 
afgelopen acht jaar. Voor sommige is deze rol nauw verbonden met dit proef-
schrift, voor andere was hun bijdrage indirecter maar daardoor zeker niet 
minder belangrijk. Voor iedereen – patiënten, maar ook mijn collega’s, vrienden 
en familie – geldt dat ze hun eigen verhaal hebben. Verhalen die me de afgelo-
pen jaren inzicht, hoop, troost en inspiratie boden. Ik ben ontzettend blij met de 
mensen om me heen en hoop dat ik jullie in dit dankwoord niks nieuws vertel 
maar vooral vastleg wat eerder al is uitgesproken. Dit proefschrift is een weten-
schappelijke vertaling van alle verhalen van een deel van jullie, namelijk de pati-
enten en hun naasten die ik de afgelopen 8 jaar heb mogen ontmoeten. Verhalen 
die hard en bitter waren, maar tegelijkertijd bol stonden van veerkracht en 
hoop. Dankjewel dat jullie de moed hadden om jullie verhalen te delen, zonder 
jullie was dit proefschrift er niet geweest.
(Co)promotoren
Agnes, zonder jou zwierf ik waarschijnlijk nog ergens in India rond met mijn 
backpack op mijn rug en was dit proefschrift er vast gekomen maar zeker niet 
door mij geschreven. Je bent mijn leermeester en ik ben je dankbaar voor alle 
kansen die je mij in die hoedanigheid hebt gegeven. Door jouw deskundigheid, 
je hoge lat, en je tomeloze geduld en ruimte wanneer ik te eigenwijs was om je 
adviezen op te volgen kon ik groeien tot de onderzoeker die ik nu ben. Je hebt 
daarnaast de bijzondere eigenschap dat je – als het even zwaar was op werk of 
daarbuiten – met slechts enkele woorden me altijd weer energie en moed weet 
te geven om door te gaan. Eni, dankjewel dat je altijd die pilaar van dit bouw-
werk bleef waarop ik terug kon vallen. Als de boel ging wiebelen – op wat voor 
een manier dan ook – zorgde jouw stevigheid, structuur en nuchterheid ervoor 
dat alles bleef staan. Je bent iemand die knopen durft door te hakken en van 
koers durft te wijzigen alsof je een pak melk koopt, waardoor je soms bijna 
vergeet hoeveel lef daar voor nodig is. Gert-Jan, dankjewel voor (het uitdragen 
van) je steun binnen onze organisatie waar zeker in het begin lang niet iedereen 
geloofde in dit onderzoek. Je bent altijd voor mij en onze onderzoekslijn opge-
komen, hielp me met strategische adviezen en accepteerde dat ik te emotioneel 
ben om deze adequaat op te volgen. Je bent iemand die de deur altijd voor me 
open houdt, ook nadat ik deze boos dicht had geknald als we het heel erg met 
elkaar oneens waren.
(Stille) krachtpatsers achter dit proefschrift
Theo, het is ongelofelijk hoe stoïcijns jij bent gebleven onder mijn ongeduld. 
Dankjewel dat je in de vele uren dat we de data geanalyseerd hebben me steeds 
geduldig hebt meegenomen in je uiterst precieze analyses. Ik heb veel van je 
geleerd. Suzéh en Zoë, jullie zijn wellicht al vergeten dat er ook nog een proef-
schrift moest komen want het is al weer jaren geleden dat jullie al mijn folders 
en vragenlijsten hebben doorgenomen om de toegankelijkheid te beoordelen 
voordat we daadwerkelijk met alle studies zijn gestart. Maar hier is dan het 
eindresultaat, dankjewel voor jullie kritische blik. Hanneke, dankjewel voor 
het redigeren van de Engelstalige teksten, Elske dankjewel voor het doorspitten 
van de Nederlandse onderdelen van dit proefschrift. Jullie corrigeren niet alleen 
maar geven daarnaast jullie liefde voor taal door. Dankjewel dat jullie meezoch-
ten naar de juiste woorden voor alle verhalen. Lieve Veerle, dankjewel dat je 
me wilde fotograferen voor dit proefschrift. Je weet op liefdevolle wijze mensen 
vast te leggen zoals ze daadwerkelijk zijn. Rémi en de rest van Dolly Warhol, 
wat word ik blij van jullie ideeën. Lieve Rémi, door jouw creativiteit waren 
de laatste loodjes van dit proefschrift vooral feestelijk. Dankjewel dat je mijn 
gevoel hebt gevangen in beeld. Wat mij betreft is dit proefschrift pas de start van 
een verdere samenwerking.
Collega’s
Als ik iedereen bij naam probeer te noemen ga ik geheid mensen vergeten en ik 
word verschrikkelijk nerveus bij dat idee. Er zijn enkele samenwerkingsverban-
den die ik graag wil noemen en enkele collega’s die ik persoonlijk wil bedanken. 
Zullen we afspreken dat als je je naam niet los vermeld ziet staan maar wel wil 
weten wat je voor me betekent, je dit gewoon aan me vraagt? Zonder gekheid, 
daar zouden we echt wat schaamtelozer in mogen worden wat mij betreft. 
Lieve Overwaal-collega’s (van vroeger en nu), dankjewel voor alle steun de 
afgelopen jaren in de vorm van het daadwerkelijk uitvoeren van de behandelses-
sies (ITB-team, yeah!), alle secretariële ondersteuning, en het bemoedigend knik-
ken op de voorste rij tijdens mijn eerste onderzoeks-presentaties. Wat zijn jullie 
toch een enthousiast en inspirerend zooitje bij elkaar! Ik ben daarnaast dank-
baar voor al jullie warmte op de momenten dat mijn (privé)leven abrupt door 
elkaar werd geschud. Mirjam, het inspireert me hoe jij altijd grond voor samen-
werking weet te vinden, hoe ver mensen ook uit elkaar staan. Ik word altijd blij 
van onze momenten samen waarin we onderzoeks- of beleidsideeën bespreken, 
of het nu boven een dampende cappuccino op vrijdag in Spinoza is, starend naar 
de zeeleeuwen in San Francisco of bibberend in Bergen. Susan, dankjewel voor 
alles wat je me op het gebied van psychotherapie geleerd hebt, je bent hierin 
mijn grote voorbeeld. Dit heeft me niet alleen een betere therapeut maar ook een 
scherpere onderzoeker gemaakt. Je hebt een enorm open blik op de wereld – vrij 
van taboes en vooroordelen. Ik kan me dan ook niemand anders voorstellen die 
beter dan jij onze lang gedroomde seksuologie-lijn kan uitzetten. Ik verheug me 
enorm op de tijd die nu vrij gaat komen om samen (nog meer) seks-taboes te 
doorbreken. Het is een cadeau dat onze samenwerking is uitgegroeid tot een zeer 
dierbare vriendschap. Lieve Manon P., jouw steun is niet te vangen in woorden 
hier, parallel aan hoe ik dat heb ervaren de afgelopen jaren. Een blik over en 
weer, een knuffel, of even die hand op een schouder. In een beroepsgroep waar 
zoveel gekletst wordt, is het een verademing om soms even samen te zwijgen. 
Dankjewel dat ik (ook) mocht putten uit jouw veerkracht.
Pro Persona Research-collega’s, dankjewel voor de ruimte en vrijheid die 
jullie creëren om onderzoek uit te voeren. Het was een cadeau om deze studies te 
Acknowledgement
175174
mogen vormgeven, uitvoeren en beschrijven zonder voortdurend druk of haast 
te ervaren. Ik zie met terugwerkende kracht steeds beter dat dit geen vanzelf-
sprekendheid is binnen de onderzoekswereld. Mijn speciale dank gaat uit naar 
alle secretariële ondersteuning (Anja, Ans en Astrid), onderzoeksassistenten en 
stagiaires. Jullie zijn de onmisbare krachten binnen onze afdeling. Boris, je bent 
één van mijn intelligentste collega’s die het vertikt om daar ook maar enigszins 
mee te koop te lopen. In een (onderzoeks)wereld waarbij het soms vooral lijkt te 
draaien om de beste prestaties, geef je me altijd het gevoel dat het goed is zoals 
het gaat en dat ik mag zijn wie ik ben. Dankjewel voor alle gesprekken tijdens 
de vele koppen koffie die we hebben gedronken. Julie, wat bijzonder dat we na 
al die jaren van de dans- naar de werkvloer zijn verschoven, ik heb zin om na 
alle drukte van het afgelopen jaar ruimte te gaan vinden om de soepelheid van 
destijds op het podium ook op werk door te voeren. Cindy, de uren die jij in dit 
proefschrift hebt gestoken zijn denk ik vergelijkbaar met die van mij. Dankjewel 
voor alle klinische interviews die je hebt afgenomen, het aansturen van de stagi-
aires, de data die je hebt ingevoerd en de dossiers die je opnieuw bent ingedoken. 
Als ik verdronk in onoverzichtelijkheid, bracht jij in korte tijd structuur aan. Je 
bent een parel! Marc, wat ben ik blij met onze onderzoekssamenwerking binnen 
de jeugdafdelingen. Ik krijg energie van je consequente focus op de inhoud en de 
voortdurende verbinding die je maakt met de klinische praktijk. Door de manier 
waarop je de bestaande hiërarchieën ondergeschikt maakt aan inhoudelijke 
ingevingen creëer je tijdens overleg een sfeer waarbij iedereen zijn ideeën durft in 
te brengen. Dankjewel voor de vrijheid en het vertrouwen dat je hiermee geeft.     
Collega’s van de vakgroep klinische psychologie aan de Radboud Universi-
teit, dankjewel dat jullie mij – als buitenpromovenda – altijd het gevoel hebben 
gegeven dat ik er bij hoor. Ook al ben ik weken afwezig vanwege patiëntenzorg, 
jullie sleepten me er altijd weer bij tijdens uitjes en schrijfweken. Dankjewel 
voor de zekerheid die jullie me gaven om altijd op de labgroup terug te kunnen 
vallen, zowel voor deskundig advies als voor een dans en een borrel. Nessa, 
dankjewel voor de belangrijke rol die je hierin gespeeld hebt. Je bent één van de 
meest onbaatzuchtige onderzoekers die ik ken en ik verheug me op onze verdere 
samenwerking.
Kairos-collega’s, jullie hebben het staartje meegemaakt van deze lange 
promotie-jaren. Een hectische periode om van werkplek te wisselen waarbij 
ik makkelijk als opleideling slechts een passant had kunnen zijn binnen jullie 
team. Niks bleek minder waar, wat hebben jullie me opgenomen in jullie stoere 
cowboy-club. Dankjewel voor de nieuwe invalshoeken die jullie me hebben 
gegeven binnen de zorg, die ik ook weer kan laten doorsijpelen in mijn onder-
zoekswerk. Ik leer ontzettend veel van jullie allemaal. Manon H., wat heerlijk 
dat onze wegen na al die jaren weer kruisen. Je bent iemand met wie je in alle 
vrijheid je successen, blunders en angsten kan delen en ik leer iedere dag veel van 
je ideeën hierover.
De waarde van onderzoek sijpelt weg wanneer resultaten niet worden geïm-
plementeerd in het dagelijks leven. Rolf, dankjewel voor je samenwerking 
binnen het rakevragen-project. Mede dankzij jouw gevoel voor stijl en taal glun-
der ik nog iedere keer wanneer ik het eindproduct zie. Rik, als het gaat om het 
verbinden van wetenschap en praktijk ben jij wat mij betreft het grote voorbeeld. 
Ik bewonder de manier waarop jij je inzet voor het verbeteren van de zorg. Je 
bent hierin net zo zichtbaar als bescheiden, een weinig voorkomende combinatie 
waar ik veel respect voor heb.
Vrienden
Lieve, lieve Saar, je bent er, altijd! Of het nu om het mooie te vieren is of om te 
troosten. Dat is een heerlijke zekerheid. Ik denk niet dat er veel mensen zijn die 
in barre tijden pakjes rozijnen voor de voordeur neerzetten. Naast jouw zorg-
zaamheid heb je een enorm vermogen tot reflectie waarbij je jezelf en de ander 
niet spaart. Ik koester onze wandelingen waarin we al analyserend steeds een 
beetje meer van de wereld en onszelf (denken te) begrijpen. 
Janna, Laura, Renske, Elske, Mirjam, en Gerwin wat hebben we veel nach-
ten met elkaar vol gedanst. In Dio en Roosje, op Down The Rabbit Hole, in 
obscure kelders in Keulen, tijdens de zomerfeesten, op literaire feestjes en op 
Ibiza om na te korte nachten vervolgens uren te ontbijten tot in de late middag. 
Je zou bijna vergeten dat de voorliefde voor het uitvoeren van onderzoek onze 
kern ooit bij elkaar heeft gebracht. Dat dit naar de achtergrond is verdwenen, is 
denk ik precies waar onze kracht zit. We focussen vooral op waar het daadwer-
kelijk om draait in het leven: samen zijn. Ook als het even geen feest is. Ik ben 
jullie ontzettend dankbaar voor al jullie liefde.
Nienke, wat een verademing om een hysterische wederhelft te vinden binnen 
het werkveld. Soms weet je het direct als je iemand aankijkt: ook vriendschap 
kan liefde op het eerste gezicht zijn. Wat gaf ik graag samen therapie met je, 
waarbij we niks van te voren hoefden af te stemmen. We zitten op dezelfde 
frequentie. Je bent – of het nu tijdens werk of er buiten is – nooit een andere 
versie van jezelf, dat is een groot goed waar ik veel bewondering voor heb. Ik 
koester de vriendschap die ontstaan is waarbij ik heel veel steun haal uit de 
ongepolijste manier waarop we onze verhalen blijven delen. 
Pascal, er zijn volgens mij geen andere mensen met wie ik de ochtend na 
een avond stappen, in de kreukels, met een te grote mok koffie al verschillende 
malen de hele GGZ hervormd heb. Je bent niet het type dat bij iedere windvlaag 
een knuffel komt geven maar wel diegene die dezelfde avond vanuit de andere 
kant van het land komt als de boel echt overstroomt. Ik ben je heel erg dank-
baar dat je er direct bent als het echt nodig is.
Anke en Suzan, we gaan al een leven lang met elkaar mee. Ook al hebben 
we alle drie andere paden gekozen, de verbinding blijft altijd stevig verankerd. 
Ondanks dat de afstand in het dagelijks leven wat groter is geworden, weten 
we elkaar op de momenten die er toe doen altijd direct te vinden. Tijdens ieders 
hoge pieken en diepe dalen was ik dankbaar voor de vanzelfsprekendheid die er 
in elkaars steun lag.    
Als je promoveren ziet als het managen van een project, dan liggen mijn 
eerste ervaringen met een dergelijke verantwoordelijkheid in India. Michel en 
Louise, dankjewel voor het vertrouwen dat jullie hadden in Gijs en mij toen wij 
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ruim tien jaar geleden met een stapel projectvoorstellen namens stichting Indi-
anRose in het vliegtuig stapten. Ik heb onbeschrijfelijk veel geleerd van jullie 
open blik op culturele verschillen. Onze project-ervaringen daar hebben alle 
moeilijke momenten tijdens mijn promotieproject hier vlotjes gerelativeerd.  
Ik koester onze vriendschap die gegroeid is uit deze samenwerking.
Hedwig, er is niemand met wie ik de nacht zo lang kan rekken. Ik bewon-
der je filter-loze associatieve geest en hoop dat we nog vaak samen de zon zien 
opkomen.
John, wat ben ik blij met jou als muziekleraar. Er is niks wat me zo losmaakt 
van alles wat nog moet gebeuren en wat zo’n troostende werking heeft, als 
mezelf verliezen in de stukken die we spelen. Je lessen hebben de laatste jaren 
van mijn proefschrift lichter gemaakt.
Lieve buren van vroeger en nu, Jan, Kasia, Jeroen, Jorine, Anne en Jaimy 
wat hebben we veel taarten, wijntjes, koffie en Ottolenghi-recepten gedeeld. 
Dankjewel voor alle momenten samen, jullie zijn stuk voor stuk mensen die we 
’s nachts wakker kunnen maken als het nodig is.
Paranimfen
Janna, wat is het fijn om iemand zo dicht bij je te hebben staan. Je kent me in 
al mijn vormen en met al mijn onhebbelijkheden en toch laat je me nooit gaan. 
Onze levens zijn op zo veel verschillende manieren met elkaar verbonden, met 
verschillende (ook professionele) rollen en ik ben blij dat we een balans hebben 
gevonden waarbij we deze rollen kunnen onderscheiden terwijl onze verbinding 
blijft. Mijn dank voor jou betreft denk ik het breedste spectrum. Er is niemand 
anders die me zowel deskundige adviezen met betrekking tot mijn proefschrift 
heeft gegeven als die me ook ’s nachts een Elmo T-shirt aantrekt, mijn lenzen in 
twee kopjes met vloeistof doet en me over mijn rug in slaap aait als dat zelf alle-
maal echt even niet meer lukt.
Rianne, dankjewel dat je altijd in mij als onderzoeker geloofd hebt, ook 
als ik dat zelf even niet meer deed. Je bent een enorme steun geweest tijdens de 
afgelopen jaren. Er is niemand met wie ik zo vanzelfsprekend en complementair 
heb samengewerkt en bij wie over en weer het succes van de ander net zo groot 
voelt als het succes van jezelf. Ik mis je ontzettend op de werkvloer maar ben 
dankbaar voor onze hechte vriendschap die blijft. 
Thuisfront
Lieve Maritte, wij kunnen alles samen aan. We hebben veel gewonnen en helaas 
ook verloren maar er is altijd het vertrouwen dat we het samen wel redden. 
Toen we ruim 20 jaar geleden stilletjes naast elkaar schoven in de schoolbanken 
voelde het direct vanzelfsprekend samen. Wat hebben we vervolgens vaak naast 
elkaar gezeten, op school, tijdens concerten, starend over de Waal, moe na uren 
dansen, benauwd tijdens de cultfilms in Lux, zwijgend met koffie op het balkon 
omdat er even geen woorden nodig waren, met je hand op mijn haar toen we 
afscheid moesten nemen van diegene van wie we zoveel houden. Je bent me 
ontzettend dierbaar. 
Lieve Janneke, dankjewel voor de doener die je was. Dat je me op gezette 
tijden uit mijn hoofd sleurde en me weer in het hier en nu plantte. Door je 
afwezigheid ben je gek genoeg eigenlijk altijd bij me. De relativering die eerder 
vanuit jou kwam, kan ik dankzij jou nu uit mezelf halen, al resoneert het nog 
altijd met de klank van jouw stem. Je was altijd ontzettend trots op de onder-
zoekslijn die nu beschreven staat in dit boekje maar de rituelen van de verdedi-
ging vond je maar overdreven. In mijn gedachten zit je straks op de eerste rij je 
wenkbrauw omhoog trekkend zoals alleen jij dat kon. 
Luuk, wat is het fijn om een broer te hebben die je met een blik en een half 
woord begrijpt. Zoals je eerder (ere wie ere toekomt) in jouw proefschrift 
schreef, kijken we op dezelfde kritische manier tegen de onderzoekswereld aan 
en zijn we wars van de spelletjes die daar gespeeld kunnen worden. Ik ben trots 
op hoe jij bij jezelf blijft hierin en je eigen keuzes blijft maken. Je weet wat echt 
belangrijk is in het leven – de mensen van wie je houdt –  en ik vind het heer-
lijk dat naarmate we ouder worden deze mensen en daarmee onze levens steeds 
meer mengen.   
Lieve pap en mam, dat Luuk en ik onze eigen keuzes durven te maken los 
van de groep, hebben we aan jullie te danken. Dankjewel dat jullie me het 
vertrouwen hebben gegeven dat je altijd jezelf mag zijn, ook als dit afwijkt van 
een maatschappelijke norm. Door jullie kan ik autonome keuzes maken in mijn 
leven, ook binnen mijn (onderzoeks)werk. Door ditzelfde werk weet ik dat het 
absoluut geen vanzelfsprekendheid is om zoveel veiligheid en liefde te krijgen 
thuis als dat wij hebben gehad. Dankjewel voor jullie warmte.
Gijs, het komt vaak voor dat ik ’s ochtends wakker word, naar je kijk, en 
ontzettend dankbaar ben dat je er bent. Je haalt een zachtere versie van me naar 
boven door alleen maar jezelf te zijn. Waar onze reizen ook naar toe gaan en 
hoe ons verhaal verder ook zal verlopen, bij jou ben ik thuis.


